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Cerebral parese i Norge - forekomst, undertyper og 
alvorlighetsgrad 
Cerebral parese (CP) er fortsatt den vanligste årsak til varig motorisk 
funksjonsnedsettelse hos barn. Det finnes ingen tidligere nasjonale studier som 
beskriver panoramaet av undertyper, alvorlighetsgrad eller risikofaktorer hos barn 
med CP i Norge. Dette er en populasjonsbasert studie av én fødselskohort, barn 
født 1996-1998, i Norge. Disse barna er registrert i Cerebral pareseregisteret i 
Norge. Definisjonen av CP og klassifikasjonen av de enkelte undertyper er den 
samme som er anbefalt og benyttes av Surveillance of Cerebral Palsy in Europe 
(SCPE).  
Studien viste at forekomsten av CP i Norge var 2.1 per 1000 levende fødte, 
likt det som er funnet i andre sammenlignbare populasjoner. De fleste var 
klassifisert i undertypen spastisk bilateral (49 %), ca. en tredel (33%) i spastisk 
unilateral og mindre enn 10% i undertypene dyskinesi eller ataksi. Både denne 
fordelingen av de ulike CP undertyper og fordelingen av grader av grovmotoriske 
vansker var i samsvar med det som er funnet i andre vestlige land. Flere barn i 
denne studien hadde fin motoriske vansker og tilleggsvansker. Som tilleggsvansker 
regnet vi både talevansker og spisevansker samt syn- og hørselshemming, kognitive 
vansker og behandlingstrengende epilepsi.  
 Vi fant at både seteleie og igangsetting av fødsel var uavhengige 
risikofaktorer for CP. Det var en signifikant økning av risiko for å få CP hvis barnet 
ved forløsningstidspunktet lå i seteleie sammenlignet med hodeleie 
(bakhodefødsel). Risikoen var høyest blant enkeltfødte forløst vaginalt til termin. 
Seteleie var imidlertid ikke forbundet med spesielle undertyper CP eller grader av 
grov- eller fin- motoriske vansker. Det var også økt risiko for CP hos de barna der 
fødselen ble igangsatt. Etter igangsetting av fødsel var det en større andel av barna 
som fikk spastisk bilateral CP og, hos de født til termin, som hadde spastisitet i både 
armer og ben (alle fire ekstremiteter). 
 Da vi undersøkte ulike risikofaktorer (sykdom hos mor, kunstig befruktning, 
unormale forhold ved morkake, blødning i svangerskapet, veksthemming, avvikende 
leie (ikke bakhodeleie), lav Apgar (<7 ved 5 min) og prematur fødsel) fant vi at en 
økning av antall risikofaktorer var forbundet en eksponentiell økning av risiko for 
CP. Kombinasjoner av risikofaktorer var vanligere hos de premature enn hos barn 
født til termin. I begge grupper (barn født prematurt og barn født til termin) var det 
få barn med CP som hadde de samme risikofaktorene.  
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Summary 
Cerebral palsy (CP) is still the most common cause of chronic motor disability in 
childhood. Until now, there has not been any previous national study of the 
panorama of subtypes, severity or risk factors among children with CP in Norway. 
This is a population based study of a cohort of children with CP born 1996 to 1998 in 
Norway. These children are recorded in the Cerebral Palsy Register of Norway. The 
CP definition and classification system agreed on by the Surveillance of Cerebral 
Palsy in Europe (SCPE) are applied. The study showed that the prevalence of CP in 
Norway was 2.1 per 1000 live births, comparable with other similar populations.  
Most children were classified in the spastic bilateral subtype (49%), about 
one third (33%) in the spastic unilateral subtype and less than 10% in the dyskinetic 
or in the ataxic subtype. Both the distribution of subtypes and gross motor function 
impairments were comparable with other populations in developed countries. More 
children in our study had fine motor function impairments, as well as associated 
impairments. The associated impairments included both impairment of speech and 
feeding, in addition to impairments of vision, hearing, cognition and presence of 
active epilepsy. 
 We identified both breech presentation and induction of labour as 
independent risk factors for CP.  There was a significant increased risk of CP in 
children born in breech presentation compared to vertex presentation, in particular 
for singletons born at term by vaginal delivery. Breech presentation was however not 
associated with specific subtypes of CP or with the extent of gross or fine motor 
impairments. There was also an increased risk for CP in children after induction of 
labour. Induction of labour was associated with a higher proportion of children with 
the bilateral spastic subtype as well as in those born at term with four-limb 
involvement. 
 When we studied multiple risk factors (maternal disease, assisted 
fertilization, plurality, abnormal placental structure, bleeding in pregnancy, small for 
gestational age, abnormal presentation, Apgar score at 5 minutes <7 and preterm 
birth) we found that increasing number of risk factors were associated with an 
exponentially increased risk for CP. Combinations of these risk factors were more 
14 
 
common in children born preterm, while both among term and preterm born children, 
few shared the same combinations of risk factors.    
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Introduction and background 
1.1 Historical perspective 
“But I, that am not shaped for sportive tricks, 
Nor made to court an amorous looking-glass; 
I, that am rudely stamp'd, and want love's majesty 
To strut before a wanton ambling nymph; 
I, that am curtail'd of this fair proportion, 
Cheated of feature by dissembling nature, 
Deformed, unfinish'd, sent before my time” 
This quote is taken from William Shakespeare (1564-1616), and is said by 
Gloucester, later King Richard, Act 1, The tragedy of Richard III. It is suggested to 
be the oldest association of prematurity (“sent before his time”) and deformities 
(“deformed and unfinished”). About 250 years later a British orthopaedic surgeon by 
the name of William John Little (1810-94), also argued that prematurity and adverse 
events leading to perinatal asphyxia could cause poor outcomes later on in life.(1) 
Little originally reported this in 1843 as he described in his course of lectures at the 
Royal Orthopaedic Hospital in London a condition of “spastic rigidity of the limbs of 
newborn children”.(2) In speaking to the obstetricians he stressed the importance of 
birth injuries and of neonatal abnormalities. His description of the syndrome was 
very complete and accurate, and by the end of the 19
th
 century it was widely known 
as Little‟s disease.(3) Little also stressed the frequency of mental impairment, speech 
defects, difficulties in feeding and swallowing,  functional disabilities of the upper 
limbs, constipation and the typical deformities in the lower limbs.(4)  
 Sir William Osler (1849-1919) introduces the concept “cerebral palsy” in his 
book The Cerebral palsies of Children.(5) He described this nonprogressive 
neuromuscular disease in children in his clinical study of children at the Infirmary for 
Nervous Diseases in Philadelphia, Pennsylvania. At the same time Sigmund Freud 
(1856-1939) expanded the clinical description of cerebral palsy and concluded that 
the condition was not a single disease but a collection of motor disorders related to 
lesions of the brain, originating during either infancy or birth.(6) He could however 
not find any neuropathological lesion that correlated with his clinical findings. 
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In a case report from 1912 by Sutherland in “Proceeding of the Royal Society 
of Medicine” a “Case of cerebral palsy” is described as follows: 
“E.C: MALE, aged 1 year. Born at full term; first child; normal labor without 
instruments. Child weighed 9 lb. breast-fed for six weeks, then cows’ milk and 
barley water. Became a fat child. At the age of 7 months began to have 
screaming attacks, drawing up his legs and twitching of head and eyes. At the 
age of 10 months had a series of general convulsions, lasting for 2 days, about 
nine each day. Since then has had an occasional general convulsion. Child is 
very fat and flabby. Face and head look large viewed from the front, but there is 
much flattening in the pantero-postero diameter, producing a brachy-cephalic 
condition. Constant jerking movements of the head, trunk and extremities take 
place, spasmodic and purposeless. He takes no notice of what is going on, 
seldom cries, and never smiles. He is unable to sit up, or to support himself 
sitting up, or to balance his head. The pupils react to light, and there is ocular 
paralysis or nystagmus. The fundi are normal. Vision is apparently present, but 
hearing seems absent.”(7) 
From this thorough description it is obvious that the doctors even at that time 
were very aware of the many aspects and consequences of a diagnosis of CP. They 
were however often pessimistic as to the prognosis. Little‟s answer to the question 
“Are these children worth all the effort and money spent on them?” was ”I have had 
many cases under observation from one to twenty years and may mention as an 
encouragement to other practitioners that treatment based upon physiology and 
rational therapeutics affects an amelioration surprising to those who have not 
watched such cases. Many of the most helpless have been restored to considerable 
activity and enjoyment of life”.(4)  
From the 1940s it is known that the founders of the American Academy for 
Cerebral Palsy and Developmental Medicine in the USA as well as the members of 
The Little Club in the UK moved the concepts and descriptions of CP forward. The 
problem that they and others ran into was how to define and classify CP further. 
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In 1959 MacKeith and Polani defined CP as “… a persisting but not 
unchanging disorder of movement and posture, appearing in the early years of life 
and due to a non-progressive disorder of the brain, the result of interference during 
its development.(8) 
Bax in 1964 suggested a new definition based upon the work of an 
international group.(9) This definition has become classic and is still often used: “CP 
is a disorder of movement and posture due to a defect or lesion of the immature 
brain.” Bax also added some “exclusion criteria”:1) disturbances of short duration 2) 
disturbances due to progressive disease and 3) disturbances solely due to mental 
deficiency.”(9) Still the definition was broad and allowed for many different 
disorders to be covered by the definition. This led Mutch, Hagberg and colleagues to 
modify the definition even further as they emphasized in their definition from 1992 
to include motor impairment and its variability, as well as the exclusion of 
progressive disease.(10) 
 In 1998 a collaborative network for cerebral palsy registers and surveys in 14 
centres in 8 countries across Europe was formed, “The Surveillance of Cerebral palsy 
in Europe”(SCPE). The aim of the network was “to develop a central database of 
children with cerebral palsy in order to monitor trends in birth weight specific rates, 
to provide information for service planning and to provide a frame work for 
collaborative research.”(11) One of the main issues of the network was “to agree on 
a definition for CP, to define inclusion and exclusion criteria, agree on a 
classification system, and define ways of describing levels of disability.”  
 
 
 
 
The SCPE definition includes five key elements: ”CP is a group of disorders 
i.e. it is an umbrella term; it is permanent but not unchanging; it involves a disorder 
of movement and/or posture and of motor function; it is due to a non- progressive 
The SCPE definition/description of cerebral palsy from 2000: 
 CP is a group of disorders i.e. it is an umbrella term; It is permanent but not 
unchanging; it involves a disorder of movement and/or posture and of motor 
function; it is due to a non-progressive interference/lesion/abnormality; this 
interference/lesion/abnormality is in the developing/immature brain. 
 
Surveillance of Cerebral Palsy in Europe, 2000 (11) 
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interference/lesion/abnormality; this interference/lesion/abnormality is in the 
developing/immature brain.” This SCPE definition agreed on in 2000 is the 
definition of CP applied further in this thesis.  
This definition or rather description also emphasizes the motor impairment as 
a key element but does not exclude other difficulties (“it involves a disorder of 
movement and/or posture and of motor function”). In 2004 an international group 
started work on updating the definition and classification of cerebral palsy “in light 
of emerging understanding of developmental neurobiology and changing concepts 
about impairments, functional status and participation.”(12)  
  
 
 
 
 
 
This “new” definition/description is very similar to the original SCPE 
definition, but has two additional important issues. First, “activity limitation” was 
added to exclude the disorders of movement and posture not associated with activity 
limitation. “Activity limitation”  is used in the terminology of the ICF (The World 
Health Organization‟s International Classification of Functioning, Disability and 
Health (ICF)) in the understanding” …difficulties an individual may have in 
executing activities” amplifies the previous concept of “disability”.(13) Secondly, 
this new definition has taken into account what Little also stressed 150 years earlier: 
“The motor disorders of cerebral palsy are often accompanied by disturbances of 
sensation, cognition, communication, perception, and/or behaviour, and /or by a 
seizure disorder.”(12)  
From the aforementioned text it is clear that the diagnosis of CP has been and 
still is a clinical diagnosis. It is also clear that CP is a heterogeneous condition with 
The definition of cerebral palsy from 2005: 
 Cerebral palsy ( CP) describes a group of disorders of the development of 
movement and posture, causing activity limitation that are attributed to non-
progressive disturbances that occurred in the developing fetal or infant brain. 
The motor disorders of cerebral palsy are often accompanied by disturbances 
of sensation, cognition, communication, perception, and/or behavior, and /or 
by a seizure disorder. 
Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D; 
Executive Committee for the Definition of Cerebral Palsy, 2005(12) 
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regards to both etiology and impairment types and severities. The etiological aspect 
of the CP definition is represented in the terms “…due to a non-progressive 
interference/lesion/abnormality; this interference/lesion/abnormality is in the 
developing/immature brain” and “…attributed to non-progressive disturbances that 
occurred in the developing foetal or infant brain.”(11;12)  
Interference/lesion/abnormality or disturbance refers to specific processes or 
events that interrupt, damage or influence the expected patterns of human brain 
maturation resulting in permanent (but non-progressive) impairment of the brain.(12) 
The terms “developing” or “immature” reflect the idea that disturbances that occur 
very early in human biological development have different impacts on motor 
function than disturbances that occur later. The maximum time limit or age for this to 
take place in order to diagnose it as CP is not precisely defined, but there is a general 
agreement that the “disturbance” must take place before function has developed for 
each considered function (walking, hand function etc).  Therefore, the age range of 
2-3 years is generally accepted.(14;15) Lesions/disturbances occurring after the age 
of 2-3 years are generally not designated as CP. In this thesis children with brain 
damage occurring after 2 years of age are not included as CP. 
 
1.2 Definition 
The definition/description of CP developed by the SCPE is applied in all of the 
papers included in this thesis: “CP is a group of disorders i.e. it is an umbrella term; 
it is permanent but not unchanging; it involves a disorder of movement and/or 
posture and of motor function; it is due to a non- progressive 
interference/lesion/abnormality; this interference/lesion/abnormality is in the 
developing/immature brain”.(11) 
Because neurological signs can be transitory or change, a progressive disease 
that starts early and slowly progresses takes time to be revealed as clearly 
progressive. This means that early diagnosis of CP can be difficult. The diagnosis 
therefore has to be confirmed by the age of at least four years.(12)  
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There is no test (genetic, metabolic or immunologic) or a specific result from 
imaging (MRI, ultrasound) needed to make the diagnosis, the diagnosis is based on a 
clinical examination of the child. A decision tree, developed by the SCPE and 
translated into Norwegian, is applied for inclusion of CP cases in this study.(11) 
(Appendix 1 Decision tree) 
Inclusion criteria 
Children are diagnosed as having CP if they fulfilled the criteria in the SCPE 
definition, at the age of at least 4 years. 
Exclusion criteria 
1. Children in whom a progressive condition is identified  
2. Children with hypotonia as the sole clinical feature 
3. Children with isolated spinal neural tube defects 
 
1.3 Classification 
1.3.1 Subtypes 
From the description of the CP case in 1912, it is clear that there were no 
standardized classification schemes or scales used to describe each case.(6) In recent 
years there has been much effort in the development of good scales for classifying 
the motor function of children with CP, while the classification of associated 
impairments has received much  less attention. There still is a lot of work to be done, 
if at all possible, to agree on how to record or describe it in a standardized way. 
As CP describes “a group of disorders” it also covers a range of clinical 
presentations and impairments. There have been many attempts made to classify CP 
to: 1) describe an individual with CP better with respect to the nature and severity of 
his or her problem, 2) compare series of cases of CP assembled in different places 
and 3) evaluate changes within the same individual with CP at different time 
points.(16) To be reliable, a classification has to be repeatable in relation to the same 
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subject, both by the same and different observers. To be valid it has to label which 
cases may or may not fall into a class according to established references. 
  Even Little back in the 19
th
 century provided accurate descriptions of the 
various types of cerebral palsy, in particular what was later called spastic diplegia.(1) 
 A classification of CP may theoretically be based on aetiology, on 
radiological distribution, on anatomical distribution or on motor abnormalities. As 
will be further explored later in this thesis, CP may result both from the interaction of 
multiple risk factors or, as in many cases, have no apparent identified cause.(17) 
Classification by cause therefore seems unrealistic at present time. A classification 
based on cerebral imaging would expand our understanding of the nature of the brain 
lesions associated with CP, due to the advances in imaging techniques.(18) The 
correlation between cerebral imaging findings and clinical presentation is becoming 
stronger.(19) Still, however 12%- 30% of children with CP have no specific finding 
on an MRI scan.(19-22) The availability of scanning equipment and access to these 
examinations greatly varies between and within countries, making this an unrealistic 
option. 
The previous classification systems have been based on the nature and 
typology of the motor disorder, as well as on the anatomical distribution. The focus 
has been on both the distributional pattern of the affected limb (hemiplegia, diplegia) 
and on the type of tone and movement abnormality (spastic, dyskinetic). 
As mentioned earlier, the SCPE agreed on a classification of CP, which is 
now widely accepted and in use.(11) This also includes a hierarchical tree of the CP 
subtypes. Appendix 2 In this classification system the individuals are classified 
according to the dominating clinical phenomenon. This is to avoid mixed types. The 
SCPE has developed a Reference and Training Manual to ascertain agreement on 
classification of individual cases.(23) The SCPE classification divides CP into three 
groups based on the neuromotor abnormality; spastic, dyskinetic and ataxic. The 
SCPE has also emphasized that it is important to identify the “dominant” motor 
abnormality, the one contributing most to the activity limitation. This view is 
supported by others.(24) The validity and reliability of the SCPE guidelines has been 
tested and it was concluded in a study from 2008 that there was moderate agreement 
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(ĸ=0.59) about inclusion as a CP case.(25) However, the agreement on the 
classification by subtype was poorer and differed in assigning dyskinetic from spastic 
bilateral and judgment of distribution of spastic involvement.(25) Anyway, the 
development of the SCPE has had positive influence in standardizing and recording 
the examination of children with CP and in classifying the subtypes compared to 
previous systems.(26;27) 
To be classified as spastic CP, spasticity has to predominate the clinical 
picture. Spasticity is defined as hypertonia in which resistance to passive movement 
increases with increasing velocity of movement or exhibits a spastic catch.(28;29) 
The spastic CP‟s are further divided into either bilateral or unilateral types depending 
on if one (unilateral) or two sides (bilateral) of the body are involved. Thus, the 
difficulties in differentiating between the quadriplegias, tetraplegias and diplegias is 
eliminated, as was the main problems with the previous classification systems of 
Ingram and Hagberg.(30;31) Some used the term diplegia to describe children with 
spastic CP whose only motor deficit was in the legs, while others included children 
who had arm involvement of lesser severity than leg involvement.(12) The WHO‟s 
International Statistical Classification of Diseases and Related Health Problems 10th 
Revision (ICD 10) also includes the terms quadriplegia and diplegia with no further 
explanation or definition on how to differentiate between them.(32) The problem has 
been whether presence or absence of prematurity, seizures and/or mental retardation 
is relevant in regards to the definitions of diplegia and/or quadriplegia or just an 
association. In a paper from 2003 Colver and Sethumadhavan  discussed this 
problem and are in support of the  SCPE classification system.(33) 
Dyskinesia is further divided into dystonia and choreathetosis depending on 
the type and nature of the involuntary movements.(11) 
The most common subtype is the spastic subtype accounting for 80-90% of 
all children with CP.(34-40) This high proportion of spastic subtype CP cases has 
been stable through the years. The spastic bilateral subtype accounts for about 45-
58% of all CP cases, while the unilateral subtype accounts for 27%-38%.(34-40) The 
distribution of bilateral spastic and unilateral spastic CP varies with the gestational 
age. A higher proportion of preterm born children have the spastic bilateral subtype 
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and a higher proportion of term born children have the spastic unilateral subtype.(41) 
This is mainly explained by the different pathology leading to CP in the different 
gestational age groups.(42) Some authors have experienced an increasing number 
and rate of children with unilateral spastic CP with a simultaneous fall in the number 
and rate of bilateral spastic CP in both preterm and term born babies.(43)  
The dyskinetic subtype accounts for 2-17% of cases.(34-40;44) This subtype 
is associated with lesions at different locations in the immature brain than the spastic 
subtype.(45) In a recent study performed by the SCPE there was an increase in 
prevalence of dyskinetic CP among children born at term. In children born preterm 
they were not able to show any significant increase.(46) 
The least frequent subtype is ataxia which accounts for 2-7% of children with 
CP.(36-40;47) 
 In investigating the interrelationship between gestational age and nosologic 
characteristics (type, distribution and severity) it is found that spastic CP is 
significantly more present in preterm born children than in children born at term, and 
that dyskinetic CP is present remarkably less in preterm born children.(48) 
Furthermore, bilateral spastic CP gradually decreases from 100% in the extreme 
premature group to 50% in the term born infants. Inversely, unilateral spastic CP 
increased with increasing gestational age.(48) 
1.3.2 Gross and fine motor function 
The Gross Motor Function Classification System (GMFCS) in cerebral palsy was 
developed by Palisano and co-workers in 1997.(49;50) This system is based on self- 
initiated movements with emphasis on sitting (truncal control) and walking. The 
focus is to determine which level best represents the child‟s present abilities and 
limitations in motor function. Emphasis is on the child‟s usual performance at home, 
in school and in community settings. This system has shown to be both reliable and 
valid and of prognostic importance.(28;49;50) In addition specific patterns of 
neuroimaging findings in children with CP are also found to be associated with 
specific GMFCS levels.(51) The GMFCS is now widely used and together with the 
SCPE classification of subtypes contributes in the harmonization of subtypes and 
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function of children with CP. The GMFCS system was revised in 2007 to include 
youths 12 to 18 years of age.(52) 
 Attempts have also been made to create a valid classification system for fine 
motor function. The most common way to classify hand function in CP has been to 
use terms like “mild”, “moderate” and “severe” impairment.(53) In addition, House, 
Zancolli and Krägeloh Mann and Beckung have made classification scales for hand 
function in cerebral palsy.(54-57) The Bimanual Fine Motor Function (BFMF) was 
developed with the aim to correspond with the levels of the GMFCS.(57) This 
system takes into account asymmetry and also allows data to be extracted from 
medical records and is still in use by the SCPE.(58) However, it is claimed that along 
with the other scales mentioned above the BFMF does not classify function but 
rather aspects of grasping.(42) None of these scales for assessment of hand function 
have been tested for reliability yet.(42) 
In 2006 a new classification, The Manual Ability Classification System 
(MACS), was designed to classify how children with CP use their hands when 
handling an object in daily activities.(59) The focus of MACS is on manual ability as 
defined in the International Classification of Functioning, Disability and Health 
(ICF).(13)  
As the child‟s motivation and cognitive capacity influence their ability to 
handle objects, that will also influence the MACS level. This means that a child may 
be classified at a lower level based on their actual performance.(59) 
A recent study showed that there was high but not perfect correlation between 
the GMFCS and the MACS (r=0.735) and that there was only fair overall agreement 
(ĸ=0.28) between them.(60) This indicates both a different basic construction of the 
scales as well as that gross and fine motor function in children with CP do not 
necessarily run in parallel and should be independently classified. Both classification 
systems are meant to discriminate and categorize rather than “assess”. Studies have 
indicated that they complement each other for a total and complete classification of a 
child with CP.(59;61;62) (63) A recent study by Mutlu et al states that the usage of  
the two classification systems, GMFCS and MACS, to describe the capacity and 
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performance as defined by the ICF provides a quick and easy classification tool for 
indicating “activity limitation” in children with CP. (64) 
1.3.3 Associated problems 
As pointed out early by Little and confirmed by the latest definition of CP the motor 
disorder though it is the hallmark for the diagnosis seldom appears alone in cases of 
CP.(1)(65) It is also claimed that for many children with CP, it is the co-occurring 
conditions that often have the greatest impact on the child and family.(66) For 
intellectual impairment one study showed that there was no definite or absolute 
correlation between the degree of intellectual impairment and the subtype of CP.(67) 
Another study found that the severity of spastic motor impairment correlated with the 
degree and cognitive deficit. Those with spastic quadriplegia (bilateral) had the 
highest risk of cognitive impairment and those with spastic hemiplegia (unilateral) 
the lowest. In the dyskinetic subtype this relationship was not shown.(68) A recent 
study of a national cohort of children with CP from Iceland showed that those with 
spastic hemiplegia and diplegia had a better outcome on standard intelligence tests or 
developmental assessments than children with spastic quadriplegia and 
dyskinesia.(69) It was also shown that some children performed different in IQ 
subscales (children with spastic diplegia and quadriplegia performed significantly 
poorer on the performance task than on the verbal tasks) and that these differences 
seemed more strongly related to gestational age at birth than to motor impairment. It 
was also pointed out that limitation of movement and motor control may mask 
cognitive skills.(69) 
The prevalence of epilepsy in children and adults with CP is shown to vary 
between 15% and 42%.(38;67;70;71). If cognitive impairment/mental retardation co-
exist the prevalence rises to above 70%. (72) The prevalence also varies between 
subtype and level of gross motor function.(27;66) Epilepsy is most common in 
children with spastic cerebral palsy (28-35% of children with hemiplegia, 29%-36% 
in children with tetraplegia) and is less frequent in children with dyskinetic CP (8-
13%).(18;67)  
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For most of the associated impairments the definition of each of them are 
often not standardized. The SCPE has defined both visual and hearing impairments 
as impaired or severely impaired.(11) 
Fewer have examined the presence of impairments of speech and language. It 
is shown however that children with CP frequently have difficulties in 
communication because of both impaired language skills and impaired motor 
function.(73;74) The prevalence of non-verbal children varies from 16% to 
43%.(66;70;73;75;76)   
Feeding problems are also common in cerebral palsy ranging from sucking 
problems to swallowing problems with aspiration.(77) Growth and nutritional 
problems are also common and are shown to be more prominent with increasing 
severity of motor impairment.(78-80) The presence of gastrostomy as an indication 
of treatment for feeding and/or nutritional problems also varies with subtype and age 
of the child.(66;81)  
 
1.4 Pathophysiology 
CP is “an umbrella term” and “involves a disorder of movement and/or posture and 
of motor function; and it is due to a non- progressive 
interference/lesion/abnormality; this interference/lesion/abnormality is in the 
developing/immature brain.”(11) This description is vague when it comes to timing 
(“developing/immature brain”) but it is a general view that the brain damage causing 
CP should take place within about 2-3 years of age.(15) Origin before the end of the 
neonatal period (28 days postpartum) is distinguished from a postneonatal origin.(11) 
In the following text the focus will be on the lesions/abnormalities occurring during 
pregnancy or in the neonatal period. 
In general the normal functioning of the brain is dependent on adequate 
oxygen and glucose supply. Acute reduction in cerebral oxygen delivery will lead to 
breakdown of the neuronal energy metabolism within a few minutes.(82) The 
resulting stop in the Na
+
/ K
+-
pump leads to neuronal depolarization which induces 
glutamate release. Glutamate regulates calcium channels and thereby activates 
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enzymes initiating processes leading to cell death.  Breakdown of energy metabolism 
also causes reduced protein synthesis. A second wave of neuronal cell damage occurs 
during the reperfusion phase induced by post ischemic release of oxygen radicals, 
synthesis of nitrogenoxid, inflammatory reactions and imbalance between different 
neurotransmitter systems. The nature of the lesions depends on the stage of brain 
development when such a pathogenic event takes place.(83) 
During the 1
st
 and 2
nd
 trimester a cortical neurogenesis takes place and is 
characterized by proliferation, migration and organization of neuronal precursor 
cells.(83) Brain pathology at this stage is characterized by maldevelopments caused 
by genetic or acquired impairments and is described in 9-12% of children with 
CP.(20;22;83-85)  
From the late second trimester (from about 20 weeks of gestational) and 
onwards it is now known that the neuropathology underlying CP includes a) white 
matter injury, known as periventricular leukomalacia, b) germinal matrix 
haemorrhage with intraventrivular extensions and/or c) gray matter injury i.e. injury 
to the cortex, basal ganglia and thalamus.(86) I will now describe each of these 
neuropathological pathways in more detail; 
a. White matter injury or periventricular leucomalacia (PLV), has two 
components: focal necrosis, a cystic form (less common) and a non-cystic 
form (most common) and diffuse white matter gliosis (DWMG). The 
highest frequency occurs between 24 and 34 postconceptional weeks, but 
may also be found in term infants.  
Three main factors are considered to underlie PVL risk: 1) the 
existence of “watershed” (end –vascular) zones in the developing 
periventricular white matter (rather than in the cortex as in a more mature 
brain). This results in injury mainly to the long motor neurons descending 
to the lower legs leading to the dominating spastic bilateral l(diplegic) 
subtype seen in the preterm born  child. 2) the immaturity of the 
autoregulatory systems of the cerebral circulation, so that drops in 
cerebral perfusion pressure are poorly compensated; and 3) the intrinsic 
28 
 
susceptibility of developing oligodendrocyte precursors to free radical, 
glutamate and cytokine injury. Studies have shown that inflammatory 
cytokines released through the course of an intrauterine infection play a 
central role in the genesis of PVL.(82;87-89) PVL is often accompanied 
by neuronal/axonal disease in cerebral white matter, thalamus, basal 
ganglia, cerebral cortex, brain stem and cerebellum and is regarded as a 
combination between destructive and impaired maturation mechanisms 
termed “encephalopathy of prematurity”.(90)  
Imaging studies indicate that PVL is present in about 50% of all 
children with very low birth weight (< 1500g) and in 19.2% to 56% of all 
children with CP.(20;83;84;90). PVL is more frequently found in preterm 
than term born children.(22;83;90) Studies reporting the highest presence 
of PVL were not population based, and therefore preterm born children 
may have been overrepresented.(83).  
One study showed that of 76 children (born GA 22-32) with cystic 
PVL 58 (44%) developed cerebral palsy. As expected, the risk of cerebral 
palsy was higher when cystic PVL was bilateral and localized in the 
parietal and occipital lobe.(91) 
b. Germinal matrix haemorrhage Several sites in the brain are prone to 
haemorrhage in the setting of hypoxia-ischemia. In particular, the vessels 
of the germinal matrix are remodelling actively during the third trimester. 
The haemorrhages are commonly graded according to their extension; 
grade 1 is limited to germinal matrix, grade II means rupture of blood into 
the ventricles, grade III is accompanied by ventricular enlargement and 
grade IV involves the hemispheric parenchyma.(90) Morbidity and 
mortality increase with increasing grade of intracranial haemorrhage.(90) 
c. Gray matter injuries These injuries involve injuries affecting the 
cortex as well as other gray matter sites (basal ganglia, thalamus, 
cerebellum and brainstem). (86) Vulnerabilities of neurons in different 
neuroanatomic locations at different postconceptional ages appear to 
29 
 
relate to developmentally regulated biochemical processes occurring at 
different rates in each gray matter site. This explains the unique pattern of 
injury at the different locations of the brain. The cortical disruptions are of 
two main types; disruption leading to abnormal neuronal organization 
(polymicrogyria, schizencephaly) and disruption of formed structures 
(hydranencephaly, porenchephaly). The former most often occurs 
between about 20 and 24 weeks of gestation and can result in gyral and 
cytoarchitectural disorganization. In contrast, the latter, occurring after 
approximately 26 weeks, results in infarction and cavitation of otherwise 
normally developed structures. 
Damage occurring as a result of profound hypoxic ischemia at or near 
term causes injury to parts of the brain with a high metabolic rate.(92) 
The posterior putamina of the lentiform nucelei, the ventro-lateral nuclei 
of the thalami, the Hippocampus and the peri-Rolandic cortex are 
commonly affected. Again the precise topography of neuronal injury 
depends on the severity and temporal characteristics of the insult and the 
gestational age of the fetus. The dyskinetic subtype is by far the most 
likely subtype to be caused by this type of injury seen by acute perinatal 
hypoxic ischemia at term.(92) 
A prolonged period of mild to moderate hypotension can cause 
damage to the brain in the parasagittal zones (”watershed areas”) that lies 
between the territories of the circulation of the anterior, middle and posterior 
cerebral arteries.(92) At or near term the pattern of this injury is characterized 
by necrosis of the cortex and immediately adjacent white matter. As was 
described under a) in the more immature preterm babies injuries in the 
watershed zones, then located more  adjacent to the ventricles, affect mainly 
the long motor neurons to the lower leg while in term born children 
parasagittal injury usually affects larger areas resulting in tetraplegia, often 
with learning difficulties. However, in term babies there is a considerable 
overlap between the patterns of watershed damage and damage to the deep 
gray matter.(93)   
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Infarcts of the middle cerebral artery are reported mainly in children 
born at or near term although they may also occur in the very preterm infants.  
Gray matter lesions are described in 18%-22% of all children with 
CP.(83;84)  
The clinical manifestations of the lesions depend on the extent and type of 
injury.(94) These manifestations may change as they result from an insult to a 
growing, developing brain and thus is dynamic although derived from static 
pathology.(95) Injuries to the upper motor neurons decrease cortical input to the 
reticulospinal and corticospinal tracts. This affects motor control, decreases the 
number of effective motor units and produces abnormal motor control and 
weakness.(94) Loss of descending inhibitory input increases the excitability of 
neurons (gamma and alfa) producing spasticity.(96) If the lesion affects the extra 
pyramidal system, this results in movement disorders such as athetosis, chorea and 
dystonia.(94) 
 
1.5 Etiology 
The etiology of CP is still poorly understood. In general, observational studies like 
the present study can measure degree of association between exposures (risk factors) 
and disease (CP) but not necessarily causation. Further, it is not surprising that there 
are considerable problems associated with studies of CP etiology; the long time lag 
between recognition of CP and the presumed brain damage, disagreements among 
examiners about clinical findings in patients, and changes in clinical findings over 
time.(95) A challenge is that children with one or more perinatal risk factor may have 
had a non identified antenatal injury making them more vulnerable and it is thus 
difficult to decide what is an exposure and what is a cause. 
In studies on the etiology focus has been put on possible antenatal causes and 
on multiple causes using the model of causal pathways.(97-101) One known and now 
successfully prevented causal pathway for the development of CP is that of 
kernicterus and choreathetoid CP.(Figure 1) 
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Figure 1: One known causal pathway. After Stanley, Blair and Alberman, 2000.(102) 
In the following I will discuss the concepts of causality and risk factors in the 
etiology of CP. 
1.5.1 Causality 
There is a general concept that some events or conditions can be considered causes 
of other events or conditions. A cause is a reason for an effect, the producer of an 
action or the one event or condition responsible for an effect. Causes of diseases are 
typically the result of multiple mechanisms. A given causal mechanism requires the 
joint action of many component factors, or component causes. Furthermore, each 
component cause is an event or condition that plays a necessary role in the 
occurrence of some cases of a given disease.(103) Due to the lack of definite tests for 
CP, multiple, and different possible causes also constitutes a challenge in this 
Rh- woman with Rh+partner 
↓ 
Pregnancy in Rh- woman with Rh+ fetus 
↓ 
Transplacental haemorrhage 
↓ 
Maternal immune response producing antibodies to fetal blood 
↓ 
Subsequent pregnancy with RH+ fetus 
↓ 
Neurotoxic bilirubin produced by destruction of fetal blood 
↓ 
Kernicterus= bilirubin crossing blood brain barrier 
↓ 
Choreathetoid cerebral palsy 
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context. Therefore, a concept of “causal pathways” has been developed, meaning 
concepts of sequences of interdependent events that result in brain damage.(100) See 
Figure 1. Birth asphyxia previously regarded the most important cause of CP is an 
example of a fundamental pathogenic sequence ( impaired gas exchange→1˚ energy 
failure→ Cytotoxic neuronal death→2˚ energy failure→ Apoptotoc neuronal 
death).(102)   K B Nelson in 1999 claimed that as multiple causes may interact via 
exitotoxic, oxidative or other pathophysiologic pathways, a single factor, unless 
present to an overwhelming degree, may often be insufficient to produce cerebral 
damage, whereas two or three interacting pathogenic assaults may overwhelm natural 
defences and produce irreversible brain injury.(104) 
1.5.2 Risk factors  
A risk factor or exposure variable is a correlation and not necessarily causal, because 
correlation does not imply causation. Attempts to produce checklists that can 
determine whether an observed relation or exposure is causal have been made. The 
most widely cited is attributed to Hill who regarded temporality the most important 
criterion.(105) This implies that the cause comes before the effect.  
The definition of CP states that the damage should occur in the developing 
foetal or infant brain.(11) It is known that the brain is vulnerable to different types of 
damage at different stages of development and also that a different range of causative 
factors is apparent for different CP subtypes.(83;86;106) Some risk factors have 
repeatedly been observed to be related to CP. Some of them are associated with CP 
at all gestational ages while others primarily affect either children born at term or 
preterm. However, in about 10-20% of children no apparent risk factor is 
identified.(107;108)) In addition, even though some of the prenatal and perinatal risk 
factors evaluated for CP are found to be fairly risky they are not necessarily 
associated with high absolute rates of CP, and most children with a given risk factor 
do not have CP. (109) 
Controlled population studies are necessary to identify causes of cerebral 
palsy, and in recent years, neuroimaging information has also added to our 
knowledge of underlying pathophysiology.(22;83;84;107;110) 
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Risk factors associated with CP in previous studies will now be discussed. A 
systematic search in Medline and Embase has been performed. (Appendix 3a and b)  
In this thesis I have emphasized the risk factors that were possibly available for 
studies from the data accessible. In addition I have discussed briefly genetic causes. 
Because many references have addressed the same topic, more recent publications, 
systematic reviews and original observations have been prioritized. In addition, those 
studies covering birth years closest to those included in the present study were 
preferred.  
Population based studies from both Sweden and Norway covering the birth 
years 1970-2002 suggested that the origin of CP is prenatal in 22-36% cases, 
perinatal/neonatal in 40-47% of cases while 19-38% of cases were 
unclassifiable.(34;44;111-113) Others have suggested that 70-80% of CP cases are 
due to prenatal factors and that birth asphyxia plays a minor role.(95) (114) Some 
prenatal risk factors are repeatedly observed to be related to CP; low gestational age, 
low birth weight, male gender, multiple gestation, intrauterine viral infection, 
maternal thyroid abnormalities and birth defects.(11;95;109;114-116)  
It is well known that the risk of CP among surviving very premature infants is 
very high.(11) It is noteworthy that term or near-term infants, although individually 
at a relative low risk, constitute a large majority of all births and contribute to at least 
half of CP cases.(104) 
In order to get an overview it seems reasonable to categorize the risk factors 
into four groups;1) pre-pregnancy factors, 2) factors early or late in pregnancy, 3) 
factors at term and 4) postneonatal factors. The last group, the postneonatal factors, 
referring to risk factors for lesions or episodes occurring more than 28 days after 
birth, will not be further explored in this thesis.(11) They account for 5-10% of all 
cases of CP.(34;117;118) 
To get an impression of the prevalence of the different risk factors in the 
general population, data, when available, from the European Perinatal Health Report 
(from birth year 2004) and/or the Medical Birth Registry of Norway (MBRN) (from 
the birth years 1967-2008) are referred in the discussion of each risk factor.(119) 
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Prepregnancy risk factors 
This group comprises factors occurring before the onset of pregnancy and includes: 
maternal age, parity, previous foetal death, in vitro fertilization, maternal disease, 
short pregnancy interval and genetic causes. 
Maternal age 
In Europe less than 3% of all children are born to mothers younger than 20 years of 
age and 7.5% - 24.3% to mothers older than 35 years.(119) In Norway about 6% of 
children are born to mothers  younger than 20 years and about 11% to those older 
than 35 years. (Data from the MBRN for the birth years 1967-2008)    
Both maternal age below 19 years and above 35 years and 40 years are 
associated with an increased risk of CP (maternal age > 40 years: OR= 1.4, maternal 
age  >35 years : OR 1.9).(120;121) In a recent study from North England only those 
with a maternal age < 20 years were associated with an increased risk of CP while 
those aged >35 years associated with a 20% increased rate of CP were not 
statistically significant.(122) 
Parity 
In Europe the percentages of first births (primiparity) ranged from 39.4%-55.6% and 
the percentages of firth and later births ranged from 2.3% to 13.8%.(119)  High 
parity (parity >3) is associated with an increased risk for CP (OR = 1.6) among 
preterm born children while primiparity is associated with an increased risk (OR 1.2-
1.8) for CP in all gestational age groups.(120;121;123) 
Previous foetal death 
Children of mothers who have previously experienced intrauterine foetal deaths have 
been associated with a 2-3 times increased risk for CP (OR = 2.23)(101;109) 
In vitro fertilization 
In Europe births after in vitro fertilization (IVF),which may include intracytoplasmic 
sperm injection, in vitro maturation, and frozen embryo transfer, represent up to 2% 
of all births.(119) In a study from Sweden of children born 1982-1995, they found 
that children born after in vitro fertilization (IVF) were at increased risk (OR = 3.7) 
of cerebral palsy.(124) It was concluded that this could largely, but not solely, be 
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explained by the high frequency of twins, by low birth weight and low gestational 
age, and that an effect of the IVF procedure per se or another factor not adjusted for 
could not be excluded.(124) In two recent studies, another Swedish and a Danish, it 
was found that the increased risk of CP in children born after IVF disappeared when 
corrected for multiplicity and gestational age.(125;126)  
Maternal disease 
In Norway maternal thyroid disease occurs in 0.6% of all pregnancies, maternal 
epilepsy in 0.6% and maternal diabetes mellitus (insulin dependent) in 0.1% of all 
pregnancies. (Data from the MBRN for the birth years 1967-2008)  Maternal 
hyperthyroidism (RR = 4.9) and seizures (any active) (RR= 3.5) were associated with 
an increased risk of CP in the study by Nelson and Ellenberg of children born 1959-
66.(109;127) They did not however find any association between maternal diabetes 
and CP. In a more recent Swedish study maternal insulin-dependent diabetes mellitus 
was associated with a twofold increased risk of CP (OR = 2.1) in children born 1984-
1998.(120) 
Short interpregnancy interval  
In the study by Pinto Martin et al in 1998 it was found that significantly higher 
proportions of mothers to children with disabling CP had short interpregnancy 
interval compared to children with no-disabling CP: “Although extensive literature 
exist on the association of short IPI and increased mortality and morbidity, the 
underlying mechanism has not been well studied. Nutritional hypothesis have been 
put forth by numerous authors but have never been carefully studied. Maternal 
depletion syndrome is a term that has been used to describe poor maternal and 
infant health in developing countries and might be applicable here. If, in fact, the 
adverse outcome experienced by infants born after a short IPI is a function of 
depleted maternal reserves, then this is amenable to interventions.”(128) 
Genes 
Mathematical analysis of prenatal and perinatal risk factors on children with CP born 
1959-1970 indicated that an estimated 40% of etiologically undiagnosed cases of CP 
in the community (48% of those born at term and 24% of those born preterm) are 
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genetically caused.(129) The author found that the frequent genetic pathology was 
not accompanied by equally frequent dysmorfic signs, hinting that a genetic cause is 
unlikely to be expressed in abnormal karyotypes. Another exploratory population 
based study invested candidate single nucleotide polymorphism (SNP) in infants of 
all gestational ages. Two of the 28 SNPs examined, iNOS and LTA, were associated 
with CP in the total population, iNOS and EPCR variants were related to CP risk in 
term infants while ADRB and IL-8 were associated with CP in children who were 
born preterm.(130) Moreover, intrauterine infection increases perinatal mortality and 
morbidity, such as cerebral palsy. The mechanism may be through a gene-
environment interaction. Polymorphisms of certain critical genes may be responsible 
for a harmful inflammatory response in those who possess them. Accordingly, 
polymorphisms that increase the magnitude or the duration of an inflammatory 
response were associated with an increased risk of preterm birth and thereby of 
cerebral palsy. (131). 
Risk factors early in pregnancy 
This group comprises factors occurring after conception and in the first part of 
pregnancy and includes: congenital malformations, gender, abnormal placenta 
structure or function, antenatal hemorrhages, preterm birth, deviation of foetal 
growth, multiple birth, preeclampsia and maternal infection. 
Congenital malformations 
In Europe congenital anomalies (any) occurs in about 2% of all life births, while 
malformations in the nervous system occurs in about 0.1%.(119) The coexistence of 
CP and congenital malformations in general and specific brain malformations in 
particular, has been reported in many studies to vary between 11% and 32%.(132-
136)  
In the study by Croen et al from the US singletons born 1983-1985 with 
congenital malformations had a five-fold increased risk of CP (OR= 5.2).(134) More 
recent studies from Western Australia and Europe have confirmed the magnitude of 
this increased risk.(133;135;137)  
The European study of children with CP born in three regions in Europe 
(Denmark, France and England) during 1991-1999 showed that the prevalence of 
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cerebral anomalies was higher among children born at term (13%) than among those 
born preterm (3.8%).(136) The most common brain malformations in CP are shown 
to be lissencephali, schizencephali, cortical heterotopias, polymicrogyria and 
porencephaly. The causes of these malformations can be migration defects, 
coagulopathies with ischemia or bleeding, infections or unknown factors.(138)  Blair 
et al in 2007 found that there was also an association between CP and non-cerebral 
congenital defects (OR= 4.8).(135) 
 Gene and chromosomal defects and environmental teratogenes are 
undoubtedly responsible for many congenital anomalies. Nevertheless, the majority 
of anomalies are of unknown etiology. The coexistence of CP with a wide variety of 
other congenital anomalies suggests a common pathogenic mechanism that may be 
distinct from genetic or teratogenic influences.(137)  
Gender 
In Norway 51.4% of all live born children are boys and 48.6% are girls. (Data from 
the MBRN for the birth years 1967-2008)  
In the study by Jarvis et al of European children with CP born 1976-1990 the 
incidence of CP was 30% higher in males than in females.(139) Both lighter and 
heavier babies were found to be more likely to develop CP if they were males. This 
increased vulnerability of male babies was not reflected in higher rates of intrauterine 
growth retardation when this was judged by low growth velocity or disproportionate 
anatomy. There was however evidence that male babies were less mature for their 
gestational age both in skeletal ossification and also in cerebral maturity.(139) 
Estrogen and other sex hormones can protect the adult brain from stroke and other 
injuries and gender differences in the human immature brain appear to be strongly 
influenced by intrinsic differences between male and female cells. It therefore 
claimed that it is plausible that the skewed male/female ratio in the incidence of CP 
and related disorders, as well as the differential vulnerability-specific structures in 
the preterm brain is influenced directly by gender related chromosomes.(140)   
Abnormal placental structure and or function 
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Pathological lesions of the placenta associated with maternal under-perfusion have 
been shown to be increased in children with CP in all BW and GA groups.(141-143) 
Among the lesions found in placentas of infants with CP, thrombotic lesions are the 
most common.(144) Vasculopathy of the placenta is also linked with encephalopatic 
manifestations in the newborn and can be recognized in children with perinatal 
stroke and later CP.(144) 
Antenatal haemorrhages 
In Norway vaginal bleeding between 13 and 28 weeks of gestation occurs in 0.8% of 
all pregnancies and in 0.7% after 28 weeks of gestation. (Data from the MBRN for 
the birth years 1967-2008)  
Antenatal haemorrhages were shown to be associated with an increased risk 
for CP (RR=1.8) in a study from the US of children born 1959-1966.(97) An 
increased risk of CP (OR= 2.9) when compared to birth year matched controls was 
also shown by Palmer et al for children born 1980-1986 in Western Australia.(145) 
However, there was no increased risk when compared to gestational age and birth 
weight controls.  
Preterm birth 
Preterm birth is defined as birth before 37 weeks of gestation. In Europe the 
proportion of preterm births varies between 5% and 11%, and in Norway they 
account for about 6% of all births.(119) (Data from the MBRN for the birth years 
1967-2008) Very preterm birth (<32 weeks of gestation) accounts for about 1% of all 
births in Europe. 
 Preterm birth is thought to be the strongest predictor for CP. The inverse 
relationship between increased risk of CP and being born at either lower birth 
weights or earlier gestational ages, or both, has been consistently well supported over 
time. (27) While overall prevalence of CP in three recent studies was about 2 per 
1000 live births (2.0-2.4 per 1000 neonatal survivor), the prevalence in children born 
at term was about 1 per 1000 live births (1.2-1.7 per 1000 neonatal survivor), in 
children born 32-36 weeks of gestation about 6 per 1000 live births (4.9-8.0 per 1000 
neonatal survivor) and in children born 28-31 weeks of gestation 50.1 per 1000 live 
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births ( 35.0-79.5 per 1000 neonatal survivor)(11;146-148) However, the risk of CP 
does not seem to decrease for each additional week of gestation; at 24, 25 and 26 
weeks of gestation the event rate of CP varies little, but from 27 weeks and on, the 
event rate of CP starts to decrease significantly.(149) The increased risk of CP in 
preterm born babies is strongly connected to the vulnerability of the preterm brain to 
damage. One explanation for the link between extremely low gestational age and 
cerebral white matter damage is that the same disorders that lead to preterm birth can 
also damage the developing brain.(150) However, even late preterm born children 
(GA 34-36 weeks) are found to have a 3-fold increased risk of CP compared to term 
born children. (151) The mechanism may either be that of an altered or damaged 
brain growth by preterm delivery per se or by complications of preterm delivery. 
Another alternative is that the events that led to preterm delivery may also have 
contributed to the brain damage causing CP.(151)  
Post term birth (GA>41 weeks) is also found to have an increased risk of CP 
(RR=1.4-3. 0) (152;153) In Norway 12.5% of all births are post term. (Data from the 
MBRN for the birth years 1967-2008)   
Deviation of foetal growth  
Babies with a low birth weight are at higher risk of poor perinatal outcome and of 
long-term cognitive and motor impairments. Babies have a low birth weight because 
of preterm birth or intrauterine growth restriction (IUGR) or for both these 
reasons.(119) Macrosomia or high birth weight (>4500 g) is also associated with 
pregnancy complications. (154) Ideally, growth restriction should be measured with 
respect to the third or tenth percentile of birth weight at each gestational age (small-
for-gestational age or SGA). However, agreed-upon norms for birth weight do not 
exist.(119) 
 In Europe the percentage of live births with a birth weight below 2500 g 
ranged from 4.2% to 8.5% of all births while the proportion of babies with very low 
birth weight (VLBW: < 1500g) was about 1%. (119) In Norway about 5% have a 
birth weight below 2500g. (Data from the MBRN for the birth years 1967-2008) 
Deviation from optimum foetal growth at any gestational age is strongly 
associated with risk of cerebral palsy, in particular in more severe forms.(139) Jarvis 
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showed  that among single births in England during 1976-1980 the risk for severe 
cerebral palsy in male babies was 16 times higher for those with a birth weight below 
the 3rd centile and four times higher when birth weight was above the 97th centile. 
In contrast, for mild cerebral palsy in female babies the excess risk at these growth 
extremes were about half of these magnitudes. 
This relation between deviant growth and cerebral palsy might exist in either 
direction i.e. abnormal growth causes cerebral palsy or vice versa.(155) Several 
mechanisms could result in a concentration of CP at the extremes of growth. CP 
could be either the consequence or the cause of growth deviation. In the former 
situation, underlying causes of growth abnormality may be pursued or early delivery 
considered before foetal brain damage occurs. In the latter situation, brain damage 
associated with cerebral palsy precedes growth changes and recognition of growth 
restriction then may occur to late for prevention.(156)  
It appears that foetal, placental and maternal hormones particularly insulin 
(IGF-I and II), epidermal growth factor, cytokines, and leptins are implicated in how 
growth velocity is normally controlled in utero.(139) In 1988 Khoury showed that 
although there seemed to be little evidence that brain lesions actually influence 
endocrine growth regulation, anencephalic foetuses did show poor growth even when 
allowing for the weight of the missing tissue. (157) Jarvis claims that at all gestations 
infants who are either smaller or larger than optimum size have a progressively 
increased risk of cerebral palsy.(155) Others have shown that poor intrauterine 
growth increases the risk of cerebral palsy particularly in moderately preterm born 
children.(158;159) Two further studies have shown that poor intrauterine growth is 
not shown to be a major risk factor in very preterm infants.(160;161)  In a study from 
England of singletons born 1984-1990 small for gestational age (SGA) was 
associated with a reduced odds ratio for CP among both electively and spontaneously 
delivered preterm infants. In contrast, the risk for CP was doubled in term born 
children.(162) Gestational age and birth weight seems to remain the predominant 
factors for poor neurodevelopment in growth restricted infants.(163)  
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Multiple births 
Compared with singletons, babies from multiple births have higher rates of stillbirth, 
infant mortality, preterm birth, low birth weight, and subsequent developmental 
problems.(119) In Europe the multiple rate varies between 1-2 %, in Norway the rate 
is about 1.3%.(119) (Data from the MBRN for the birth years 1967-2008)  
 The higher risk of CP in multiple births is well known.(104;164-167) 
Multiple pregnancies are related to preterm delivery, intrauterine growth restriction, 
birth defects and intrapartal complications. (95)It seems that the increased risk of 
cerebral palsy to twins is not entirely explained by their increased risk of prematurity 
and low birth weight.“Overall the CP rates for twins vary less with BW and GA than 
the rates for singletons. Being a twin itself increases the risk for CP.”(164)  Topp in 
2004 found a fourfold increased risk for CP in multiples (RR = 4.4).(168) She claims 
that as the rates are the same for multiples and singletons in gestational age and birth 
weight groups below 37 weeks and 2500g, the increased CP risk in multiple born 
infants is mainly associated with the risk of being born preterm. Furthermore, that the 
borderline higher CP rate in multiples born at term and with a birth weight above 
2500g might be related to the higher risk of growth retardation in multiples.(168) In 
2006 Pharoah also partly explains the increased risk in multiples with the increased 
risk of being born preterm.(166) For children of birth weight > 2500g he reported a 
highly statistically significant three to fourfold increased risk of CP in twins 
compared with singletons. He reported that this increased risk was probably 
associated with monochorionic placentation with vascular anastomosis and possible 
hemodynamic instability with to-and fro shunting of blood between fetuses.(166) 
Pharoah also reported a greatly increased risk of CP in triplets. (RR = 12.7) 
Preeclampsia 
Preeclampsia is characterized by hypertension and proteinuria with or without 
oedema. (169) In Norway about 3% of all pregnancies are complicated by 
preeclampsia. (Data from the MBRN for the birth years 1967-2008) In the study 
from Sweden in 2006 it was found that an increased risk for CP was associated with 
preeclampsia (OR = 1.5).(120) Others have reported a decreased risk for CP 
associated with preeclampsia in preterm born children (OR for CP=0.7).(170) 
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Preeclampsia is also a known maternal risk factor for stroke in the infant.  In 
addition, an arterial ischemic stroke in the perinatal period has been recognized as a 
major cause of CP especially in unilateral CP born term or near term.(171) (See 
Perinatal stroke) In a recent US study of singletons born 1996-2002  it was 
concluded that preeclampsia before the onset of 37 weeks of gestation was a 
significant risk factor for CP; “that some of the association is probably attributable 
to high risk of preterm birth because of early preeclampsia, while a direct effect of 
preeclampsia on foetal brain development also seems likely”.(172) 
 Maternal infection 
A clinical diagnosis of chorioamnionitis is usually based on criteria such as maternal 
fever, uterine tenderness, malodorous amniotic fluid, maternal or foetal tachycardia 
and maternal leukocytosis.(173) In a US study of term born children with disabling 
CP born 1983-1985 with both a maternal fever exceeding 38˚ C in labour and a 
clinical diagnosis of chorioamnionitis was associated with increased risk of 
unexplained CP (OR=9.3).(174) This was supported in two studies of term or near-
term born children, one of children born 1991-1998 where chorioamnionitis was 
found an independent risk factor for CP (OR =3.8) and in another of term singletons 
born 1984-1993 where the presence of either chorioamnionitis, intrapartum pyrexia 
or neonatal sepsis were associated with a ten-fold increased risk of CP 
(OR=10.3).(162;175) Most studies investigating the association between intrauterine 
infection and CP among preterm born children have reported an increased 
risk.(162;173;175-178) One study of preterm born children reported no association; 
however in that study only singletons with GA< 32 weeks were included.(179) In the 
recent study by Neufeld et al of children born 1982-1998, infants born of woman 
who had any infection during their hospitalization before delivery had an increased 
risk for CP (OR = 3.1).(180)This increased risk was observed both in term (OR= 1.8) 
and preterm born children (OR  = 2.3).  The authors also concluded that the effect of 
maternal infection on CP was greater in preterm than in term infants.(180)  
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Risk factors late in pregnancy or at birth 
This group comprises factors apparently occurring late in pregnancy or at birth. It 
includes: perinatal stroke, induction of labour, placental abruption and birth 
asphyxia. 
Perinatal stroke 
Stroke is 17 times more common in the perinatal period than later in childhood or 
beyond. In a population based study that included children whose perinatal stroke 
was diagnosed after the first month of life the rate was reported to be 1 of 5000 live 
births.(181) 
Cerebral palsy is a common outcome for perinatal stroke.  Thirty seven 
percent of infants with a recognized stroke in the newborn period and 82% of those 
with a later identified stroke had CP.(182) (171) 
Artherial ischemic stroke is diagnosed primarily in neonates born at term and 
is reported to be responsible for 50% to 70% of congenital unilateral cerebral palsy 
in this population.(175;183;184) Risk factors for stroke must therefore also be 
considered risk factors for CP; they include maternal thromboembolic disease 
(thrombophilia, including history of thrombosis and the antiphospholipid syndrome) 
(OR for perinatal stroke= 16), preeclampsia (OR for perinatal stroke= 5.3), 
prolonged rupture of membranes (OR for perinatal stroke=3.8), chorioamnionitis 
(OR for perinatal stroke= 3.4), gestational hypertension (OR for perinatal stroke=4.4) 
and maternal diabetes (OR for perinatal stroke= 2.5).(184;185) 
Induction of labour 
The definition of induction of labour may vary between countries or even between 
maternity units within the same country, according to the use and timing of the 
procedures.(119) In some places, induction includes the use of drugs for cervical 
ripening and oxytocin for induction. In other places (including Norway) artificial 
rupture of membranes is also included. Thus, the prevalence also varies from less 
than 9% to well above 35% between different countries.(119) In Norway about 12% 
of all labours are induced. (Data from the MBRN for the birth years 1967-2008) 
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 Induction of labour is found to increase the risk for CP in a Danish study of 
all singletons born 1982-1990 (OR for spastic CP=2.5) and in a study from England 
of singletons born at term during 1984-1993 (OR = 2.1).(162;186) In a number of 
developed countries the proportion of births following induction of labour have 
increased because even if  labour is usually induced for maternal or foetal medical 
indications there has been a trend towards elective labour induction on maternal 
request with no medical indications.(187-189) One possible mechanism for early 
brain injury and later CP after induction could be that induction of labour is more 
often required in children with an antenatal brain insult. This assumption could be 
supported by animal studies showing that labour starts late in pregnancies in which 
the offspring had an antenatal brain insult.(190;191) Alternatively, induction of 
labour may directly or indirectly compromise the child during birth and may lead to, 
or exaggerate, a global brain insult. All drugs used for labour induction 
(prostaglandin E1(misoprostol), prostaglandin E2 and oxytocin) may lead to 
deceleration of the foetal heart rate, tachycardia or decreased short term variability; 
most likely through hyperstimulation of the uterus.(192-194). Hyperstimulation of 
the uterus, or excessive uterine activity, leads to less oxygen supply to the foetal 
brain and the development of metabolic acidosis which thereby may lead to or 
exaggerate a brain insult.(195;196)  
Breech presentation  
Breech deliveries account for a relatively small proportion, around 4%, of all 
births.(119) 
In a study of children born in the 1960s, Nelson and Ellenberg found that 
breech presentation was a risk factor for cerebral palsy, while breech delivery was 
not.(109) A case- control study from Turkey found no association.(197) In that study 
a significant proportion of deliveries were home births. In contrast, two population 
based studies, one Danish and one Swedish, both found that breech presentation was 
associated with an increased risk for cerebral palsy (OR (term children vaginal 
birth)=3), although in the Danish study the increased risk was borderline (OR for 
CP=1.5).(198;199) The Danish study reported the increased risk to be independent of 
delivery mode, whereas the results of the Swedish study suggested that cerebral palsy 
might be prevented in some cases by caesarean section. Since breech delivery has 
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been associated with adverse perinatal outcome it may be reasonable to speculate 
that birth asphyxia could be in the causal pathway leading to cerebral palsy.(109) If 
this were the case one would expect lower Apgar scores, and more severe subtypes 
of cerebral palsy, such as dyskinetic-athetoid CP and spastic tetraplegia, to be more 
common in children with CP born in breech.(200-202)
 
In the Danish study of 
singletons born at term, children with CP delivered by breech were not associated 
with these subtypes or with low Apgar scores.(198)
 
Another possible mechanism 
could be that children with a prenatal brain injury are more likely to be born in 
breech presentation. Previous studies have reported conflicting results; both 
increased frequency of foetal malformations and no such association in children born 
in breech.(97;203). A third possible mechanism between breech presentation and CP 
is through the association of foetal growth restriction.(95;159) CP has been shown to 
correlate with SGA and studies have reported that neonates in breech weigh less than 
vertex controls. (204;205;205))  
Placental abruption 
The incidence of placental abruption is reported to be about 1% and it has been 
associated with a 20%-40% increased risk for preterm delivery. (206)   
Placental abruption was highly associated with CP (OR= 8.58) in the Swedish 
study of children born 1984-1998.(120) Others have also shown that placental 
abruption has profound impact on both maternal and perinatal complications 
including severe birth asphyxia and perinatal death.(206-209) 
Birth asphyxia 
Intrapartum conditions leading to birth asphyxia was long believed to be the primary 
cause of CP.(115)This may be partly due to the use of nonspecific markers (low 
Apgar score, abnormal foetal heart rate, meconium in the amniotic fluid) that can be 
markers of foetal and newborn difficulties and not necessarily asphyxia.(175) What 
is asphyxia? One description is that of “a condition of impaired gas exchange which 
leads, if persistent, to hypoxemia and hypercapnia”. The process occurs during the 
first and second stages of labour secondary to interruption of placental blood flow 
and is identified by foetal acidosis which reflects the degree of anaerobic metabolism 
that is required during periods of hypoxia or increased oxygen demand”.(210) The 
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challenge for diagnosing perinatal asphyxia is that there is no single gold standard for 
accurate diagnosis of the condition due to the low specificity and sensitivity of the 
markers used.(211) 
Since 1996 three consensus statements have addressed the diagnosis.(212-
214) In all of them umbilical cord blood assessment (pH <7.00) is included. 
Umbilical cord blood assessment is regarded the most objective determinant of this 
foetal metabolic condition at the moment of birth.(215) Evidence suggests that an 
umbilical pH less than 7.00 is associated with an increased risk of adverse 
neurological sequelae.(216) All statements also included a low Apgar score as a 
criterion, but the two most recent only includes Apgar score as a criterion suggestive 
of intrapartum timing. Numerous factors can affect an Apgar score, they include 
intrapartum maternal sedation or anesthesia, congenital malformations, the individual 
assigning the score, resuscitate efforts and the presence of an infection. Although it 
can be subjective and by many regarded a poor predictor of long term neurological 
outcome, others have shown that there is a strong association between CP and Apgar 
score of 3 or less at both 1 and 5 minutes. (OR = 145)(217) On the other hand, most 
children with CP have normal Apgar scores.(218)  In the European Perinatal Health 
Report with data from 2004 less than 2% of all children had Apgar score at 5 minutes 
of 3 or less.(119)  
In a review article by Graham et al from 2008 five studies were identified that 
measured the proportion of cerebral palsy associated with intrapartum hypoxi-
ishemia.(34;147;200;219-221) The studies covered the birth years 1975 to 2001 and 
the proportion of cerebral palsy caused by intrapartum hypoxia-ischemia varied 
between 8% and 28%. However, all studies had different definitions of hypoxia-
ischemia as well as different levels of what was defined as low Apgar score. The 
relationship of the type of CP to acute perinatal events and asphyxia has been 
examined and it is shown that spastic CP is often associated with either severe 
partial, prolonged asphyxia with resulting subcortical white matter and cortical 
damage or acute total asphyxia resulting in extensive necrosis of the brain.(92) 
Furthermore, there seems to be strongest evidence for a causal link between acute 
prolonged hypoxic-ischemic and dyskinetic CP.(92)  
47 
 
1.6 Prevalence 
The prevalence of CP in several recent population based studies varies between 1.6 
and 3.6 per 1000 live births.(147;222-225) This variation is most likely due to the 
different definitions used; how the cases were ascertained and what denominator was 
used. Although most studies use live births as the denominator, many may argue that 
in the lower birth weight and gestational age groups neonatal survivors are the 
correct denominator to not underestimate the magnitude of cerebral palsy risk when 
neonatal survival is lowest. Some even suggest that because cerebral palsy has 
predominantly prenatal etiology fetuses at any gestation (rather than live births at 
that gestation) constitute the epidemiology appropriate denominator for calculating 
gestational age specific cerebral palsy rates.(226)  
There has not been any consistent change in overall prevalence during the last 
50 years.(227) The longest observations of CP prevalence have been performed in 
Western Sweden, Western Australia and North East England. 
(31;111;112;147;148;223;228) A decreasing trend has been reported from end of the 
1950‟s to the beginning of the 1970‟s, thereafter increasing towards the beginning of 
the 1990‟s and from then on a decreasing trend.(31;111;112;147;148;223;228)  
  The prevalence varies with different gestational age and birth weight groups. 
The prevalence in different studies among  children born at term is about 1 per 1000 
live births (1.2-1.7 per 1000 neonatal survivor) , in children born 32-36 weeks of 
gestation about 6 per 1000 live births (4.9-8.0 per 1000 neonatal survivor) and in 
children born 28-31 weeks of gestation 50.1 per 1000 live births (35.0-79.5 per 1000 
neonatal survivor).(44;146;153;225;229) The trend in prevalence among the different 
birth weight and gestational age groups also varies. The study by Platt et al from the 
SCPE showed that the prevalence of children with CP born with very low birth 
weight (VLBW)(BW< 1500g) decreased from 1980 to 1998.(230) Another recent 
study from the SCPE of children with normal birth weight showed that the 
prevalence remained stable for the same birth years.(231) In children born with 
moderate low birth weight (1500-2499g) the trend in prevalence is also stable, while 
among those born moderately preterm the trend decreased during the same 
period(200;232-234) 
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2. Aims 
The general aim of this thesis is to describe the population of children with CP in 
Norway born 1996-1998. Until now there has not been a national registration of 
children with CP in Norway. My goal was to describe the children according to both 
subtypes and severity. In addition, because many risk factors have been identified by 
others to be associated with CP, I chose to concentrate on breech and induction of 
labor because there are few previous studies, and none in Norway.  Because CP 
obviously has many possible etiologies I also wanted to look at how multiple risk 
factors could act together. 
 
More specifically, the aims of the separate papers were to: 
 
I:   describe the prevalence, subtypes and severity of cerebral palsy (CP) 
in Norway. 
 
II:  study whether breech presentation is a risk factor for cerebral palsy 
(CP). 
 
III:  investigate the association between labor induction and later 
development of cerebral palsy (CP). 
 
IV:  examine the effects of multiple risk factors on cerebral palsy (CP). 
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3. Material and Methods 
3.1 Study design 
This is a population based study based on information recorded in a national cerebral 
palsy registry. Data from this registry is linked with data from The Medical Birth 
Registry of Norway (MBRN). A cohort of three birth years is included in the study.  
 
3.2 Study population 
 All children with CP in Norway born between January 1
st
 1996 and December 31
st
 
1998 were eligible for registration in the registry and thereby in this study. Data were 
collected between January 1
st
 2003 and March 31
st
 2006 and all children were at least 
four years old when their CP diagnosis was confirmed. This is in accordance with the 
recommendations of the SCPE.(11)  
We received summary information on 374 children. Detailed information was 
obtained from 294 children (79%) (Paper I and II). After the two first papers were 
completed, we were informed that one child was excluded from the register which 
reduced the number of CP children to 373, and detailed information on 293 children. 
(Paper III and IV) 
To describe the perinatal data (Paper I) and to examine the different risk 
factors (Paper II, III and IV) in children with CP the detailed clinical information 
(Appendix 4) was linked to the Medical Birth Registry of Norway (MBRN). 
Appendix 5 The perinatal data that were missing in children born abroad (N=15) 
(Paper II, III and IV) and children with a verified postneonatal cause were excluded 
(N=15). In Paper I and II we were able to link data on 245 children with CP with data 
from the MBRN.  
 On December 1
st
 1998 the MBRN changed their notification form for 
perinatal data and for information on the different risk factors. In Papers III and IV 
we decided to exclude children recorded according to the new notification form in 
order to avoid different definitions on some of the perinatal variables and risk 
50 
 
factors. In these two papers we were able to link data on 241 children with CP with 
data from the MBRN.  
 
Background population 
  
In Norway registration in the MBRN has been mandatory (since 1967) and ensures 
that obstetric and perinatal data are recorded prospectively at birth. (Appendix 5) The 
data are recorded by birth attendants (midwifes and pediatrians) within one week of 
delivery for all deliveries after 16 weeks of gestation. During 1996-98 177 272 
children in Norway survived the first 7 days of life. In Paper I and II children with 
postneonatal CP (N=15) were also excluded from the background population leaving 
177 257 children. In Paper III and IV we decided to exclude children recorded 
according to the new birth notification form (see Study population) leaving a 
background population of 176 591 children.  
 
3.3 Data collection and ascertainment 
In Norway all children with severe neurological disorders are treated in public 
hospitals and each of the 19 counties has 1-2 neurohabilitation centers. All these 
neurohabilitation centers accepted the invitation to participate in the registration of 
children with CP with 1-2 contact persons (mainly paediatricians) per centre 
responsible for collecting the data. 
Summary data, based upon the neurohabilitation centres‟ own data recording 
systems, were mainly the number of children with CP, including those who had died.  
These data were used to calculate the overall prevalence, and to validate case 
ascertainment. The data were ascertained by the individual paediatricians. The age at 
diagnosis and classification of subtypes varied (age at registration), but all children 
were at least four years old when diagnosis and subtype were confirmed for this 
register. 
 
51 
 
3.4 Study variables 
Outcome variables 
Cerebral palsy was based upon the definition and classification agreed upon by the 
Surveillance of Cerebral Palsy in Europe in 1999.(11) A decision tree for inclusion 
and exclusion of cases and a hierarchical classification tree of CP subtypes 
developed by SCPE, translated into Norwegian, were distributed to each 
participating paediatrician in order to ensure consistency. In addition, a CD 
comprising of a Reference and Training Manual, developed by the SCPE was given 
to all participating professionals.(23) The manual includes detailed descriptions and 
definitions of CP and subtypes as well as videos of findings in typical cases. The 
ICD 10 codes for CP subtypes were applied, subdividing spastic unilateral CP further 
into a right and left type depending on whether the right or left side limbs were 
affected (i.e. right or left hemiplegia) and spastic bilateral type into quadriplegia and 
diplegia. 
Gross motor function was reported as walking and sitting ability. Walking 
ability was classified on a four level scale ranging from normal walking without 
restrictions (level 0), walking with restrictions but without assistive devices (level 1), 
walking with assistive devices (level 2) to children completely unable to walk (level 
3). Sitting ability was classified on a scale from zero to three, where zero indicated 
stable sitting, one indicated children sitting unstable but not in need of support, two 
indicated children in need of support, and three indicated children who were unable 
to sit even with support. We used the recorded walking and sitting ability data to 
assess gross motor function according to Gross Motor Function Classification 
System (GMFCS).(49;50;235) Walking ability zero or one corresponded to GMFCS 
level I-II. Walking ability two corresponded to GMFCS level III.  Walking ability 
three and sitting ability one or two corresponded to GMFCS level IV. Walking 
ability three and sitting ability three corresponded to GMFCS level V. Gross motor 
function was further dichotomized by defining GMFCS level I-III as being “good” 
and GMFCS level IV-V as being “poor” function. 
Fine motor function was described as hand function in each hand separately 
on a scale from zero to three. Zero indicated normal hand function, one mild 
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impairment, two obviously reduced function and three indicated severely reduced 
hand function. We used the recorded information on hand function on each side to 
estimate Bimanual Fine Motor Function (BFMF)(Table 1)(57) Consistent with the 
dichotomization of gross motor function, BFMF level I-III was defined as “good” 
and BFMF level IV-V was defined as “poor” function. 
 Normal 
function 
left hand  
Impaired, 
but almost 
normal 
function in 
left hand 
Obviously 
impaired 
function in 
left hand 
Severely 
impaired 
function in 
left hand 
Normal 
function right 
hand 
 BFMF I BFMF II BFMF III 
Impaired, but 
almost normal 
function in 
right hand 
BFMF I BFMF II BFMF III BFMF III 
Obviously 
impaired 
function in 
right hand 
BFMF II BFMF III BFMF IV BFMF IV 
Severely 
impaired 
function in 
right hand 
BFMF III BFMF III BFMF IV BFMF V 
Table 1 Estimated Bimanual Fine Motor Function  
Associated impairments recorded in the study included cognitive 
development, feeding ability, communication, vision, hearing and epilepsy. 
Cognitive development was assessed by a cognitive test or by clinical judgement. 
The results were described as normal (i.e. IQ level  85), general learning difficulties 
(i.e. IQ level 70-84), mildly retarded (i.e. IQ level 50-69), moderately to severely 
retarded (i.e. IQ level < 50) or unknown. Mental retardation was defined as IQ below 
70. 
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  Feeding ability was classified on a scale from being independent (0), in need 
of some assistance (1), totally dependent on assistance (2), partly tube fed (3) to 
mainly tube fed (4). The presence of gastrostomy was also recorded.  
Communication was recorded as verbal communication (i.e. speech), sign 
language and language understanding. Speech was classified on a scale from zero to 
four where zero indicated normal speech, one indicated indistinct speech, two 
indicated obviously indistinct speech, three indicated severely indistinct speech 
difficult to understand and four indicated children without speech. For children using 
graphic communication the type was recorded (writing, pictogram, pictures). 
Vision was described as normal, impaired or severely impaired (i.e. no useful 
vision on the better eye, with correction, or when functional blindness occurred).  
Hearing was described as normal, impaired or severely impaired (i.e. the child 
considered functional deaf). 
Epilepsy was defined as two unprovoked seizures, excluding febrile or 
neonatal seizures. Use of antiepileptic drugs was recorded and epilepsy was 
considered active when the child at the time of registration was taking an 
antiepileptic drug. 
Exposure variables 
Obstetric and perinatal data were obtained from the Medical Birth Registry of 
Norway (MBRN). 
In all papers Apgar scores at 1 and 5 minutes were categorized into 3 groups; 
(group 1: scores 0 – 3, group 2: scores 4 – 6 and group 3: scores 7 – 10). Birth weight 
(BW) was recorded in grams and categorized (Paper I) into four groups (BW<1000g, 
BW 1000-1499g, BW 15000-2499g and BW > 2500g). Gestational age (GA) was 
recorded in completed weeks based on the last menstrual period (LMP) and 
categorized (Paper I) into four groups (GA < 28 weeks, GA 28-32 weeks, GA 32-36 
weeks and GA < 37 weeks) 
In Paper II the following additional exposure variables were studied as 
dichotomized (yes/no) variables: breech presentation, vertex presentation, assisted 
fertilization (included in-vitro fertilization (IVF) and intracytoplasmic sperm 
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injection (ICSI) methods), plurality, and prelabour rupture of membranes (PROM; 
any rupture of membranes persisting for more than 24 hours and prior to the onset of 
labour). Delivery mode was recorded as vaginal birth or caesarean section and 
caesarean section was specified as planned or emergency caesarean section. Small 
for gestational age (SGA) was defined as a newborn with a birth weight below the 
10
th
 gestational age specific percentile. Gestational age (GA) was included in the 
multivariable analyses as a continuous variable (GA weeks) as well as dichotomized 
in preterm birth (i.e. born before 37 completed weeks) and term (i.e. equal to or 
above 37 weeks of gestation)  
In Paper III and IV the following additional exposure variables were 
included: Induction of labor is recorded as amniotomy, oxytocin (Syntocinon®) 
infusion and prostaglandin analogues. Data on dosages or sequence of procedures 
were not detailed enough to study each induction method separately and we therefore 
decided in the main analyses and presentation of the results (Paper III) to exclude 
cases where caesarean section was listed as the method of induction. Data were also 
analyzed including cases where caesarean section was listed under labor induction. 
In the MBRN, other available variables included maternal diseases such as 
diabetes, anemia, hypertension, preeclampsia, eclampsia, epilepsy, thyroid 
dysfunction, chronic renal disease, urinary tract infection, venereal diseases and 
rubella. In paper III we studied each maternal disease separately as well as maternal 
disease as a group, while in paper IV only as a group. The presence of congenital 
malformations detected in the first week of life was recorded (yes/no). Standard 
deviation scores for birth weight (z-score = (actual birth weight – mean)/ standard 
deviation (SD)) were calculated, corrected for gestational age and sex, using 
Norwegian reference curves.(236) The z-score as a continuous variable was used as a 
proxy for fetal growth. Large for gestational age was defined as a birth weight z-
score higher than +2 SD.  
Prolonged prelabour rupture of membranes (PROM) was defined as rupture 
of membranes 24 hours or longer prior to delivery. Preterm prelabour rupture of 
membranes (PPROM) was defined as rupture of membranes earlier than 37 weeks of 
gestation. 
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 In paper IV the risk associated with abnormal placenta structure was also 
studied (defined as presence of fibrin or calcium depositions, placental oedema, 
bleeding in placenta, infarction in placenta, necrotic placenta or other pathological 
conditions in placenta), bleeding in pregnancy (yes/no) as well as placental abruption 
(yes/no). 
 
3.5 Ethics 
The study was approved by the Norwegian Data Inspectorate and the Regional 
Ethical committee (REC) for medical research in Mid-Norway. Written informed 
consent was obtained from the parents to record detailed data in the register and to 
link data from the Cerebral Palsy Register in Norway with data from the MBRN. 
 
3.6 Statistical analyses 
The statistical package for social sciences (SPSS) for Windows (SPSS Inc, Chicago, 
IL) was used for data analysis (version 12.0.1 for Paper I, version 16.0 for Paper II 
and version 17.0 for Paper III and IV). A significance level of 0.05 was chosen. 
The 2 test or Fisher‟s exact test were used to analyse differences in proportions 
between groups. Correlations between severity of gross and fine motor impairment 
with perinatal data were analysed using Spearman‟s rank correlation 
coefficient.(Paper I) We used Kappa statistics to compare different classification of 
subtypes (Paper I). By convention a kappa value higher than 0.80 suggests excellent 
agreement, 0.60-0.80 good, 0.40-0.60 moderate, 0.20-0.40 fair, and a kappa value 
below 0.20 suggests poor agreement.(237)
  
In Paper II and III logistic regression analyses were used to calculate crude 
and adjusted odds ratios (OR) with 95% confidence intervals (CI) as estimates of the 
relative risk for CP among children born after breech presentation (Paper  II) or 
labour induction (Paper III) compared with children born after vertex presentation 
(Paper II) and  non-induced labour (Paper III). Covariates evaluated as possible 
confounders were selected based upon theoretical considerations as well as upon 
bivariate statistical analyses. In Paper IV odds ratios (OR) with 95% confidence 
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intervals (CI) were calculated as estimates of the relative risk for CP. Odds ratios 
were also calculated for the combinations of two to seven risk factors, using children 
without any of the recorded risk factors as a reference. The number of cases with 
each specific combination of risk factors was counted in order to identify if some 
combinations were more common than others. For the most common combinations 
we estimated their combined OR and their interaction using the interaction contrast 
ratio ICR = OR( AB ) – OR( BA ) – OR( BA ) + 1 where OR( A B ) denotes the OR 
for the combination of risk factor A and B, OR( BA ) denotes the OR for the presence 
of A, but not B, and OR( BA ) denotes the OR for the presence of B, but not A. An 
ICR-value above 0 indicates that the odds for CP for a given combination of risk 
factors is higher than the additive effect of each of the factors, and suggests 
biological interaction. For combinations with a positive ICR we calculated the 
proportion attributable (AP) to interaction as AP = ICR/ OR ( AB )(238;239) For both 
ICR and AP the confidence intervals were calculated according to the  methodology 
described by Hosmer and Lemeshow (1992).(240) All analyses were done for the 
total study population as well as for children born at term (≥ 37 weeks) and preterm 
(< 37 weeks) separately. 
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4. Summary of results 
4.1 Results of papers included in this thesis 
Paper I: Cerebral palsy in Norway: Prevalence, subtypes and 
severity. 
In this paper we used the summary data to estimate the overall prevalence of CP in 
Norway for children born 1996-1998. The prevalence was 2.1 per 1000 live births. 
Detailed clinical data were used to describe the distribution of the different CP 
subtypes according to the classification system developed by the SCPE. Among all, 
96 (33%) had the spastic unilateral CP type, 143 (49%) the spastic bilateral, 19 (6%) 
the dyskinetic and 15 (5%) the ataxic type. In 21 (7%) the subtype could not be 
classified by the referring centre. Altogether 161 (55%) children were able to walk, 
while 83 (29%) were unable to walk and in need of wheelchair. According to the 
GMFCS the gross motor function in this study was similar to other populations. Fine 
motor impairments according to BFMF were however more common in our study.  
Only 81(28%) children solely had a motor impairment. Among the associated 
impairments feeding difficulties (dependent feeding) were present in 101 (35%), 
active epilepsy in 80 (28%), severely impaired or no speech in 82 (28%), mental 
retardation in 75 (28%), severely impaired vision in 15 (5%) and severely impaired 
hearing in 12 (4%) children. There were no differences in the distribution of 
associated impairments by gestational age except for epilepsy being present in a 
higher proportion of children born at term (p < 0.01 vs. children born < 32 weeks). 
Among children with bilateral spastic CP, more severe impairments in gross motor 
function were associated with increasing birth weight (Spearman‟s rho = 0.20; p < 
0.05) and decreasing Apgar score at five minutes (Spearman‟s rho = - 0.20; p < 
0.05), however not with gestational age (Spearman‟s rho = 0.16; p = 0.09) or with 
Apgar score at one minute (Spearman‟s rho = - 0.10; p = 0.25).   
More severe impairments in fine motor function were associated with 
increasing birth weight (Spearman‟s rho = 0.32; p < 0.01) and gestational age (; 
Spearman‟s rho = 0.34; p < 0.01), with decreasing Apgar score at five minutes 
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(Spearman‟s rho = - 0.20; p < 0.05), but not with Apgar score at one minute 
(Spearman‟s rho = - 0.07; p = 0.44).   
Paper II: Is breech presentation a risk factor for cerebral palsy? A 
Norwegian birth cohort study. 
In this study we found that breech presentation was associated with an almost 4-fold 
risk of CP compared to children born in vertex presentation (OR 3.6; 95% CI 2.4-
5.3). The increased risk was unaffected when adjusted separately for assisted 
fertilization and sex, but was reduced when adjusted for preterm birth, plurality, and 
smallness for gestational age. Multivariate adjustment only marginally affected the 
OR further. The increased risk persisted among singletons born at term (OR 3.0; 95% 
CI 1.5–5.9) and preterm (OR 2.6; 95% CI 1.4–5.0). Analyses stratified by mode of 
delivery showed that for vaginal breech delivery the increased risk for CP was 
confined to children born at term (OR 3.9 ;95% CI 1.6-9.7) whereas for those 
delivered in breech by Caesarean section the increased risk was only statistically 
significantly increased among children born preterm (OR 3.3; 95% CI 1.6-6.7). 
When we restricted the analyses to breech deliveries only, the relative risk for CP 
was 1.7 (95% CI 0.5–6.4) among singletons born at term vaginally compared with 
Caesarean section. No statistically significant differences were observed in subtype 
or severity of CP between children born after breech or vertex presentation. We 
concluded that breech presentation is a significant risk factor for CP especially 
among singletons born vaginally at term.  
Paper III: Induction of labor and cerebral palsy: a population-based 
study in Norway 
In this study we found that induction of labor had been performed in 24.1% of 
children with CP compared with 13.4% among children without CP (p-value < 
0.001). Induction of labor was associated with an increased risk of CP compared to 
non-induced labor (OR 2.1, 95% CI 1.5-2.8) and in particular bilateral spastic CP 
was more frequent after labor induction compared with non- induced labor (OR 3.08; 
CI 2.09 – 4.54). Adjustment for maternal disease, gestational age, z-score for birth 
weight and PROM/ PPROM in the same model reduced the OR, but the association 
between induction of labor and CP (all and bilateral spastic) remained statistically 
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significant. In contrast, unilateral spastic CP was not associated with labor induction.  
The risk for bilateral CP when labor induction was performed was further increased 
among children born at term (OR 4.4; 95% CI 2.3 – 8.6). This risk was marginally 
reduced after adjustment for confounding effect of maternal disease, gestational age, 
z-score for birth weight and PROM/ PPROM in the same model (OR: 3.65; CI: 1.78 
– 7.49). Further, four-limb involvement (i.e. quadriplegia) was significantly more 
frequent after labor induction (45.5 %) compared with non-induced deliveries 
(8.0%)(p< 0.001). For preterm children there was no association between CP and 
induction.  
Among children born after labor induction with CP seven (12%) had Apgar 
scores at 5 minutes equal to or below 3, and eight (12%) had Apgar scores at 5 
minutes between 4 and 7. In contrast, among children born after labor induction that 
did not develop CP 410 (1.8%) had Apgar score at 5 minutes equal to or below 3 and 
330 (1.5%) had scores between 4 and 7 (p < 0.001 versus CP-group).  
In conclusion labor induction at term was associated with excess risk of CP 
bilateral spastic CP and in particular CP with four-limb involvement. 
Paper IV: The effects of multiple risk factors on cerebral palsy. A 
register based study.  
In this paper we examined the combined effects of multiple risk factors  (maternal 
disease, assisted fertilization, plurality, pathological placental structure, bleeding in 
pregnancy, preterm birth, SGA, breech delivery, rupture of membranes 24 hours 
prelabour and placental abruption) for CP. Among all children 43 (18 %) had no risk 
factors, 22 % had one, 51 % had two to four, and 10 % had five or more risk factors . 
The odds ratio for CP increased exponentially (p < 0.001) from 2.4 (95% CI: 1.6; 
3.6) if one risk factor was present to 2240 (95% CI: 138; 36395) if eight of the 
selected risk factors were present. Among patients born at term 33 (30 %) had no risk 
factors, 37 % had one, 33 % had two or more, and none had five or more risk factors. 
Among patients born preterm 9 % had no additional risk factor (p < 0.001 vs. term), 
21 % had one, and 70 % had two or more (p <0.001 vs. term) risk factors. In both 
groups very few children shared the same combinations of risk factors. However, 
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among all children with CP the four most common combinations of risk factors were 
maternal disease and preterm delivery (in 27.4%), preterm delivery and induction (in 
17.8%), maternal disease and induction (in 17.0%), and maternal disease and 5-
minute Apgar score < 7(in 11.2%). Maternal disease and 5-minute Apgar score < 7 
was the combination with the highest OR among both term and preterm born 
children. 
 In conclusion, we found that the risk for CP increased with increasing 
number of risk factors. Among children born preterm 70% had more than one risk 
factor in addition to being premature possibly consistent with the theory of a cascade 
of events resulting in CP. 
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5. Discussion 
5.1 Main Findings 
This is the first national population based study on CP in Norway.  The prevalence 
was 2.1 per 1000 live births for children born 1996-1998. The panorama of CP was 
described according to subtypes using a new classification system (SCPE) and 
according to gross and fine motor function as well as associated impairments. We 
found that 33% had the spastic unilateral subtype, 49% the spastic bilateral, 6 % the 
dyskinetic and 5% the ataxic subtype. The distribution of the different subtypes and 
the degree of gross motor impairment were similar to other populations.(11;39;241-
243) Associated impairments (severely impaired vision or hearing, active epilepsy, 
mental retardation or impaired speech) were present in 72% of the children and that 
was more common than in other populations. (70;225;242) 
Two independent risk factors for CP, breech presentation and induction of 
labor were studied. In total 11.8% of children with CP were born in breech compared 
with 3.6 % of children without CP. Among those born in breech presentation 4.5 per 
1000 children were diagnosed with CP compared to 1.3 per 1000 of those born in 
vertex. Thus, breech presentation was associated with an almost four-fold increased 
risk for CP (OR=3.6). When adjusted for preterm birth, plurality and smallness for 
gestational age the increased risk was reduced. The increased risk was highest among 
singletons born at term delivered vaginally. Severity or subtype did not differ 
between children with CP born in breech and vertex presentation. 
Induction of labor had been performed in 24.1% of children with CP 
compared with 13.8% of children without CP. We found a twofold increased risk for 
spastic CP in children born after induced labor compared to non-induced labor 
(OR=2). Adjustments for gestational age, z-score for birth-weight and 
PPROM/PROM reduced the risk. The increased risk after induced labor were highest 
(OR =3.1) among children with bilateral spastic CP while there was no increased risk 
for unilateral spastic CP.  Multiple pregnancy, placental abruption and birth 
presentation were also significantly associated with spastic CP. 
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We also found that multiple risk factors interact and increase the risk for CP. 
The risk increased exponentially with increasing number of risk factors. Among all 
children with CP only 18% had none of the identified risk factors. However, among 
children born preterm 70% had more than one risk factor. The most common 
combinations of risk factors among all children with CP were maternal disease and 
preterm delivery, preterm delivery and induction, maternal disease and induction, 
and maternal disease and 5-minute Apgar score < 7. Maternal disease and 5-minute 
Apgar score < 7 was the combination with the highest OR among both term and 
preterm born children. However, both among children born at term and preterm very 
few shared the same combinations of risk factors. 
 
5.2 Validity 
The internal validity of scientific research is to what degree the conclusions drawn 
are correct based on the available data. In the following I will discuss this by 
considering whether my results may be explained by chance, bias or confounding. 
5.2.1 Chance  
Estimates small in magnitude and with wide confidence intervals (CI) approaching 
the null value are more likely to be caused by chance than estimates with great 
magnitude and narrow CI‟s. For the prevalence estimates on subtypes in Paper I the 
CI‟s are small making them being due to chance unlikely. However, even though the 
results are consistent with other studies the magnitude of the estimates for the 
dyskinetic and ataxic subtypes are small and we have to be more cautious about the 
results.  
 In both Paper II and Paper III the CI‟s were small and the p values very low 
making the finding of an increased risk for CP in children born in breech 
presentation (Paper II) and after induction of labor (Paper III) due to chance unlikely. 
However, when we compared the association between CP and the mode of delivery 
in children born in breech the numbers in the different subgroups (singletons born at 
term and singletons born preterm) were small and we cannot rule out that these 
results are due to chance.  
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In Paper IV the findings of an increased risk for CP with increasing number 
of risk factors and with specific combinations of risk factors also had very low p-
values making the results unlikely due to chance. 
5.2.2 Bias 
Bias can be defined as any systematic error that results in an incorrect estimate of the 
association between exposure and outcome.  
Information bias 
Systematic error in a study can arise because the information collected about or from 
study subjects is erroneous.(103) It can be in the form of differential 
misclassification, such as recall bias, or of nondifferential misclassification in which 
either exposure or disease is misclassified.  
In this study the data from the Medical Birth Registry are collected before the 
neurological outcome of the infant is known, eliminating the risk of recall bias. 
All children with CP had their diagnosis confirmed by the clinicians who 
themselves examined them. These clinicians received thorough information on the 
SCPE definition, inclusion and exclusion criteria as well as the classification tree for 
classification of subtypes to standardize the recordings as much as possible. The 
distribution of subtypes is also in accordance with other recent studies on 
CP.(38;43;244-246) In addition, ICD10 codes, familiar to the clinicians, were 
reported making information bias less likely. A recent publication has estimated 
misclassification to be about 5.2% in a population based CP register and we cannot 
rule out that this may be a possibility also in our register.(247) However, we find it 
unlikely that a systematic misclassification should have taken place. 
 When we assessed severity of cerebral palsy we decided to look at both gross 
and fine motor function as well as those associated impairments frequently reported 
by others (cognitive impairment, vision and hearing impairment, epilepsy) and those 
scarcely reported but experienced from our clinical work with children. To record 
gross motor function we decided to use walking and sitting ability. This was because 
by the time we first started to include children in the CP register for this study the 
GMFCS was not in general use neither in the SCPE nor by clinicians in Norway even 
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though it was well validated. However, when we were analyzing our data we decided 
to use the data on walking and sitting ability to assess the gross motor function 
according to the GMFCS. This was because more recent studies had assessed gross 
motor function according to the GMFCS and this gave us the ability to compare our 
results with others. To do so we were not able to differentiate between GMFCS level 
I and II and had to report them has one group (GMFCS I-II).  For fine motor function 
we recorded hand function on each side separately to estimate the BMFM level. 
Even though validated instruments such as GMFCS and MACS were not applied in 
this study I consider information bias in gross and fine motor function less likely. 
Some of the associated impairments (cognitive abilities, presence of active 
epilepsy, vision and hearing impairments) were reported according to the SCPE 
registration form. (Appendix 6)As far as we were aware, no other validated 
instruments were available for registration of these items at the start of the study (or 
at present time). Few studies had reported on speech abilities, language 
understanding and feeding abilities and impairments of which were not as generally 
accepted as possible accompanied impairments of children with CP, when this study 
started. On the basis of our clinical experience we decided to include these items in 
our register. We made five level scales to record each of these impairments. 
According to the new definition of CP, cognition, vision, hearing and communication 
is now well accepted as possible impairments in children with CP.(12) More recently 
two scales for classification of communication in individuals with CP, 
Communication Function Classification System (CSFS) and Functional 
Communication Classification System (FCCS) have been developed. (248;249) Both 
of them will be validated in many European languages next year.(Personal comment 
Daniel Vireilla, SCPE)  
Selection bias 
Selection bias is a systematic error that stems from the procedure used to select the 
subject of the study. A potential selection bias of this study could be that we received 
individual data on only 79% of children with CP. This includes only six (2%) parents 
that refused to let details of their child be recorded. The lack of data was mainly due 
to the poor response from four of the 19 counties due to work overload.  Thus, 
selection bias is less likely. 
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 We also find it most unlikely that perinatal data in children from 
neurohabilitaion centres able and unable to provide clinical data differ systematically 
making selection bias for the studies on risk for CP unlikely. 
5.2.3 Confounding 
A variable is considered to be a confounder if it can theoretically be associated with 
both exposure and outcome. In order to control for possible confounding factors in 
this study we used 1) multivariate analyses and 2) stratification. 
1) Multivariable analyses: The variables were entered into the model according to the 
conceptual hierarchal framework approach proposed by Victora et al.(250) 
According to this framework variables are included by first adjusting for the variable 
being most apart and ”ahead” of the relevant exposure in a time-line leading to the 
outcome. Assisted fertilization, sex of the child, plurality, gestational age and 
smallness for gestational age were assessed as possible confounders in Paper II. 
Possible effects on the association between breech presentation and CP were 
explored for each possible confounder separately and by multivariate adjustments. In 
Paper III the variables included as possible confounders were maternal disease, 
assisted fertilization, multiple pregnancy, child‟s sex, congenital malformations, 
preeclampsia, fetal lie, prolonged rupture of membranes, SGA or LGA and preterm 
birth. Finally, risk factors that changed the OR by at least 10% were included in our 
multivariable model. Apgar scores at one and five minutes were not included as 
potential confounders as it is likely to be an intermediate variable. 
2) Stratification: In Paper II, III and IV confounding was assessed by stratified 
analyses among children born term and preterm. Prematurity is by many authors 
identified as the strongest predictors of CP.(27) Preterm birth may possibly be 
directly associated with both the different identified risk factors (exposures) and with 
CP (outcome). In Paper II we also performed stratified analyses among singletons 
because multiples (exposure) may be independently associated with CP (outcome). 
5.3 Causality 
The scientific method of investigating causality is to observe the effects of the 
exposure under a systematic planned series of experimental conditions.(102) In 
66 
 
epidemiological research natural occurring events must be observed and non causal 
associations may arise. These associations have been dealt with in the discussion of 
chance, bias and confounding. Thus, if the association between the exposure and 
outcome are unlikely to be due to chance, bias or confounding, the possibility of a 
causal relationship may be discussed. 
 Hill in 1964 proposed some criteria or characteristics widely applied as 
suggestive of a causal association. (103) These characteristics are: strength of 
association, consistency, specificity, temporality, biologic gradient, plausibility, 
coherence, experimental evidence and analogy. I will now discuss causality in light 
of some of these criteria.  
5.3.1 Strength of association  
We found strong associations between breech delivery and risk of CP, and in 
particular among singletons born at term delivered vaginally. This is reflected in high 
odd ratios (OR > 3). Induction of labor showed an even stronger association with CP 
in children with the spastic bilateral subtype (OR >4). Both these findings may be 
consistent with a causal relationship. 
In the study of multiple risk factors (Paper IV) we found very high OR„s (OR: 
2-48) as well as exponentially increasing ORs with increasing number of risk factors. 
Again we interpret this as genuine effects of the different risk factors on the 
development of brain injuries resulting in CP. 
5.3.2 Consistency with other studies 
Prevalence and subtypes 
The overall prevalence of CP was found to be consistent with previous and recent 
studies in similar populations and of children born in the same time 
period.(43;43;44;67;148;241;241;251-254)  
The distribution of subtypes and severity is also consistent with most other 
studies.(39;70;242;255) Compared to the results from a recent study from Denmark 
the distribution of subtypes was similar for the birth years 1991-1994, but differed in 
that they found a higher proportion of the spastic unilateral subtype in both the 
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preterm and term born children born during the birth years 1995-1998.(43) In that 
study the proportion of unilateral CP had increased significantly from the previous 
birth year period (1991-1994) and they speculated in both better neonatal care and 
better ascertainment of the less severe unilateral cases as an explanation for this 
increase.  
Gross and fine motor function  
In general our result on gross motor function assessed as GMFCS were similar to 
other studies, except for the proportion of children with the most severe gross motor 
function (GMFCS V) which was reported less in our study.(39;147;243) The fact that 
we estimated the GMFSC from walking and sitting ability may be an explanation. 
The previous studies recorded GMFCS directly. However, the proportion of children 
able to walk is quite similar to a recent study from Denmark. (43)  
Few other studies have described fine motor function using BFMF, although 
a study from Sweden reported lower proportions of BFMF level IV and V than in our 
study.(38) This may be due to our study making estimations of BFMF while in the 
study by Himmelmann et al the reporting physicians recorded in the BFMF 
directly.(38) The differences between the two studies can also be due to the different 
birth years covered in the two studies. More severe impairments in both fine and 
gross motor function were associated with low Apgar scores, consistent with another 
previous Norwegian study.(217) 
Associated impairments 
The results from other population based studies  have shown that the proportion of 
children with co-occurring impairments range from 31% to 65% for intellectual 
disability ( IQ< 70), 20% to 46% for epilepsy, 2%-6% for hearing loss and 2% to 
19% for visual impairment. (38;40;58;75;253;256;257) Our results are consistent 
with these findings. The proportion of children without any associated impairments 
was smaller in our study than in the study by Himmelmann et al, but they did not 
include speech impairment in their study. (38) We did not find any differences in the 
distribution of associated impairments by gestational age except for epilepsy being 
present in a higher proportion of children born at term consistent with others.(38)  
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In the present study the proportion of children with mental retardation was 
higher in children with bilateral spastic CP compared to those with the unilateral 
subtype consistent with previous and recent studies. (67;69;258) 
Few previous studies had described the prevalence of speech and 
communication disorders among children with cerebral palsy but those available 
reported that the prevalence of children unable to speak (non-verbal)was about 
20%.(70;73;225) In our study 28% had severely impaired or no speech. If we 
consider both those with severely impaired and no speech as non-verbal the 
proportion is higher than in the other studies. However, in a recent publication from 
the Cerebral Palsy Register in Norway including 564 children born 1996-2003 19% 
had no speech consistent with those previous reports.(259) In a recent study from 
Iceland they reported 16% of children with CP as non-verbal.(74) 
Feeding difficulties reported as dependent feeding were found in 35% of all 
children  and in the majority of children with most severe motor impairments, 
consistent with others.(260) We found that gastrostomy was present in 15 % of all 
children and in 40% of children with dyskinetic CP. In a study from the Netherlands 
they reported gastrostomy present in 19% of children. In that study only children 
with mental retardation and severe motor impairment were included. Thus, both 
findings are consistent with others reporting presence of gastrostomy to vary with CP 
subtype.(81) 
Breech presentation 
Breech delivery has been associated with adverse perinatal outcome in general and 
with CP in particular in previous studies.(109;120;198) The magnitude of the 
association was similar in the study from Sweden but less and not significant in the 
Danish study. A case- control study from Turkey found no association, but in that 
study a significant proportion of deliveries were home births.(197) In our study the 
increased risk was seen in all children with CP and also in both term and preterm 
born children separately. In the Danish study only singletons at term were studied but 
in the Swedish all children with CP were included.(120;198) We did not find that 
breech presentation was associated with specific subtypes of CP. In the Danish study 
breech presentation was associated with the diplegic subtype.(198) 
69 
 
We also found that singeltons in breech delivered vaginally at term had an 
increased risk compared to those born by Caesarean section consistent with the 
Swedish study.(120) In Europe, in 9 of the 19 countries or regions for which data 
were available, in 2004 80% or more of breech babies were delivered by caesarean 
section. In contrast, only 35% of those in Lithuania, 55% of those in Italy, 65% of 
those in Slovenia, and 66% of those in Norway were delivered by caesarean 
section.(119) 
When we restricted the analyses to breech deliveries only the risk for CP was 
only marginally increased for singletons born at term delivered vaginally compared 
to Caeserean section. In a review by Krebs in 2005 she concludes that results from 
larger population based studies in Sweden, the Netherlands and UK are consistent in 
showing an increased foetal risk associated with vaginal delivery of term 
breech.(204). In a recent publication Kotaska also claims that vaginal breech birth 
can be associated with a higher risk of perinatal mortality and short term neonatal 
morbidity than elective Caesarean section.(261). Further that careful case selection 
and labour management may achieve a level of safety similar to elective caesarean 
section. These statements were based upon knowledge of the physiology of breech 
birth, and the result of the term Breech Trial and cohort studies.(261;262)  However, 
few have studied long term morbidities such as CP.   
Labour induction 
In this study labour induction was associated with an increased risk for total CP but 
in particular for bilateral spastic CP. Few studies have addressed induction of labour 
as a possible independent risk factor. Another more recent population based study 
also found an increased risk of CP among children after induction of labour.(186) 
 A theory is that induction of labour may compromise the child and thereby 
induce a brain injury.  In support of this, studies addressing short term outcome of 
labour induction have found associations with neonatal seizures and encephalopathy 
and others have suggested that newborn encephalopathy may be a precursor of CP at 
term.(263-267).  
 In contrast two previous studies, one from 1985 and one from 1994, did not 
find any association between induction of labour and CP.(109;268) The former was a 
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case control study of singletons at term born 1987-90 while the latter was a 
prospective study of children born between 1959 and 1966. Thus, differences in 
study design and time period may explain the diverging results. 
Multiple risk factors 
We found that 12 selected single risk factors (maternal disease, assisted fertilization, 
plurality, pathological placental structure, bleeding in pregnancy, preterm birth, 
SGA, breech delivery, rupture of membranes 24 hours prelabour and placental 
abruption) were associated with an increased risk for CP. The magnitude of the 
increased risk was similar to findings by others for each single risk factor. (Figure 2) 
  Few previous studies have looked at the combination of risk factors. 
Consistent with our study, Blair and Stanley found that the risk for spastic CP 
increased exponentially with increasing number of risk factors, that risk factors were 
more common in preterm birth than in term born children, that some combinations 
increased the risk for spastic CP when occurring together and that each route leading 
to CP contributed only a small portion of cases.(100;101) We found that in 18% of 
the children none of the identified risk factors were present. In the study by Blair and 
Stanley the proportion without identified risk factors was 35%.(100;101) This 
difference may be explained by differences in design and in the quality and 
availability of the recorded risk factors.  
 Palmer in 1995 stated that as there is probably an interrelationship between 
many antenatal antecedents of CP these factors can interact in many different 
ways.(145) Nelson in 2008 proposed that a causal web of risk factors is a realistic 
model on how these factors interact.(185) Our finding of a large number of different 
combinations may be consistent with this. In term born children we found that only 
1/3 had more than one risk factor, hence individual susceptibility as part of a causal 
web may play a larger role, However we also found that the OR‟s increased 
exponentially with increasing number of risk factors and that the consecutive 
combination of some risk factors (maternal disease and low Apgar score and 
maternal disease and preterm delivery) were more detrimental. In addition multiple 
risk factors were present in 70% of children born preterm and in 90% if prematurity 
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are included. Both these findings may be consistent with the theory of a causal 
pathway or a cascade of events also proposed by others.(102) 
 
Figure 2: OR or RR for CP in the presence of single specific risk factors.For the 
present study the reference is the children without the specific risk factor. For 
references of previous studies see section 1.5.2 Risk factors 
5.3.2 Biological plausibility 
Breech presentation 
A possible mechanism for the association of breech presentation and CP is birth 
asphyxia as it has been speculated that birth asphyxia could be in the causal pathway 
leading to cerebral palsy.(109) If this were the case, one could expect lower Apgar 
scores and more severe subtypes of cerebral palsy, such as dyskinetic-athetoid CP 
and spastic tetraplegia, to be more common in children with CP born in breech.(200-
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202) The spastic bilateral subtype and the dyskinetic subtype are more often 
associated with extensive brain injuries or gray matter injuries originating late in 
pregnancies.(92) The two most recent consensus statements on diagnosing asphyxia 
include CP to be either quadriplegic or dyskinetic as an essential criterion.(212;214) 
We did not find any association between breech delivery and specific subtypes of 
CP. On the other hand we did find that children with CP born in breech presentation 
had a lower Apgar score after 1 minute, but not at 5 minutes compared to those born 
in vertex. Others have found a depressed Apgar score at 1 minute after all vaginal 
breech deliveries compared to vertex.(202;269) A low Apgar score is associated with 
increased risk for CP in other studies.(217;270) 
 
In the Danish study of singletons 
born at term, children with CP delivered by breech were not associated with either of 
these subtypes or with low Apgar scores.(198) 
 
Another possible mechanism could be that children with a prenatal brain 
injury are more likely to be born in breech presentation. We found that 7% of 
children born in breech had a congenital malformation compared with 3% born in 
vertex in support of this interpretation. Previous studies have reported conflicting 
results; both increased frequency of foetal malformations and no such association in 
children born in breech.(97;203) 
A third possible mechanism between breech presentation and CP is through 
the association of foetal growth restriction.(95;159) CP has been shown to be 
associated with SGA and studies have reported that neonates in breech weigh less 
than vertex controls.(204;205;205)) In this study after adjusting for SGA, the 
increased risk for CP persisted. 
  Another finding in our study was the less increased risk among children born 
in breech delivered by Caesarean section.  This is consistent with the findings of 
Thorngren-Jerneck et al.(120) If a vaginal delivered child in breech presentation is 
injured during the delivery this may explain the findings. This was also the theory 
behind the recommendation after The Term Breech Trial and the later Cochrane 
review, Caesarean section being a more indulgent way of delivering children in 
breech.(262) (271) The Danish study by Kreps et all found that the increased risk 
was independent of delivery mode and that breech presentation possibly itself is an 
independent risk factor.(198) Breech presentation may thus be associated with CP 
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through more than one mechanism and perhaps be part of a network or web of causal 
factors.  
 Labor induction  
Labor induction at term was associated with an increased risk of spastic bilateral CP, 
and in particular the quadriplegic subtype in favor of a causal relationship. The lower 
Apgar score at five minutes in the CP group also supports this view. (217;270) This 
is also supported by studies finding that induction of labor may directly or indirectly 
compromise the child during birth.(192;272) 
 Another possible mechanism is that in pregnancies with children with 
antenatal brain injuries, labour starts late and consequently is more often induced. 
This is supported by animal studies.(190;191) This is also in support of the theory 
that CP results from the interaction of multiple risk factors.(273) 
Multiple risk factors 
We found that among both children born at term and preterm increasing numbers of 
risk factors were associated with increasing risk for CP. This may support the view 
that more than one risk factor interact either consecutively or in a web resulting in 
brain injury.(100;182;273) For the more vulnerable preterm born children a “chain 
reaction “or cascade of events may be more likely. For children born at term if one 
risk factor is not sufficient, a web of risk factors my interact and possibly result in 
brain damage in a vulnerable child.(102;273)  In addition, very few children shared 
the same combinations of risk factors. This supports both possible mechanisms in 
that the child‟s own resistance, depending on their genotype, leads to different 
vulnerability for environmental damage.(101;182;227) Because there are genetic 
contributions to a number of obstetric risk factors for CP, including preterm birth, 
abruption of the placenta, breech presentation, preeclampsia, foetal growth 
restriction, chorioamnionitis and others it has been claimed that genes can influence 
vulnerability to CP at a number of points along the causal pathway. (130) 
In the study of multiple risk factors we even found evidence for biological 
interaction between the combination of two specific risk factors; preterm birth and 
maternal disease and CP using statistical methods.(237-239) 
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6. Generalizability 
To assess the external validity referring to the extent to which the results may be 
applicable to other similar populations we have to evaluate if our population is 
representative. Our population represents a cohort of three birth years in a whole 
country. The overall prevalence of CP was found to be consistent with previous 
studies in similar populations. (43;67;241;251-253) It also seems representative to 
similar populations born in the same time period.(44;148;241;254) (43) For children 
born earlier (before 1996) or later (after 1998) neonatal care may possibly have been 
somewhat different but the great advances in neonatal care were achieved more than 
a decade before our oldest children were born. The long time lag between possible 
causes and diagnosis of CP is common for all populations having accepted 4-5 years 
of age as the optimal age for classification of a CP subtype, as was recommended by 
the SCPE in 2000.(11) Different countries may have different recommendations or 
guidelines for both delivery of breech presentation and induction of labor which also 
can make the results of these studies possibly less generalizable. However, the results 
of our study have relevance for most populations of children with CP in the 
industrialized world born until present time.  
Thus, the study on prevalence, subtypes and severity are more consistent than 
the studies on breech and induction of labour, in which more research with more 
detailed information are needed to support or not support our findings. I also 
consider the study on multiple causes representative for those birth years. 
 
 
7. Clinical implications 
Our description of subtypes and impairments in a three year birth cohort of children 
with CP in Norway is important in the identification of needs and treatment options 
for these children. Because of the relative large proportion of children with 
associated impairments such as feeding problems and speech problems more 
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emphazise can be put on these problematic areas. Traditionally motor impairments 
have been the target for treatment and habilitation of children with CP. Studies have 
shown that quality of life and participation are domains in which we have less focus 
on and know less about.(274) Feeding difficulties in a child with CP have been 
identified by parents to significantly impair their families‟ participation and quality 
of life. (275;276)A recent publication identified that about 35% of children with CP 
had impaired or no speech, while no more than 60% of them used alternative or 
augmentative communication aids.(259) Non verbal children are more often to have 
multiple disabilities. Both non verbal status and severe dysarthria are shown to be 
associated with intellectual status, gross motor function (GMFCS), and the 
quadriplegic and dyskinetic subtypes.(74) 
 Feeding problems are associated with poor growth and nutritional status in 
children with CP.(277) Longitudinal investigations have found that early nutritional 
supplementation by gastrostomy results in improved linear growth in children with 
severe CP if commenced early in life.(278;279) Being non-verbal and dependent on 
tube feeding are factors that have even been associated with early death.(280) By 
identifying both feeding problems and speech problems we have the opportunity to 
intervene on these important areas. 
The identification of two independent as well as combinations of risk factors 
and how they possibly act and interact may give a rise in hope of prevention.  The 
finding of an increased risk for CP among singletons born in breech delivered 
vaginally compared to caesarean section, though not statistically significant, may 
mean that a few cases could theoretically be prevented had caesarean section been 
performed in all cases of breech delivery. In addition, the finding of an association of 
labour induction and bilateral spastic CP with four limb involvement may indicate 
perinatal injury, also possibly preventable if the increased risk is associated with 
certain drugs or procedures. Still, of course there are probably risk factors which are 
not yet identified and in particular not identified in this study. Further, if the different 
risk factors act together in a web or a chain it might be difficult to identify exactly 
how they interact. Nevertheless, if we are able to remove one or two factors in such a 
web or chain this might prevent the risk. If the antenatal brain injury occurs very 
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early in pregnancy this will make prevention difficult. One also has to be aware of 
that genetic causes cannot be expected to respond to attempts to prevent CP even 
early in pregnancy. On the other hand prevention in a wider context could imply 
prevention of the extent of the injury and thereby the severity of CP. In a study by 
Blackman et al from 2009 they found that the presence of a specific variant (ԑ 4) of a 
certain gene (APOE) on chromosome 19 is associated with a lowered severity of 
CP.(281) The protein encoded by this gene (Apolipoprotein E) has an important 
function in the maintenance of neurons and repair after injury and the authors 
therefore claim that it could have a protective effect in brain development.  
 
8. Future studies 
This was the first national study of subtypes and severity of children with CP in 
Norway.  The children in the study were born more than 12-15 years ago. The 
Cerebral Palsy Registry in Norway allows us to study the panorama of children born 
more recently. The use of validated scales for classification on gross and fine motor 
function and associated impairments (i.e. speech) may give us an even better picture 
of the panorama of CP in Norway and thereby possibilities to plan services better for 
these children.  
By including more recent birth cohorts our sample sizes will be larger and 
results from studies on risk factors may be more robust. Multicenter studies on 
breech presentation and induction of labour are needed to explore the possible 
associations further. The linkage of the CPRN to the MBRN is very important and 
the recordings in their new notification form allow for more details in the studies of 
risk factors. Moreover, future studies should include more details on antenatal, 
obstetric and perinatal factors. Finally, the influence on genes in the etiology as well 
as studies on trends in CP will be needed to clarify the etiology further. 
9. Conclusion 
In this study of the panorama of CP in Norway we found that the prevalence, the 
distribution of subtypes and the gross motor impairments were similar to other 
Western populations. In contrast, a higher proportion in our population had fine 
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motor impairments and associated impairments. We also found that both breech 
presentation and induction of labour were associated with an increased risk for CP. 
More studies are needed to clarify if brain injury associated with these risk factors 
may be preventable. Combinations of risk factors were more common in children 
born preterm than at term, but few children shared the same risk factors. With 
increasing number of risk factors the risk for CP increased exponentially.  
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Appendix 1 Decision tree for cerebral palsy  
   with permission (C.Cans 2010) 
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Appendix 2 Classification tree for subtypes of Cerebral palsy. 
 with permission (C.Cans 2010) 
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Appendix 3 a)Search history, Embase 1980-2010 week 45 
 
Search Strategy: 
# Searches Results 
1 cerebral palsy/ 18036 
2 cerebral pals*.tw. 14034 
3 or/1-2 19697 
4 fertilization in vitro/ 30716 
5 maternal age/ 14969 
6 parity/ 16434 
7 fetus death/ 17690 
8 pregnancy complication/ 66027 
9 multiple pregnancy/ 9374 
10 newborn hypoxia/ 5353 
11 Apgar score/ 8664 
12 cesarean section/ 44029 
13 labor induction/ 9041 
14 congenital disorder/ 58459 
15 prolonged pregnancy/ 2151 
16 (placenta disease* or ((premature or preterm) adj3 birth*) or bleeding in 
pregnancy or (intrauterine adj3 growth restriction) or fetal growth 
retardation).tw. 
15929 
17 (pre-eclampsi* or eclampsi*).tw. 9641 
18 ((maternal adj3 thyroid disease*) or (maternal adj3 diabetes) or (maternal adj3 
epilepsy)).tw. 
2021 
19 ((Fertili?ation adj3 in adj3 vitro) or maternal age or parity or (previous adj3 fetal 
death) or congenital abnormalit*).tw. 
45543 
20 ((pregnancy adj3 complication*) or pregnancy multiple*).tw. 7433 
21 (Asphyx* neonatorum or neonatal asphyx* or (labo?r adj3 induced) or (pregnancy 
adj3 prolonged) or (breech adj3 presentation) or c?esarean section or (pregnancy 
adj3 complication*)).tw. 
39443 
22 or/4-21 293112 
23 3 and 22 1823 
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 Search history, Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations 
and Ovid MEDLINE(R) 1950-2010 week 45 
Search Strategy: 
# Searches Results 
1 Cerebral Palsy/ 13125 
2 cerebral pals*.tw. 12065 
3 or/1-2 15961 
4 exp Fertilization in Vitro/ 23938 
5 maternal age/ 14533 
6 Parity/ 18793 
7 Fetal Death/ 21916 
8 exp Pregnancy Complications/ 298139 
9 exp Epilepsy/ 112165 
10 exp Pregnancy/ 649570 
11 9 and 10 3675 
12 exp Pregnancy, Multiple/ 25434 
13 Asphyxia Neonatorum/ 6249 
14 Apgar Score/ 6013 
15 Cesarean Section/ 29979 
16 Labor, Induced/ 7225 
17 Congenital Abnormalities/ 27830 
18 Pregnancy, Prolonged/ 2156 
19 ((Fertili?ation adj3 in adj3 vitro) or maternal age or parity or (previous adj3 fetal 
death) or congenital abnormalit*).tw. 
43296 
20 ((maternal adj3 thyroid disease*) or (maternal adj3 diabetes) or (maternal adj3 
epilepsy)).tw. 
1816 
21 (pre-eclampsi* or eclampsi*).tw. 8805 
22 (placenta disease* or ((premature or preterm) adj3 birth*) or bleeding in 
pregnancy or (intrauterine adj3 growth restriction) or fetal growth 
retardation).tw. 
14328 
23 or/4-8,11-22 425143 
24 3 and 23 1855 
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Appendix 4  The Cerebral palsy Registry of Norway Registration form  
 (2003-2006) 
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Appendix 5 The birth notification form (1967-Dec 1998) 
The Medical Birth Registry of Norway 
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Appendix 6 SCPE Data Collection Form for Cerebral Palsy 
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Background/aim: To describe prevalence, subtypes and severity of cerebral palsy (CP) in
Norway using criteria proposed by the Surveillance of Cerebral Palsy in Europe (SCPE)
network.
Material: All children in Norway with CP born in January 1996–December 1998 were
registered in the Cerebral Palsy Registry of Norway. The Medical Birth Registry of Norway
provided the perinatal data.
Results: A total of 374 children with CP were identified with a prevalence of 2.1 per 1000
live births. Detailed information was obtained from 294 (79%) children. Median age at
clinical assessment was 6.9 years (range: 1.9–10.2 years). Thirty-three percent of the
children had spastic unilateral CP, 49% spastic bilateral, 6% dyskinetic, 5% ataxic CP and 7%
were not classified. Severely impaired vision and hearing were present in 5% and 4% of the
children, respectively. Active epilepsy was present in 28%, mental retardation in 31% and
severely impaired or no speech in 28% children. The most severe impairments in gross
motor function were observed in children with low Apgar scores, and the most severe
impairments in fine motor function in children born at term, with normal birth weight and
low Apgar scores.
Conclusion: Compared with other populations, the prevalence of CP as well as the
proportions of subtypes and gross motor impairments were similar, whereas fine motor
impairments and associated impairments were more common. The classification of
children with mixed forms of CP is still a challenge. Children were more severely affected if
Apgar scores were low, and if they were born at term.
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1. Introduction
Cerebral palsy (CP) comprises a group of permanent and non-
progressive disorders of movement and posture caused by a
central nervous lesion, damage or dysfunction originating
early in life (Surveillance of Cerebral Palsy in Europe (SCPE)
2000).1
Studies have reported that the prevalence of CP may vary
between 1.5 and 3.0 per 1000 live births.2–8 These differences
in prevalence may reflect ‘‘true’’ differences but may also be
the result of variations in ascertainment of CP cases or
inconsistent definition and classification of CP. We are not
aware of other studies comprising a complete national
cohort.
Moreover, the subtypes and severity of CP as well as the
proportion of patients with associated impairments vary
between studies, and this variation is likely to be due to
differences in diagnostic criteria and classification.7,9–15
Recently, a European network, the Surveillance of Cerebral
Palsy in Europe (SCPE), has agreed upon a definition of CP, and
has suggested a revised classification in subtypes which may
be less dependent on individual judgement.1
In 2002, the Cerebral Palsy Registry of Norway (CPRN),
comprising data of all children with CP born in 1996 onwards,
was established in Norway. As essentially all children with CP
are diagnosed and treated at public hospitals or habilitation
centres, Norway may be well suited for population-based
studies. Moreover, the child neurologists who diagnose and
are responsible for the medical follow-up are relatively few in
number and have a well-established network enabling agree-
ment on definitions and classification. Finally, the Medical
Birth Registry of Norway (MBRN) established in 1967 provides
essential perinatal data on risk factors for CP as well as
perinatal survival.
In this article, we want to report the first results of CPRN.
The aims are to describe (a) prevalence of CP in Norwegian
children born in 1996–1998; (b) relative proportions of CP
subtypes based on the SCPE classification system; (c) severity
of CP; (d) occurrence of associated impairments and (e)
associations between CP subtypes, severity and associated
impairments on one hand and gestational age, birth weight
and Apgar scores on the other.
2. Materials and methods
All Norwegian children with a diagnosis of CP born between
January 1, 1996 and December 31, 1998 were eligible for
registration. Data were collected between January 1, 2003 and
March 31, 2006.
2.1. Case ascertainment
In Norway, all children with severe neurological disorders are
treated in public hospitals, and each of the 20 counties has
one habilitation centre caring for children with CP. All centres
were invited to take part in the study providing summary and
individual data. Summary data, based upon the habilitation
centres’ own data recording systems, were mainly the
number of children with CP, including children who had
died. These data were used to calculate the overall pre-
valence, and to validate case ascertainment. The diagnosis
was confirmed when the children were at least 4 years.
The individual data were collected by a senior paediatrician
in a standardised form. In principal, registration was based
upon the definition and classification agreed upon by the
Surveillance of Cerebral Palsy in Europe in 1999 (SCPE 2000).1
A decision tree for inclusion and exclusion of cases and a
hierarchical classification tree of CP subtypes developed by
SCPE, translated into Norwegian, were distributed to each
participating child neurologist in order to ensure consistency.
In addition, a CD comprising a Reference and Training
Manual, developed by SCPE (Kra¨geloh-Mann I 2003) was given
to all participating professionals. The manual comprised
detailed descriptions and definitions of CP and subtypes as
well as videos of findings in typical cases. According to the
guidelines, CP is divided into spastic, dyskinetic and ataxic
subtypes. The spastic subtype is further divided into a
unilateral (limbs on one side of the body are involved) and a
bilateral (limbs on both sides of the body are involved) type. In
this study, spastic unilateral CP was further subdivided into a
right and left type depending on whether the right or left side
limbs were affected (i.e. right or left hemiplegia). The spastic
bilateral type was further subdivided into quadriplegia and
diplegia.
2.2. Gross and fine motor function
Gross motor function was reported as walking and sitting
ability. Walking ability was classified on a four-level scale
ranging from normal walking without restrictions (level 0),
walking with restrictions but without assistive devices (level
1), walking with assistive devices (level 2) and to children
completely unable to walk (level 3).
Sitting ability was classified on a scale from zero to three,
where zero indicated stable sitting, one indicated children
sitting unstable but not in need of support, two indicated
children in need of support, and three indicated children who
where unable to sit even with support.
Fine motor function was described as hand function in each
hand separately on a scale from zero to three. Zero indicated
normal hand function, one minor motor signs, but nearly
normal function, two obviously reduced function and three
indicated severely reduced hand function (no useful func-
tion).
We used the recorded walking and sitting ability to assess
gross motor function according to Gross Motor Function
Classification System (GMFCS).16–18 Walking ability zero or
one corresponded to GMFCS levels I–II. Walking ability two
corresponded to GMFCS level III. Walking ability three and
sitting ability one or two corresponded to GMFCS level IV.
Walking ability three and sitting ability three corresponded to
GMFCS level V. Gross motor function was further dichoto-
mised by defining GMFCS levels I–III as being ‘‘good’’ and
GMFCS levels IV–V as being ‘‘poor’’ function.
We used the recorded information on hand function on
each side to estimate Bimanual Fine Motor Function (BFMF) as
indicated in Table 1.13 Consistent with the dichotomisation of
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gross motor function, BFMF levels I–III was defined as ‘‘good’’
and BFMF levels IV–V was defined as ‘‘poor’’ function.
2.3. Associated impairment
Cognitive development was assessed by a cognitive test or by
clinical judgement.
The results were described as normal (i.e. IQ levelX85),
general learning difficulties (i.e. IQ level 70–84), mildly
retarded (i.e. IQ level 50–69), moderately to severely retarded
(i.e. IQ levelo50) or unknown. Mental retardation was defined
as IQ below 70.
Feeding ability was classified on a scale from being
independent (0), in need of some assistance (1), totally
dependent on assistance (2), partly tube fed (3) to mainly
tube fed (4). The presence of gastrostomy was also recorded.
Communication was recorded as verbal communication
(i.e. speech), sign language and language understanding.
Speech was classified on scale from zero to four where zero
indicated normal speech, one indicated indistinct speech, two
indicated obviously indistinct speech, three indicated se-
verely indistinct speech difficult to understand and four
indicated children without speech. For children using graphic
communication, the type was recorded (writing, pictogram,
pictures).
Vision was described as normal, impaired or severely
impaired (i.e. no useful vision on the better eye, with
correction, or when functional blindness occurred). Hearing
was described as normal, impaired or severely impaired (i.e.
the child considered functional deaf).
Epilepsy was defined as two unprovoked seizures, exclud-
ing febrile or neonatal seizures. Use of antiepileptic drugs was
recorded and epilepsy was considered active when the child
at the time of registration was taking an antiepileptic drug.
2.4. Risk factors
Obstetric and perinatal data were obtained from the MBRN.
2.5. Ethics
The study was approved by the Regional Ethical Committee
(REC) for Medical Research in Mid-Norway, and by the
Norwegian Data Inspectorate. The individual registration of
data and the linkage of data to the MBRN required consent by
the parents.
2.6. Statistical methods
The statistical package for social sciences (SPSS) for Windows
version 12.0.1 (SPSS Inc., Chicago, IL) was used for data
analysis, and a significance level of 0.05 was chosen. The w2-
test or Fisher’s exact test were used to analyse differences in
proportions between groups. Correlations between severity of
gross and fine motor impairment with perinatal data were
analysed using Spearman’s rank correlation coefficient. We
used Kappa statistics to compare the classification of children
with bilateral CP in being quadriplegic or diplegic with a
classification of the same children based upon the severity of
motor impairment in ‘‘poor’’ or ‘‘good’’. By convention, a
kappa value of higher than 0.80 suggests excellent agreement,
0.60–0.80 good, 0.40–0.60 moderate, 0.20–0.40 fair and a kappa
value below 0.20 suggests poor agreement.19
3. Results
In all, 374 children born in 1996–1998 were identified with CP
corresponding to a prevalence of 2.1 per 1000 live births.
Detailed data were recorded for 294 (79%) of these children,
149 (50.7%) boys and 145 (49.3%) girls. Fifteen (5%) children
were born abroad and 19 (6%) had a postneonatal cause.
Median age at diagnosis was 15 months (range: 0–100 months)
and median age at clinical assessment was 6.9 years (range:
1.9–10.2 years).
3.1. Subtypes of CP
Of the 294 children, 96 (33%; 95% CI: 28–39) had the spastic
unilateral CP type, 143 (49%; 95% CI: 41–53) the spastic
bilateral, 19 (6%; 95% CI: 4–10) the dyskinetic and 15 (5%;
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Table 1 – Bimanual fine motor function estimated from recording of hand function in each hand separately
Normal
function
left hand
Minor motor signs, but
almost normal function in
left hand
Obviously
impaired function
in left hand
Severely impaired function
in left hand (no useful
function)
Normal function right hand BFMF I BFMF I BFMF II BFMF III
Minor motor signs, but
almost normal function in
right hand
BFMF I BFMF II BFMF III BFMF III
Obviously impaired
function in right hand
BFMF II BFMF III BFMF IV BFMF IV
Severely impaired function
in right hand (no useful
function)
BFMF III BFMF III BFMF IV BFMF V
E U RO P E A N J O U R NA L O F PA E D I AT R I C N E U RO L O G Y 12 ( 2008 ) 4 – 136
95% CI: 3–8) the ataxic type. In 21 (7%; 95% CI: 4–11), the
subtype could not be classified by the referring centre. These
were recorded as non-classified.
3.2. Gross and fine motor function
Table 2 shows gross and fine motor function. Altogether, 161
(55%) children were able to walk independently. Median age
when these started to walk was 22 months (range: 10–77
months). Another 46 (16%) children were able to walk with
assistive devices and the median age when they started to
walk was 36 months (range: 18–80 months). Eighty-three
(29%) children were unable to walk, 17 of 19 children with
dyskinetic and 54 (38%) of 141 children with bilateral spastic
CP.
Severely impaired gross motor function (GMFCS: IV–V) was
present in 1 (1%) child with unilateral CP compared with 53
(38%) children with bilateral (po0.01) and 16 (89%) of children
with dyskinetic CP (po0.01 vs. unilateral).
BFMF was estimated to level IV or V in 97 (35%) children. In
children with spastic bilateral CP 61 (44%) had level IV or V
and in children with dyskinetic CP all except one had level IV
or V (po0.01). Among 61 children with BFMF level I 26 (42%)
had normal function in both hands. Twenty-one of these 26
children had spastic bilateral CP, all spastic diplegia.
3.3. Risk factors
Table 3 shows the occurrence of CP subtypes according to
birth weight, gestational age and Apgar scores. Informed
consent to link the child’s clinical data to the MBRN was
obtained for all 294 children. Gestational age (GA) was
recorded in the MBRN in 236 (80%) children, birth weight
(BW) in 264 (90%) and Apgar score at 1 min in 261 (89%) and at
5 min in 256 (87%) children.
3.3.1. Gestational age
Of all children, 124 (53%) were born at term and 28 (12%)
children were born before 28 weeks of gestation. In the
general Norwegian population, 93% of children were born at
term, and 0.9% were born before week 28 of gestation in
1998.20 A lower proportion, 43/116 (38%), of children with
spastic bilateral CP was born at term compared with 81/120
(68%) of the other subtypes (po0.01), and a higher proportion
of children with dyskinetic and ataxic CP were born at term
(po0.01 vs. other subtypes).
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Table 2 – Gross and fine motor function in 294 children with cerebral palsy
CP subtype
Unilateral
N (%)
Bilateral N
(%)
Dyskinetic
N (%)
Ataxic N
(%)
Not
classified N
(%)
Total N (%)
Walking ability
Walks without restrictions 3 (3) 0 0 0 1 (5) 4 (1)
Walks without assistive devices 87 (92) 52 (37) 0 12 (80) 6 (29) 157 (54)
Walks with assistive devices 4 (4) 35 (25) 2 (10) 3 (20) 3 (14) 46 (16)
Unable to walk, in need of wheelchair 1 (1) 54 (38) 17 (90) 0 11 (52) 83 (29)
Total 95 (100) 141 (100) 19 (100) 15 (100) 21 (100) 290 (100)
Sitting abilitya
Sits stable 88 (94) 47 (31) 0 (0) 8 (53) 7 (33) 150 (52)
Mild impairment, sits a little unstable 6 (6) 50 (33) 1 (5) 7 (47) 3 (14) 67 (23)
Sits only with support 0 39 (26) 12 (67) 0 8 (38) 49 (17)
Unable to sit, even with support 0 15 (10) 5 (28) 0 3 (14) 23 (8)
Total 94 (100) 151 (100) 18 (100) 15 (100) 21 (100) 289 (100)
GMFCS levelb
GMFCS 1 or 2 90 (95) 51 (36) 0 12 (80) 7 (33) 160 (55)
GMFCS 3 4 (4) 36 (26) 2 (11) 3 (20) 3 (15) 48 (17)
GMFSC 4 1 (1) 38 (27) 11 (61) 0 8 (38) 58 (20)
GMFCS 5 0 15 (11) 5 (28) 0 3 (14) 23 (8)
Total 95 (100) 140 (100) 18 (100) 15 (100) 21 (100) 289 (100)
BFMF levelc
BFMF level I 29 (32) 29 (21) 0 1 (8) 2 (10) 61 (21)
BFMF level II 44 (48) 39 (28) 0 7 (54) 4 (19) 94 (33)
BFMF level III 18 (20) 10 (7) 1 (5) 0 3 (14) 32 (11)
BFMF level IV 1 (1) 30 (22) 4 (21) 4 (31) 5 (24) 44 (16)
BFMF level V 0 31 (22) 14 (74) 1 (8) 7 (33) 53 (19)
Total 92 (100) 139 (100) 19 (100) 13 (100) 21 (100) 284 (100)
a One unilateral unknown.
b Gross Motor Function Classification System levels estimated from walking and sitting abilities.
c Bimanual Fine Motor Function levels estimated from hand function in each hand separately.
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3.3.2. Birth weight
A birth weight X2500 g was found in 139 (53%) children
compared with 95% in the total population, and 23 (9%) had
BW below 1000 g, against 0.9% in the total population.20 A
lower proportion of children with bilateral CP had birth
weight X2500 g compared with the other subtypes (po0.01).
3.3.3. Apgar scores
A higher proportion of children with dyskinetic CP had low
Apgar scores (0–3) at 1 and 5 min compared with all other
subtypes (po0.05). Among children with bilateral CP, low
Apgar scores (0–3) at 1 min were more common than among
children with the unilateral subtype (po0.05).
Severity of impairments in gross motor function (Table 4)
was not associated with gestational age or birth weight, but
increased with decreasing Apgar score at 1 (Spearman’s
r ¼ 0.30; po0.01) and 5 min (Spearman’s r ¼ 0.32;
po0.01). The severity of impairments in fine motor function
increased with increasing gestational age (Spearman’s
r ¼ 0.34; po0.01) and birth weight (Spearman’s r ¼ 0.32;
po0.01) and with decreasing Apgar score at 1 (Spearman’s
r ¼ 0.22; po0.01) and 5 min (Spearman’s r ¼ 0.30; po0.01).
3.4. Associated impairments (Table 5)
Cognitive development was assessed by a cognitive test in 85
(29%) children or based upon clinical judgement in 161 (54%)
children. In 28 (9%), cognitive development was unknown, in
12 (4%) children, it was not known if a test was performed and
in 11 (4%) data on cognitive development were missing.
Seventy-five (31%) of the children who had their cognitive
development assessed were considered mentally retarded.
The proportion of children with mental retardation was
higher among children with spastic bilateral than among
children with spastic unilateral CP (po0.01).
A higher proportion of children with bilateral spastic CP
had severely impaired vision compared with children with
unilateral CP (po0.05), whereas there were no differences
between the CP subtypes in hearing impairment.
Active epilepsy was found in 18 (19%) children with unilateral
CP compared with 8 (42%) with dyskinetic (p ¼ 0.07) and 42 (30%)
children with spastic bilateral CP (p ¼ 0.05).
Among all children, 201 (72%) had normal or impaired,
however, understandable speech. Thirty-one (11%) children
communicated with the help of pictures or pictograms, but
only 28 (34%) of 82 children with severely or no speech used
these communication forms. In children with spastic uni-
lateral CP, 85 (90%) had normal speech, whereas 17 of 19 with
dyskinetic CP had severely impaired or no speech (po0.01).
However, in the latter group, language understanding was
assessed as normal or only slightly impaired in 14 children.
Only one child had all of these associated impairments (i.e.
mental retardation, severely impaired vision, severely im-
paired hearing, impaired speech and active epilepsy).
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Tabel 3 – Children with CP born in Norway 1996–1998 according to CP subtype by gestational age (GA), birth weight (BW)
and Apgar score
Unilateral N
(%)
Bilateral N
(%)
Dyskinetic N
(%)
Ataxic N
(%)
Not classified N
(%)
Total N (%)
GA
GA o28 weeks 7 (10) 18 (16) 1 (6) 1 (7) 2 (5) 29 (12)
GA 28–32
weeks
6 (9) 29 (25) 1 (6) 0 3 (16) 39 (17)
GA 32–36
weeks
10 (15) 26 (22) 2 (11) 2 (15) 4 (21) 44 (19)
GA X37 weeks 45 (66) 43 (38) 14 (81) 11 (79) 11 (58) 124 (53)
Total 68 (100) 116 (100) 18 (100) 14 (100) 20 (100) 236 (100)
Birthweight
BW o1000 g 6 (7) 13 (11) 1 (6) 1 (7) 2 (10) 23 (9)
BW 1000–1499 g 10 (12) 28 (22) 1 (6) 0 2 (10) 41 (16)
BW 1500–2499 g 14 (17) 40 (32) 1 (6) 1 (7) 5 (24) 61 (23)
BW X2500 g 53 (64) 45 (36) 16 (84) 13 (87) 12 (57) 139 (53)
Total 83 (100) 126 (100) 19 (100) 15 (100) 21 (100) 264 (100)
Apgar (1 min)
Apgar 0–3 8 (10) 25 (20) 9 (50) 3 (21) 8 (40) 53 (20)
Apgar 4–6 10 (12) 34 (27) 5 (28) 1 (7) 4 (20) 54 (21)
Apgar 7–10 64 (78) 67 (53) 4 (22) 11 (73) 8 (40) 154 (59)
Total 82 (100) 126 (100) 17 15 (100) 20 (100) 261 (100)
Apgar (5 min)
Apgar 0–3 3 (4) 11 (9) 5 (29) 1 (7) 4 (21) 24 (9)
Apgar 4–6 5 (6) 21 (17) 6 (35) 2 (13) 4 (21) 38 (15)
Apgar 7–10 74 (90) 91 (75) 6 (35) 12 (80) 11 (58) 194 (76)
Total 82 (100) 123 (100) 17 (100) 15 (100) 19 (19) 256 (100)
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In contrast, 81 (28%) children had solely a motor impair-
ment. A higher proportion of children with unilateral CP (43/
96 (45%)) had motor impairment only compared with 35 (24%)
of 143 children with bilateral CP (po0.01), 2 (13%) of 15
children with ataxic (po0.05) and 1 (5%) of 21 children with
non-classified CP (po0.01). No children with dyskinetic CP
had motor impairment only. Sixty-six (82%) of these 81
children without associated impairment had GMFCS levels
I–II, 8 (10%) had level III and 6 (7%) had level IV. An even
stronger association was found for fine motor function with
71 (87%) children with BFMF levels I–II, 4 (5%) with level III and
3 (4%) with level IV.
A total of 101 (34%) children were unable to eat indepen-
dently and needed help from a care taker, either for oral
feeding (N ¼ 66), or for tube feeding partly or mainly (N ¼ 35).
Among children with dyskinetic CP, 8 (40%) of 20 had
gastrostomy, compared with 26 (19%) of 139 children with
spastic bilateral CP (po0.05).
There were no differences in the distribution of associated
impairments by gestational age except for epilepsy being
present in a higher proportion of children born at term
(po0.01 vs. children born o32 weeks) (data not shown).
3.5. CP subtypes
3.5.1. Unilateral spastic CP
Among the 96 children with unilateral spastic cerebral palsy,
the extremities on the right side were affected (right-sided
hemiplegia) in 52 (54%) and on the left side (left-sided
hemiplegia) in 44 (46%) children. There were no major
differences in right and left unilateral CP in cognitive
development, speech abilities, vision, hearing, epilepsy or
feeding. Fine motor function of the non-affected hand was
normal in all children classified as right unilateral CP.
However, in the children classified as left unilateral CP, the
function in the non-affected hand was impaired in six (14%)
(po0.05 vs. right unilateral).
3.5.2. Bilateral CP
Among children with bilateral spastic CP, more severe
impairments in gross motor function were associated with
increasing birth weight (Fig. 1a; Spearman’s r ¼ 0.20; po0.05)
and decreasing Apgar score at 5 min (Spearman’s r ¼ 0.20;
po0.05), however not with gestational age (Fig. 2a; Spear-
man’s r ¼ 0.16; p ¼ 0.09) or with Apgar score at 1 min (Spear-
man’s r ¼ 0.10; p ¼ 0.25).
More severe impairments in fine motor function were
associated with increasing birth weight (Fig. 1b; Spearman’s
r ¼ 0.32; po0.01) and gestational age (Fig. 2b; Spearman’s
r ¼ 0.34; po0.01), with decreasing Apgar score at 5 min
(Spearman’s r ¼ 0.20; po0.05), but not with Apgar score at
1 min (Spearman’s r ¼ 0.07; p ¼ 0.44).
Among children with spastic bilateral CP 25 (71%) of 35
children born before 32 weeks of gestation had normal IQ
compared with 12 (34%) of 35 children born at term (po0.01).
Thirty-seven (84%) of 44 children born before 32 weeks had
normal or only slightly impaired speech compared with 17
(40%) of 43 children born at term (po0.01).
Among the children with spastic bilateral CP, 99 were
diplegic and 44 were quadriplegic. Instead of using these
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Table 4 – Severity of impairments in gross and fine motor function in children with CP by gestational age (GA), birth weight
(BW) and Apgar score
Estimated GMFCSa Estimated BFMFb
I–II N (%) III N (%) IV–V N (%) Total N (%) I–II N (%) III N (%) IV–V N (%) Total N (%)
GA
GA o28 weeks 15 (54) 5 (18) 8 (29) 28 (100) 19 (70) 3 (11) 5 (19) 27 (100)
GA 28–31 weeks 17 (44) 10 (26) 12 (31) 39 (100) 24 (63) 4 (11) 10 (26) 28 (100)
GA 32–36 weeks 24 (57) 8 (19) 10 (24) 42 (100) 23 (54) 7 (16)) 13 (30) 43 (100)
GA X37 weeks 68 (55) 16 (13) 39 (32) 123 (100) 50 (42) 14 (12) 55 (46) 119 (100)
BW
BW o1000 g 14 (64) 3 (14) 5 (23) 22 (100) 15 (71) 3 (14) 3 (12) 21 (100)
BW 1000–1499 g 20 (49) 11 (27) 10 (24) 41 (100) 26 (65) 4 (10) 10 (25) 40 (100)
BW 1500–2499 32 (53) 10 (17) 18 (30) 60 (100) 39 (64) 5 (8) 17 (28) 61 (100)
Vekt X2500 g 79 (58) 19 (14) 39 (29) 137 (100) 58 (44) 18 (14) 57 (43) 133 (100)
Apgar (1 min)
Apgar 0–3 16 (31) 10 (19) 26 (50) 52 (100) 17 (33) 3 (6) 31 (61) 51 (100)
Apgar 4–6 27 (51) 8 (15) 8 (34) 53 (100) 30 (57) 7 (13) 16 (30) 53 (100)
Apgar 7–10 100 (66) 25 (16) 27 (18) 152 (100) 89 (60) 20 (14) 39 (26) 148 (100)
Apgar (5 min)
Apgar 0–3 4 (17) 5 (22) 14 (61) 23 (100) 3 (13) 1 (4) 19 (83) 23 (100)
Apgar 4–6 15 (40) 7 (18) 16 (42) 38 (100) 16 (44) 5 (11) 16 (44) 36 (100)
Apgar 7–10 123 (64) 30 (16) 38 (20) 191 (100) 114 (61) 25 (13) 49 (26) 188 (100)
a GA was available in 232 children, BW in 260, Apgar 1 in 257 and Apgar 5 in 252 children who had their GMFCS assessed.
b GA was available in 227 children, BW in 255, Apgar 1 in 252 and Apgar 5 in 247 children who had their BFMF assessed.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY 12 (2008) 4– 13 9
terms, SCPE has proposed to further describe children with
bilateral CP by their gross (GMFCS) and fine (BFMF) motor
abilities. According to our definition, 87 of the children with
spastic bilateral CP had ‘‘good’’ gross motor function, 76 had
‘‘good’’ fine motor function, 53 had ‘‘poor’’ gross motor and 63
had ‘‘poor’’ fine motor function. Kappa values suggested good
agreement in the classification of children as diplegic or
quadriplegic and ‘‘good’’ or ‘‘poor’’ gross (k ¼ 0.69) or fine
(k ¼ 0.72) motor function.
4. Discussion
In this study, we found that the prevalence of CP as well as the
proportions of subtypes and severity were essentially the
same as in other populations.1,2,7,9,12 However, fine motor
function may be more severely impaired and associated
impairments may be more common in Norway than in some
other populations.7,14,15 The different proportions of dyski-
netic CP reported in other studies are probably due to
differences in classification. The severity of gross motor
function was not associated with gestational age or birth
weight. In contrast, the severity of fine motor impairment
increased with increasing gestational age and birth weight.
The impairments of both fine and gross motor function
increased with decreasing Apgar scores.
To standardise the recordings as much as possible, the
reporting clinicians were thoroughly informed of the SCPE
guidelines on definition and subclassification in a number of
meetings and by receiving the R&T Manual. It may thus be
considered a strength of the study that the assessments of
the children were done by these clinicians who themselves
examined the patients. The prospective recording of perinatal
data is another strength of the study making information or
recall bias unlikely. It may be considered a limitation of the
study that we received individual data on only 79% of the
children. However, only six (2%) parents refused to let details
of their child be recorded. Lack of data was mainly (67%) due
to poor response from 4 of the 20 counties. Thus, selection
bias is less likely and we consider the data on distribution of
subtypes and severity to be representative of the total CP
population in Norway.
The prevalence of CP has been reported to vary between 1.5
and 3 per 1000 live borns, and our results are consistent with
this.1,2,7,9,12 Due to the public and homogenous organisation
of the care for handicapped children in Norway, we consider
the ascertainment of cases to be complete, however, we
cannot rule out that we have missed a few cases.
The proportion of children with various subtypes of CP in
this study was essentially similar to the proportions reported
in other studies.7,12,14,21
In children with unilateral spastic CP it may be noteworthy
that children with paresis of the left side more often than
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Table 5 – Associated impairments in 294 children with CP
CP subtypes
Unilateral N (%) Bilateral N (%) Dyskinetic N (%) Ataxi N (%) Not classified N (%) Total N (%)
Mental retardationa
No 75 (89) 72 (61) 7 (47) 5 (56) 6 (43) 165 (69)
Yes 9 (11) 46 (39) 8 (53) 4 (44) 8 (57) 75 (31)
Speech
Normal 85 (90) 78 (56) 0 9 (60) 7 (35) 179 (62)
Impaired, understandable 7 (7) 13 (9) 2 (7) 4 (27) 2 (10) 28 (10)
Severely impaired/no 2 (2) 49 (35) 17 (90) 2 (13) 11 (55) 82 (28)
Visionb
Normal/impaired 91 (98) 120 (92) 19 (100) 15 (100) 16 (89) 261 (95)
Severely impaired 2 (2) 11 (8) 0 0 2 (11) 15 (5)
Hearingc
Normal/impaired 90 (98) 128 (95) 17 (94) 14 (93) 19 (95) 268 (96)
Severely impaired 2 (2) 7 (5) 1 (6) 1 (7) 1 (5) 12 (4)
Active epilepsy
No 76 (81) 96 (70) 11 (58) 11 (73) 13 (62) 207 (72)
Yes 18 (19) 42 (30) 8 (42) 4 (27) 8 (38) 80 (28)
Feeding
Independent 87 (92) 80 (57) 1 (6) 12 (80) 7 (33) 188 (65)
Dependent 8 (8) 59 (42) 17 (94) 3 (20) 14 (67) 101 (35)
Gastrostomi
No 89 (98) 113 (81) 12 (60) 14 (93) 16 (76) 244 (85)
Yes 2 (2) 26 (19) 8 (40) 1 (7) 5 (24) 42 (15)
a Mental status was unknown in 42 children, 8 of these had unilateral, 19 bilateral, 3 dyskinetic, 6 ataxic and 6 unclassified CP.
b Vision was unknown in 13 children, 1 had unilateral, 10 bilateral and 2 unclassified CP.
c There were 1 unknown in the unilateral, 8 in the bilateral and 1 in the dyskinetic group.
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children with paresis of the right side had impaired hand
function on the non-affected side. Other authors have also
reported that children with hemiplegia may have impairment
in bimanual coordination beyond their unilateral impair-
ments, although they did not report differences between
paresis on the left- and the right side.22 It may thus be
questioned whether such children should indeed have been
classified as bilateral CP; however, impairments of the non-
affected side were mild in our study.
Children with bilateral spastic CP were further charac-
terised by the severity of motor impairments and by using the
traditional diagnoses of diplegia and quadriplegia. When we
compared these two different ways of characterising children
with bilateral CP, we found good agreement in the classifica-
tion of children with less severe motor impairments (i.e.
GMFCS or BFMF levels I–III) and diplegia, and between those
with more severe motor impairments (i.e. GMFCS or BFMF
levels IV–V) and quadriplegia. However, the proportion of
children with quadriplegic CP in our study (15%) was lower
than reported in one study from Australia (32%),12 whereas it
was higher than in two studies from western Sweden (6% and
10%, respectively).7,9
That different classifications explain the different propor-
tions of quadriplegic and dyskinetic cases is also supported by
the differences in proportions of unclassified cases, which
was 7% in our compared with none in the Swedish
studies.6,9,11 Moreover, the children with non-classified CP in
our study had gross and fine motor function and occurrence
of associated impairments similar to children with spastic
bilateral or dyskinetic CP. It is therefore likely that some of the
children in the unclassified group are children with dyskinetic
CP and spasticity, and that the reporting clinician had
difficulties in deciding on the most dominating symptom in
cases of mixed forms. Thus, our results suggest that the
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Fig. 1 – Severity of CP and birth weight. (a) Gross motor
function classification (GMFCS) and birth weight (grams) in
children with spastic bilateral CP. Birth weight is shown in
four categories on the x-axis. The y-axis shows percent of
children with estimated GMFCS levels I–II (less severe
impairment), III (intermediate impairment) and IV–V (most
severe impairment). (b) Bimanual fine motor function (BFMF)
and birth weight (grams) in children with spastic bilateral
CP. Birth weight is shown in four categories on the x-axis.
The y-axis shows percent of children with estimated BFMF
levels I–II (less severe impairment), III (intermediate
impairment) and IV–V (most severe impairment).
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Fig. 2 – Severity of CP and gestational age. (a) Gross motor
function classification (GMFCS) and gestational age (GA) in
children with spastic bilateral CP. Gestational age is shown
in four categories on the x-axis. The y-axis shows percent of
children with estimated GMFCS levels I–II (less severe
impairment), III (intermediate impairment) and IV–V (most
severe impairment). (b) Bimanual fine motor function (BFMF)
and gestational age (GA) in children with spastic bilateral CP.
Gestational age is shown in four categories on the x-axis:
o28, 28–31, 32–36 and X37 weeks. The y-axis shows
percentage of children with estimated BFMF levels I–II (less
severe impairment), III (intermediate impairment) and IV–V
(most severe impairment).
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discrimination between these two subtypes as proposed by
SCPE is still a challenge to clinicians.
Only 8% of the children were not able to walk or to sit even
with support, assessed as GMFCS V in our study. Other studies
have reported higher proportions of children with GMFCS
level V.9,11,12
Few studies have so far described fine motor function using
BFMF. We found a somewhat higher proportion (35%) of
children with BFMF levels IV and V than the 26% reported by
Himmelmann et al.7 This may mainly be due to differences in
the recording of the data, since BFMF levels in our study were
estimated from descriptions of fine motor function in each
hand separately, whereas in the study of Himmelmann et al.,7
the reporting physicians estimated BFMF levels directly.
Moreover, our children were born in 1996–1998 while Him-
melmann et al. covered the birth years 1991–1998.7
In the present study, the proportion of children without any
associated impairment was 28%. Himmelmann et al.7 re-
ported 48% of children with CP to be without associated
impairment; however, they did not include speech impair-
ment. When we excluded speech impairments, we found that
34% of the children had no associated impairment, which is
still lower than reported by Himmelmann et al.7
There are few reports on speech abilities and language
understanding in children with CP. However, the proportion
(28%) of children with severely impaired or no speech in our
study was higher than the 20% reported in two previous
studies.14,15 Eleven percent of the children used graphic
communication, a higher proportion than reported by Chan
et al. (3%).14 The age of the children and the distribution of
subtypes is very similar to Chan, but in their study, parents
were the informants, in contrast to health professionals in
our study. Whereas health professionals may report children
who have the necessary equipment, however using this
equipment only in specific training sessions, parents are
likely to report daily use of communication aids.23 This may in
part explain the differences. The severity of associated
impairments increased with increasing gross and fine motor
impairment, as observed by Himmelmann et al.7
Although children born before week 28 of gestation had a
substantial increased risk of getting CP, they comprised only
12% of the total CP population. The major part of children
with CP was born at term, consistent with most other
studies.11,21,24,27 However, a Swedish study reported that only
35% of children with CP born between 1991 and 1993 were
born at term.9
More severe impairments in both fine and gross motor
function were associated with low Apgar scores, consistent
with Moster et al.28 However, whether severe perinatal stress
is the cause, or whether newborns with more severe brain
damage tolerate the stress of birth less well, cannot be
answered in this study. Moreover, the severity of gross motor
impairment was not associated with gestational age or birth
weight, whereas severity of fine motor impairment increased
with increasing gestational age and birth weight. These
findings could be due to variations in the timing and
mechanisms of the insult leading to different subtypes of
CP with different degrees of severity. However, similar results
were observed when we restricted the analyses to children
with bilateral CP. The findings may therefore, at least partly,
be explained by the hypothesis of selective vulnerability of
the periventricular regions of the brain in the 24–34 weeks of
pregnancy (watershed areas), and by assuming that children
with CP born prematurely have an injury to the brain limited
to these areas and therefore have better gross and fine motor
function and lesser degree of associative impairments.25,26
The children with bilateral CP born at term with evidence of a
peri- or neonatal hypoxic ischemic event, however, are at risk
of more extensive brain injury including the grey matter,
cortex and central nuclei and therefore more severe CP
involving both upper and lower limbs.25,26 Our results may
thus be consistent with the current opinion that both
perinatal stress as well as the timing of an insult play
significant roles in determining the severity of impairments
in motor function.29
We found no differences in the distribution of associated
impairments by gestational age except for epilepsy being
present in a higher proportion of children born at term. Also
Himmelmann et al.7 found that a higher proportion of
children born at term had epilepsy, however, they found that
children born o28 weeks of gestation had the highest
proportion of all other accompanying impairments. However,
when we restricted the analyses to children with the spastic
bilateral subtype, we found that more children born at term
had mental retardation and severely affected communicative
abilities than children born o32 weeks of gestation, and that
more severe gross and fine motor function impairment
indicated increasing degree of severity of associative impair-
ments. Again, this may be explained by different vulnerability
of the immature and the mature brain.25,26
In conclusion, the prevalence of CP in Norway as well as the
proportions of subtypes and severity were essentially the same
as in other populations.1,2,7,9,12 However, fine motor function
may be more severely impaired and associated impairments
more common in Norway than in some other populations.7,14,15
The severity of gross motor function was associated with low
Apgar score at 1 and 5 min but not with gestational age or birth
weight. In contrast, the severity of fine motor impairment
increased with increasing gestational age and birth weight, and
with decreasing Apgar score at 1 and 5 min.
The classification of CP proposed by SCPE, supplemented by
a description of gross and fine motor function, was a useful
tool for recording and describing the panorama of CP in
Norway, but the classification of children with mixed forms
remains a challenge.
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AIM To study whether breech presentation is a risk factor for cerebral palsy (CP).
METHODS Perinatal data from 177 272 children born in breech or vertex presenta-
tion in Norway during 1996 to 1998 were retrieved from the Medical Birth Regis-
try of Norway. Data were collected between 1 January 2003 and 31 March 2006.
Data on 245 children with CP were recorded in the Norwegian Cerebral Palsy
Registry. Odds ratios (OR) with 95% conﬁdence intervals (CI) for CP among
children born in breech compared with vertex presentation were calculated.
Confounding was addressed in logistic regression and stratiﬁed analyses.
RESULTS Among the 245 children with CP (46.5% females and 53.5%males), 31%
had unilateral, 49% bilateral, 7% dyskinetic, and 5% the ataxic subtype, and 8%
of cases were unclassiﬁed. Among children born in breech, the OR for CP was
3.6 (95% CI 2.4–5.3). The increased risk was reduced when adjusted for preterm
birth, plurality, and smallness for gestational age. Among singletons born in
breech by vaginal delivery at term, the OR for CP was 3.9 (95% CI 1.6–9.7).
Severity or subtype of CP did not differ between breech and vertex presentation.
INTERPRETATION Breech delivery is a signiﬁcant risk factor for CP, in particular
among singletons born by vaginal delivery at term.
The term cerebral palsy (CP) covers a group of perma-
nent, but not unchanging, disorders of movement, pos-
ture, and motor function, which are due to a non-
progressive interference, lesion, or abnormality of the
immature or developing brain.1 In most cases, the cause
is unknown.
Breech delivery is associated with increased perinatal
morbidity and mortality,2–10 and investigators in the Term
Breech Trial6 and the authors of a Cochrane review7 con-
cluded that planned Caesarean delivery should be preferred
for the term fetus. However, this recommendation has
been challenged.11–16
Few investigators have reported the long-term outcome
of children born in breech presentation.3,6–10,17 In a study
of children born in the 1960s, Nelson and Ellenberg found
that breech presentation was a risk factor for CP, whereas
breech delivery was not.18 In a review of studies published
between 1969 and 1993, Scheller and Nelson did not ﬁnd
clear evidence that Caesarean section reduced the risk of
CP associated with breech presentation.19 However, they
were not able to identify any randomized controlled stud-
ies, and observational studies had insufﬁcient sample size
to address this question appropriately.19
More recently, three studies of the association between
CP and breech delivery had diverging results.3,10,17 In a
case–control study in Turkey, the investigators found no
association;17 in that study a signiﬁcant proportion of
deliveries were home births. In contrast, in two popula-
tion-based studies, one Danish and one Swedish, breech
presentation was found to be a risk factor for CP.3,10
However, whereas the Danish investigators reported the
increased risk to be independent of delivery mode,3 the
results of the Swedish study suggested that CP might
be prevented in some cases by Caesarean section.10
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Differences in obstetric practice, study design, and sample
size may partly explain the diverging results in those previ-
ous studies.
Because breech delivery has been associated with adverse
perinatal outcome, and in light of the Term Breech Trial,6
it may be reasonable to speculate that birth asphyxia could
be part of the causal pathway leading to CP. If this were
the case one would expect lower Apgar scores and more
severe subtypes of CP, such as the dyskinetic–athetoid
form and spastic tetraplegia to be more common in chil-
dren with CP born in breech.20,21 In the Danish study of
singletons born at term, breech delivery was not associated
with these subtypes.3
In the present study, we have used data from a
national CP registry linked with data from the Medical
Birth Registry of Norway (MBRN) to test the hypothe-
sis that breech presentation is a risk factor for CP, inde-
pendent of other risk factors, and to study whether a
possible increased risk is associated with mode of deliv-
ery. We also aimed to assess whether breech presenta-
tion is associated with low Apgar scores and severity or
subtype of CP.
METHOD
Study design
All children born in breech or vertex position in Norway
between 1 January 1996 and 31 December 1998 who sur-
vived the early neonatal period (ﬁrst 7d of life) were
included. Data on maternal health, pregnancy, delivery,
and the early neonatal period were obtained from the
MBRN.
For this cohort, clinical information on CP was col-
lected between 1 January 2003 and 31 March 2006,
when the children were at least 4 years old. Neuro-
paediatric habilitation centres in Norway provided
summary and detailed data, including national identiﬁca-
tion numbers.22
Study population
A total of 177 272 children were eligible, comprising 98%
of all births in Norway during 1996 to 1998.
CP was diagnosed in 374 children, and detailed data
were recorded in 294 (79%). Fifteen children were born
abroad, and perinatal data were missing. Fifteen children
had a postneonatal cause (i.e. more than 28d after birth)22
and were excluded. We were successfully able to match
245 (93%) of the remaining 264 children with CP with
data from the MBRN. The matching was done by the
MBRN using each child’s unique 11-digit personal identi-
ﬁcation number. Thus, the ﬁnal study population com-
prised 177 257 children, of whom 245 had CP (46.5%
females and 53.5%males).
Study variables
Exposure variables
Since 1967, the medical registration of births has been com-
pulsory in Norway, ensuring that obstetric and perinatal
data are recorded prospectively at birth. Covariates
recorded in theMBRN include assisted fertilization, plural-
ity, pre-labour rupture of membrane (any rupture persisting
for more than 24 hours and occurring before the onset of
labour), mode of delivery, gestational age, birthweight, sex,
and smallness for gestational age. Deliverymode is recorded
as vaginal birth or Caesarean section, and Caesarean section
is speciﬁed as planned or emergency. Smallness for gesta-
tional age is calculated by theMBRNas a birthweight below
the 10th centile for the gestational age.23
Gestational age was calculated from the ﬁrst day of the
last menstrual period and was classiﬁed into term (37wks
or more) and preterm (before 37wks). Gestational age was
also analysed as a continuous variable. Information on
gestational age was missing in 9% of all newborns.
Outcome variables
CP was diagnosed according to the deﬁnition and classiﬁ-
cation agreed by the Surveillance of Cerebral Palsy in Eur-
ope in 1999.1,22 Data for each child with CP were
recorded by a senior paediatrician on a standardized form.
Gross and ﬁne motor functions were recorded according
to the Gross Motor Function Classiﬁcation System and
the Bimanual Fine Motor Function scales.22
Ethics
The study was approved by the Regional Ethical Com-
mittee for Medical Research in Mid-Norway and by the
Norwegian Data Inspectorate. The individual registra-
tion of data and linkage to the MBRN required parental
consent.
Statistical methods
The Statistical Package for Social Sciences (SPSS) for
Windows version 16.0 (SPSS Inc, Chicago, IL, USA) was
used for data analyses. Differences in proportions between
groups were analysed using v2 statistics. The signiﬁcance
tests were two-tailed and a signiﬁcance level of 0.05 was
chosen.
We calculated odds ratios (OR) with 95% conﬁdence
intervals (CI) as estimates of the relative risk that a child
born in breech presentation would be diagnosed with CP,
using children born in vertex as reference. The OR is
approximately equal to the relative risk if the outcome of
interest is rare, as is the case in the present study.24
In the assessment of possible confounders we used both
multivariate analyses and stratiﬁcation. Logistic regression
analyses were used to calculate OR adjusted for possible
2 Developmental Medicine & Child Neurology 2009
confounders. We explored a number of possible confound-
ers, applying the hierarchical model proposed by Victora
et al. as a conceptual framework.25 A variable was consid-
ered to be a confounder if it could theoretically be associ-
ated with both exposure and outcome. Thus, assisted
fertilization, sex of the child, plurality, gestational age, and
smallness for gestational age were assessed as possible con-
founders. In addition, we also assessed the confounding
effect of being born preterm or at term. Possible effects on
the association between breech presentation and CP were
explored for each possible confounder separately and by
multivariate adjustments. In addition, confounding was
assessed by stratiﬁed analyses among children born at term
and preterm, and among singletons.
RESULTS
Table I shows that 29 children born after breech presenta-
tion (4.5 per 1000 live births) were diagnosed with CP,
compared with 216 children (1.3 per 1000 live births) born
after vertex presentation (OR 3.6; 95% CI 2.4–5.3). The
increased risk was unaffected when adjusted separately for
assisted fertilization and sex, but was reduced when
adjusted for preterm birth, plurality, and smallness for ges-
tational age. Multivariate adjustment only marginally
affected the OR further. Moreover, in stratiﬁed analyses
the increased risk persisted among children born at term
and preterm (Table I).
Table II shows that among singletons with CP 24
children were born in breech presentation compared
with 180 children in vertex (OR 4.1; 95% CI 2.7–6.3).
Among singletons with CP, for those born at term nine
children were born in breech compared with 99 in ver-
tex (OR 3.0; 95% CI 1.5–5.9), whereas for those born
preterm 12 children were born in breech compared with
64 in vertex (OR 2.6; 95% CI 1.4–5.0). Analyses strati-
ﬁed by mode of delivery showed that for vaginal breech
delivery the increased risk for CP was conﬁned to chil-
dren born at term, whereas for those delivered in
breech by Caesarean section the increased risk was only
statistically signiﬁcantly increased among children born
preterm (Table II).
When we restricted the analyses to breech deliveries
only, the relative risk for CP was 1.7 (95% CI 0.5–6.4)
among singletons born at term vaginally compared with by
Caesarean section.
No statistically signiﬁcant differences were observed in
subtype or severity of CP between children born after
breech or vertex presentation (Table III).
Table IV shows that a higher proportion of children
with CP born in breech than in vertex had low Apgar
scores at 1 minute (p=0.040). There were no statistically
signiﬁcant differences between the groups in sex,
plurality, gestational age, Apgar scores at 5 minutes,
birthweight, pre-labour rupture of membranes, or
abruptio placentae (Table IV).
Among children born in breech, 479 (7%) had a congen-
ital birth defect compared with 4851 (3%) in children born
in vertex (OR 2.7; 95% CI 2.4–3.0).
Table I: Crude and adjusted odds ratio (OR) with 95% confidence intervals (CI) for cerebral palsy (CP) among children born in breech
All live births Term birtha Preterm birtha
CP,
n
Not CP,
n OR (95% CI)
CP,
n
Not CP,
n OR (95% CI)
CP,
n
Not CP,
n OR (95% CI)
Birth presentation
Breech 29 6 384 3.6 (2.4–5.3) 9 4 857 2.6 (1.3–5.1) 17 975 2.0 (1.2–3.4)
Vertex 216 170 628 1.0 103 144 169 1.0 90 10 455 1.0
OR adjusted separately for:
Assisted fertilization 3.4 (2.3–5.0) 2.6 (1.3–5.1) 2.0 (1.2–3.4)
Sex 3.6 (2.4–5.3) 2.6 (1.3–5.1) 2.1 (1.2–3.5)
Plurality 2.3 (1.6–3.6) 2.5 (1.2–4.9) 1.8 (1.0–3.1)
Gestational age 2.9 (1.9–4.3) 2.5 (1.2–4.9) 2.2 (1.3–3.6)
Smallness for gestational ageb 3.3 (2.2–4.9) 2.4 (1.2–4.7) 1.9 (1.1–3.3)
Preterm birth 2.2 (1.5–3.4) NA NA
Multivariate adjustments 2.1 (1.3–3.2)c 2.3 (1.2–4.7)c 1.9 (1.1–2.4)c
2.2 (1.5– 3.3)d 2.4 (1.2– 4.9)d 1.9 (1.1–3.2)d
aInformation on gestational age was missing for 552 children (9%) in breech and 16 004 (9%) in vertex. bSmallness for gestational age was
recorded in the Medical Birth Registry of Norway for children born at gestational age >28wks. cAdjusted for assisted fertilization + sex +
plurality + gestational age. dAdjusted for assisted fertilization + sex + plurality + gestational age + smallness for gestational age. NA, not
available.
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DISCUSSION
We found that breech presentation is a signiﬁcant risk fac-
tor for CP, in particular among singletons born by vaginal
delivery at term. Breech presentation was not associated
with speciﬁc subtypes of CP or with the extent of ﬁne or
gross motor impairments.
For the comparison of differences in CP subtypes and
motor impairments, and when we restricted the analyses to
breech deliveries, the numbers were low, as is the case in
most other studies.3,12,18–20 Lack of statistically signiﬁcant
differences between groups must therefore be interpreted
with caution. This is of particular relevance for the sub-
analysis restricted to children born in breech where we
compared the association between CP and mode of deli-
very (vaginal vs Caesarean section). However, our ﬁnding
of a trend towards increased risk for CP among singletons
born at term in breech by vaginal delivery compared with
those delivered by Caesarean section may be noteworthy,
and it may be consistent with the largest study so far, the
study from Sweden by Thorngren-Jerneck and Herbst.10
The diagnosis of CP was standardized in accordance
with European guidelines,1 and all children were at least 6
years old when the diagnosis was conﬁrmed. However,
detailed information was missing for 80 children (21%). It
is very unlikely that birth presentation differed systemati-
cally between children with or without detailed informa-
tion on CP.22 However, those 80 children were
misclassiﬁed into the group without CP, although in com-
parison with the total number of children in that group the
number of misclassiﬁed children is negligible.
The prospective recording of perinatal data is a speciﬁc
strength, making information bias unlikely. The results of
the multivariate analyses as well as the stratiﬁed analyses
suggest that our results are unlikely to be due to con-
founding by preterm birth, plurality, sex, or fetal growth
restriction.
In general, we found strong effects of breech presenta-
tion on the risk of CP. Most noteworthy was the fourfold
increased risk among singletons born at term and delivered
vaginally, which may be consistent with a causal relation-
ship.
Our results are consistent with two other cohort stud-
ies.3,10 In one study from Sweden, the investigators found
a threefold increased risk of CP in term infants born in
breech presentation between 1984 and 1998,10 whereas in
a study from Denmark only a borderline increased risk was
found among children born at term between 1979 and
1986.3 In contrast, in a recent case–control study from
Turkey no association was found between birth presenta-
tion and risk of CP.17 In addition to the difference in study
designs, more than 50% of the children with CP in the
Turkish study were born at home, which may have
obscured a possible increased risk associated with breech
delivery.
Table II: Crude and adjusted odds ratio (OR) with 95% confidence intervals (CI) for cerebral palsy among singeltons born in breech
All singletons Singletons born at term Singeltons born preterm
CP,
n
Not CP,
n OR (95% CI) CP, n
Not CP,
n OR (95% CI) CP, n
Not CP,
n OR (95% CI)
Birth presentation
Breech
All 24 5394 4.1 (2.7–6.3) 9 4329 3.0 (1.5–5.9) 12 606 2.6 (1.4–5.0)
Vaginal 8 2247 3.3 (1.6–6.7) 5 1826 3.9 (1.6–9.7) 3 239 1.7 (0.5–5.4)
Caesarean section 16 3147 4.7 (2.8–7.3) 4 2503 2.3 (0.8–6.2) 9 367 3.3 (1.6–6.7)
Vertex
All 180 166 128 1.0 99 141 988 1.0 64 6625 1.0
OR adjusted separately for:
Assisted fertilization 4.1 (2.7–6.3) 3.0 (1.5–5.9) 2.7 (1.4–5.0)
Sex (male) 4.1 (2.7–6.3) 2.9 (1.5–5.8) 2.7 (1.5–5.1)
Gestational age 3.3 (2.1–5.2) 2.9 (1.5–5.7) 2.8 (1.5–5.1)
Smallness for gestational agea 4.0 (2.6–6.1) 2.9 (1.4–5.7) 2.6 (1.4–5.0)
Preterm birth 2.8 (1.8–5.2) NA NA
Multivariate adjustments 2.8 (1.8–4.4)b 2.9 (1.4–5.7)b 2.8 (1.5–5.2)b
2.8 (1.7–4.4)c 2.7 (1.4–5.4)c 2.7 (1.4–5.3)c
aSmallness for gestational age only available for gestational age >28wks. bAdjusted for assisted fertilization + sex + gestational age.
cAdjusted for assisted fertilization + sex + gestational age + smallness for gestational age. NA, not available.
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One possible explanation for the increased risk of CP
associated with breech delivery may be that children with
antenatal brain injuries are more likely to be born in breech
presentation. In the present study, the lack of an associa-
tion between breech delivery and a speciﬁc CP subtype
and the higher proportion of children with a congenital
malformation among those born in breech than in vertex
position may support this interpretation. Moreover, this
interpretation may be consistent with the Danish study
whose investigators reported that the risk for CP was inde-
pendent of delivery mode, and with their ﬁnding of a
higher proportion of the diplegic and not the more severe
subtypes of CP among children born after breech presenta-
tion. We found increased risk for CP among all singletons
after breech Caesarean delivery. However, among those
born at term the increased risk was not statistically
signiﬁcant.
Consistent with the larger Swedish study,10 we found a
signiﬁcantly increased risk of CP among children born as
singeltons in breech at term and delivered vaginally,
whereas the trend towards an increased risk among those
in breech delivered by Caesarean section was not statisti-
cally signiﬁcant. In the larger Swedish study, elective Cae-
sarean section was associated with a signiﬁcantly reduced
risk of CP. Thus, we may speculate that another possible
explanation for the increased risk of CP could be that
infants born in breech presentation are more likely to suf-
fer from peripartal asphyxia. We found that children born
in breech with CP had lower Apgar scores at 1 minute, but
not at 5 minutes. In the Danish study the authors found
that breech delivery was associated with low Apgar scores
at 5 minutes,3 whereas investigators in a more recent
Dutch study found that more children born in breech had
low Apgar scores at 1 minute, but not at 5 minutes.26
However, a low Apgar score may also be a more common
ﬁnding in a child with an antenatal brain insult.
Both the investigators in the Term Breech Trial6 and the
authors of a Cochrane review from 20037 concluded that
plannedCaesarean sections in term breech deliveries reduce
peri- or neonatal death and serious neonatal morbidity.
However, more recent studies have indicated that vaginal
delivery of selected fetuses in breech presentation can be
safely pursued, under speciﬁc guidelines for eligibility and
Table IV: Perinatal information in children with cerebral palsy
according to birth presentation
Breech
presentation
n=29
Vertex
presentation
n=216 p value
Sex, n (%)
Male 13 (45) 118 (55%)
Female 16 (55) 96 (45%) 0.320
Plurality, n (%)a
Singelton 24 (86) 180 (84%)
Plural 4 (14) 35 (16%) 0.79
Gestational age, n (%)b
‡37wks 9 (35) 103 (53%)
<37wks 17 (65) 90 (47%) 0.073
Apgar score at 1min, n (%)c
0–3 7 (26) 43 (20%)
4–6 10 (37) 41 (19%)
7–10 10 (37) 131 (60%) 0.040
Apgar score at 5min, n (%)d
0–3 3 (11) 19 (9%)
4–6 4 (15) 32 (16%)
7–10 20 (74) 159 (76%) 0.94
Birthweight, n (%)e
<1000g 4 (14) 18 (8%)
1000–1499g 7 (24) 32 (15%)
1500–2499g 5 (17) 52 (24%)
‡2500g 13 (45) 113 (53%) 0.408
Pre-labour rupture of
membrane >24h, n (%)
2 (7) 19 (9%) 0.731
Abruptio placentae, n (%) 2 (7) 21 (10%) 0.469
aInformation on plurality missing in two children. bInformation on
gestational age missing in 26 children. cInformation on Apgar
score at 1min missing in three children. dInformation on Apgar
score at 5min missing in eight children. eInformation on
birthweight missing in 33 children without cerebral palsy.
Table III: Subtype and severity of cerebral palsy (CP) among children
born in breech and vertex position
Breech
presentation
n=29
Vertex
presentation
n=216 p value
CP subtype, n (%)
Spastic unilateral 12 (41) 65 (30)
Spastic bilateral 12 (41) 107 (50)
Dyskinetic 4 (14) 13 (6)
Ataxic 0 13 (6)
Unclassiﬁed 1 (3) 18 (8) 0.189
GMFCS, n (%)a
Level I–II 15 (52) 115 (55)
Level III 5 (17) 35 (16)
Level IV–V 9 (31) 59 (28) 0.940
BFMF, n (%)a
Level 1–2 16 (55) 115 (55)
Level 3 5 (17) 17 (8)
Level 4–5 8 (28) 77 (37) 0.198
aInformation on Gross Motor Function Classiﬁcation System
(GMFCS) and Bimanual Fine Motor Function (BFMF) is missing in
seven children in vertex presentation.
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labour management.11–16,27 Although observational studies
do not allow deﬁnite conclusions, our results and those of
the Swedish study10 may be in favour of the conclusions of
the TermBreechTrial and the Cochrane review.
A reasonable interpretation of the results of the present
study and of the current literature may be that both ante-
natal and perinatal factors are responsible for the increased
risk of CP associated with breech presentation. Because
only a minor proportion of children with CP were born
vaginally after breech presentation, and because some of
these few may have suffered an antenatal brain insult, the
proportion of CP cases that theoretically may be prevented
if Caesarean section is performed in all term breech
deliveries is low.
In conclusion, we found that breech presentation is a
signiﬁcant risk factor for CP. The most striking ﬁnding
was a fourfold increased risk for CP in singletons in breech
born vaginally at term. It is possible that a few cases of CP
could have been prevented had Caesarean section been
performed in all cases of term breech delivery, but to clar-
ify this question signiﬁcantly larger multicentre studies are
needed.
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Abstract
Objective. To investigate the association between labor induction and later develop-
ment of cerebral palsy (CP). Design. Registry-based cohort study. Setting. Perinatal
data on all children born in Norway 1996–1998 were obtained from the Medical
Birth Registry of Norway (MBRN). Neurodevelopmental data were collected from
the Norwegian Cerebral Palsy Registry (CPRN). Population. A total of 176,591 chil-
dren surviving the neonatal period. Of 373 children with CP, detailed data were
available on 241. Methods. Unadjusted and adjusted odds ratios (OR) with 95%
conﬁdence intervals (CI) were calculated as estimates of the relative risk that a
child with CP was born after labor induction. Main outcome measures. Total CP
and spastic CP subtypes. Results. Bilateral cerebral palsy was more frequently ob-
served after induced labor (OR: 3.1; 95% CI 2.1–4.5). For children born at term the
association between bilateral CP and labor induction was stronger (OR: 4.4; 95%
CI 2.3–8.6). The association persisted after adjustment for maternal disease, gesta-
tional age, standard deviation score for birthweight (z-score) and prelabor rupture
of membranes (PROM) (adjusted OR: 3.7; 95%CI 1.8–7.5). Among children with
CP born at term, four-limb involvement (quadriplegia) was signiﬁcantly more fre-
quent after induced (45.5%) compared with non-induced labor (8.0%). There was
no signiﬁcant association between labor induction and unilateral CP subtype or
CP in preterm born children. Conclusions. In this study population, we found that
labor induction at term was associated with excess risk of bilateral spastic CP and
in particular CP with four-limb involvement.
Introduction
Cerebral palsy (CP) is the most common physical disabil-
ity in children comprising a heterogeneous group of condi-
tions with different etiological pathways (1,2). The processes
leading to CP are still poorly understood although a num-
ber of antenatal and perinatal risk factors have been studied
(3). Perinatal risk factors and events such as intrapartum as-
phyxia (4), breech presentation (5) and hyperbilirubinemia
(6,7) are of particular interest, since they may theoretically
be preventable.
While the proportion of births following induction of la-
bor has been fairly stable (∼15%) over years in Norway (8),
this proportion has increased in a number of other devel-
oped countries during the last decade (9–12). In the USA,
induction of labor more than doubled between 1990 and
2005 (from 9.5% to 22.3%) (13). Labor is usually induced
for maternal or fetal medical indications, but in the recent
years there has been a trend toward elective labor induction
on maternal request with no medical indications (14–16).
Such practice has been questioned (17) due tomounting evi-
dence of adverse neurological outcome even among children
born slightly preterm (at 34–36 weeks) (18–20). However,
few studies have addressed induction of labor as a possible
independent risk factor for CP and the results have been con-
ﬂicting. While Nielsen et al. (21) found increased risk of CP
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among children after induction of labor, Gaffney et al. (22)
and Nelson (23) found no such association.
Since CP is a heterogeneous group of disorders, it is likely
that differentCP subtypes have different etiologies.Unilateral
spastic CP in children born at term is most likely caused by
a cerebrovascular insult (24,25). Bilateral spastic CP, mainly
diplegia, is more common among preterm born children
(3,26,27). Ataxic subtypes are more likely caused by brain
maldevelopment (28), while dyskinetic and quadriplegic CP
are associated with acute perinatal hypoxia (29,30). Thus,
in the search for speciﬁc causes and risk factors for CP, it
is important to study possible associations with speciﬁc CP
subtypes.
In this study, we aimed to study labor induction as an
independent risk factor for CP in general, and for unilateral
and bilateral spastic CP in particular.
Material and methods
In this registry-based cohort study, we linked data from the
Medical Birth Registry of Norway (MBRN) with data from
the Norwegian Cerebral Palsy Registry (CPRN). Data from
the two registries were matched by the MBRN using each
child’s unique 11-digit personal identiﬁcation number. An
unchanged birth notiﬁcation form was in use from 1967 to
1 December 1998. Notiﬁcation is mandatory and data on
each pregnancy are recorded on standard forms by birth
attendants within one week of delivery for all deliveries after
16 weeks of gestation. The record includes information about
the mother’s health before and during pregnancy as well as
data on labor and characteristics of the newborn within the
ﬁrst week after delivery.
The CPRN has recorded data on all children born in Nor-
way with CP since 1996 (31). Brieﬂy, this is an informed con-
sent based registerwhere all the 19 child rehabilitation centers
in Norway provide detailed clinical data on children with CP.
These centers serve all children with neuro-developmental
disabilities in Norway. To ensure ascertainment of all cases,
the centers provide summary data on how many children
with CP are identiﬁed at each center. The detailed clinical
data include subtypes of CP, severity of motor dysfunction
and associated impairments.
In all 177,272 children were born in Norway during
1996–1998. Among these children, data weremissing for 293,
and 388 children died in the perinatal period. Thus, the total
study population comprised 176,591 children who survived
the early neonatal period.
Based on summary data, 373 childrenwere diagnosedwith
CP among all children born 1996–1998 (prevalence: 2.0 per
1000 births). The CPRN has collected detailed clinical data
on 293 (79%) of all children with CP. Among the 80 missing
cases, parents of only eight (2%) children refused to par-
ticipate while some participating centers could not provide
detailed data on 72 cases due to work overload. Among the
remaining 293 children, we could not technically merge data
with the MBRN in 22 cases, 15 children were born abroad
and another 15 children had a post-neonatal etiology and
were excluded from the study, leaving 241 children with CP
for further analysis.
The outcome variable, CP, was deﬁned as a ‘group of per-
manent and non-progressive disorders of movement and
posture caused by a central nervous lesion, damage or
dysfunction originating early in life’ according to the deﬁ-
nition proposed by the European CP network, Surveillance
of Cerebral Palsy in Europe (SCPE) (32). Applying these cri-
teria, unilateral spastic CP involves one side of the body and
includes hemiplegia or hemiparesis. In bilateral spastic CP
both sides of the body are involved. Furthermore, we used
the Swedish classiﬁcation to divide bilateral CP into diple-
gia (lower limbs most affected) and quadriplegia (four limbs
affected with upper limbs more affected) (33,34). The diag-
nosis was conﬁrmed by a child neurologist when a child was
at least 4-year old before inclusion in CPRN. Mean age at
conﬁrmed diagnosis was 6.9 years.
As exposure variable, we studied induction as a dichoto-
mous yes/no variable. Induction of labor is recorded in the
MBRN as amniotomy, oxytocin (Syntocinon R©) infusion and
prostaglandin analogues. Data on dosages or sequence of
procedures were not detailed enough to study each induc-
tion method separately and we therefore decided in the main
analyses andpresentation of the results to exclude caseswhere
cesarean section was listed as the method of induction. How-
ever, we have also analyzed our data including cases where
cesarean section was listed under labor induction.
Other, in theMBRN available variables, includedmaternal
diseases such as diabetes, anemia, hypertension, preeclamp-
sia, eclampsia, epilepsy, thyroid dysfunction, chronic renal
disease, urinary tract infection, venereal diseases and rubella.
In the present study, we have studied each maternal dis-
ease separately as well as maternal disease as a group. As-
sisted fertilization included in-vitro fertilization (IVF) and
intra-cytoplasmic sperm injection (ICSI)methods. Congeni-
talmalformationsdetected in theﬁrstweekof life are reported
in theMBRN. Gestational age (GA) is recorded in completed
weeks based on the last menstrual period (LMP) and was in-
cluded in the multivariable analyses as a continuous variable
as well as dichotomized in preterm birth (i.e. born before 37
completedweeks) and term (i.e. equal to or above 37weeks of
gestation). Birthweight is recorded in the birth registry and
we calculated standard deviation scores (z-score = (actual
birth weight − mean)/standard deviation (SD)) for birth-
weight, corrected for GA and sex, using Norwegian reference
curves (35). The z-score as a continuous variable was used
as a proxy for fetal growth. In addition, small-for-gestational
age (SGA), recorded in the registry as a birthweight of less
than the 10th percentile for GA adjusted for sex and parity,
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was used as another approach to study fetal growth restric-
tion. Moreover, we also deﬁned large-for-gestational age as a
birthweight z-score higher than +2 SD.
Prolonged prelabor rupture of membranes (PROM) was
deﬁned as rupture of membranes 24 hours or longer prior to
delivery. Preterm prelabor rupture of membranes (PPROM)
was deﬁned as rupture of membranes earlier than 37 weeks
of gestation. Finally, Apgar scores at 1 and 5 minutes are
recorded in the birth registry, and we categorized the scores
into three groups; (group 1: 0–3, group 2: 4–6 and group 3:
7–10).
The study was approved by the Norwegian Data Inspec-
torate and theRegional Ethical Committee (REC) formedical
research in the Central Norway Regional Health Authority.
Written informed consent was obtained from the parents to
record detailed data in the register and to link data from
CPRN with data from the MBRN. Ethical approval for the
CPRNand linking to the birth registerwas granted byNorwe-
gian Data Inspectorate and the Regional Ethical Committee
(REC) for medical research in Mid-Norway; reference num-
ber: 046–02 (2002).
Statistical analyses
Data analyses were conducted using the Statistical Package
for Social Sciences (SPSS) version 17. Chi-squared statistics
or Fisher’s exact test were performed to explore differences
in proportions. Logistic regression analyses were used to cal-
culate crude and adjusted odds ratios (OR) with 95% conﬁ-
dence intervals (CI) for CP among children born after labor
induction compared with children born after non-induced
labor.
Covariates evaluated as possible confounders were selected
based upon theoretical considerations as well as upon bi-
variate statistical analyses. The variables were entered in the
model according to the conceptual hierarchal framework ap-
proach proposed by Victora et al. (36). Brieﬂy, according to
this framework, variables are included by ﬁrst adjusting for
the variable beingmost apart and ‘ahead’ of the relevant expo-
sure in a time-line leading to the outcome. In this study, this
was considered to bematernal age and parity. However, none
of these factors had any effect on the OR. Then, the next vari-
ablewouldbematernal disease, assisted fertilization,multiple
pregnancy, child’s sex, congenitalmalformations, preeclamp-
sia, fetal lie, prolonged rupture of membranes, SGA or LGA
then preterm birth, in this order. Finally, risk factors that
changed the OR by at least 10% were included in our mul-
tivariable model. We also explored if these variables could
be confounders of the association between CP and labor in-
duction in term and preterm born children separately. Apgar
scores at 1 and 5 minutes were not included as potential
confounders as it is likely to be an intermediate variable. A
p-value of <0.05 was chosen as the level of signiﬁcance
Results
Table 1 displays the prevalence of some risk factors for chil-
dren with and without CP. Induction of labor had been
performed in 24.1% of children with CP compared with
13.4% among children without CP (p < 0.001).
Table 2 shows the distribution of some risk factors in births
after labor induction compared to non-induced births. Bi-
lateral spastic CP was more frequent after labor induction
Table 1. Occurrence (%) of risk factors for cerebral palsy (CP) in CP births and non-CP births, Norway 1996–1998.
CP (n = 241) Controls (n = 176,350)
n (%) n (%) p−value
Maternal disease 104 (43.2%) 38,837 (22.0%) <0.001
Nulliparity 105 (43.9%) 71,271 (40.5%) 0.29
Assisted fertilization 13 (5.4%) 2,011 (1.1%) <0.001
Multiple pregnancy 20 (8.3%) 2,747 (1.6%) <0.001
Boys 126 (52.3%) 90,920 (51.6%) 0.85
Congenital malformations 8 (3.3%) 5,183 (2.9%) 0.70
Pre-eclampsia 12 (5.0%) 5,640 (3.2%) 0.14
Preterm birth 105 (48.8%) 11,349 (7.1%) <0.001
SGA∗ 34 (14.1%) 12,075 (6.8%) 0.07
LGA 9 (4.7%) 6,282 (4.1%) 0.59
Breech 27 (11.2%) 6,249 (3.5%) <0.001
PROM/ PPROM 24 (10.0%) 2,860 (1.6%) <0.001
Labor induction 58 (24.1%) 23,543 (13.4%) <0.001
Placental abruption 21 (8.7%) 933 (0.5%) <0.001
Low Apgar score∗∗ 23 (12.8%) 818 (0.5%) <0.001
Note: ∗SGA: Small for gestational age, recorded only for pregnancies >28 weeks.
∗∗Low Apgar is deﬁned as Apgar score of 3 or less at 5 minutes after birth compared with Apgar score of 7 or higher.
PROM, Prelabor rupture of membranes ≥24 hours before delivery.
PPROM, Preterm prelabor rupture of membranes ≥24 hours before delivery.
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Table 2. Occurrence (%) of risk factors for cerebral palsy in births after labor induction compared with non-induction, Norway 1996–1998.
Induction (n = 23,601) No induction (n = 176,350)
n (%) n (%) p−value
Maternal disease 9,309 (39.4%) 29,632 (19.4%) <0.001
Nulliparity 11,006 (46.8%) 60,370 (39.6%) <0.001
Assisted fertilization 490 (2.1%) 1,534 (1.0%) <0.001
Multiple pregnancies 842 (3.6%) 1,925 (1.3%) <0.001
Boys 12,834 (54.6%) 78,212 (51.1%) <0.001
Congenital malformation 1,063 (4.5%) 4,128 (2.7%) <0.001
Pre-eclampsia 3,229 (13.7%) 2,423 (1.6%) <0.001
Preterm birth 3,073 (14.6%) 8,381 (6.0%) <0.001
SGA∗ 2,390 (10.1%) 9,719 (6.4%) 0.064
LGA 1,222 (6.3%) 5,069 (3.7%) <0.001
Breech 889 (3.8%) 5,387 (3.5%) 0.058
PROM/PPROM 1,189 (5.0%) 1,695 (1.1%) <0.001
Placental abruption 368 (1.6%) 586 (0.4%) <0.001
Low Apgar∗∗ 408 (1.9%) 433 (0.3%) <0.001
Note: ∗SGA: Small for gestational age, recorded only for pregnancies >28 weeks.
∗∗Low Apgar is deﬁned as Apgar score of 3 or less at 5 minutes after birth compared with Apgar score of 7 or higher.
PROM: Prelabor rupture of membranes ≥24 hours before delivery.
PPROM: Preterm prelabor rupture of membranes ≥24 hours before delivery.
compared with non- induced labor (OR 3.08; CI 2.09–4.54)
(Table 3). Adjustment for maternal disease, GA, z-score for
birthweight and PROM/ PPROM in the samemodel reduced
the OR, but the association between induction of labor and
CP remained signiﬁcant. In contrast, unilateral spastic CP
was not associated with labor induction (Table 3). Multiple
pregnancy, placental abruption and fetal lie were signiﬁcantly
associated with CP but did not affect the association between
labor induction and CP assessed by multiple logistic regres-
sion (data not shown). Maternal age, parity, preeclampsia,
LGA, congenital malformations and the sex of the child were
not associated with CP in this study population (data not
shown).
The OR for bilateral CP when labor induction was per-
formed among children born at termwas 4.42(CI: 2.27–8.59)
compared with an OR of 1.31 among children born preterm.
This risk was marginally reduced after adjustment for con-
founding effect of maternal disease, GA, z-score for birth-
weight and PROM/ PPROM in the same model (OR: 3.65;
CI: 1.78–7.49). For pretermchildren, therewasno association
between CP and induction (Table 4).
Table 5 shows the classiﬁcation of CP in children born
after induced versus non-induced deliveries, according to CP
subtype. Among children with CP born at term (n = 100),
four-limb involvement (i.e. quadriplegia) was signiﬁcantly
more frequent after labor induction (45.5%) compared with
non-induced deliveries (8.0%).
Children born between 37 and 40 gestational weeks had an
OR for bilateral CP (adjusted OR: 3.74; CI: 1.54–9.04) that
was comparable to the OR for children born at 40 weeks of
gestation or more (crude OR: 5.33; CI: 2.24–12.65).
Among children born after labor induction with CP seven
(12%) had Apgar scores equal to or below 3, and eight (12%)
had Apgar scores between 4 and 7. In contrast, among chil-
dren born after labor induction who did not develop CP 410
(1.8%) had Apgar score equal to or below 3, and 330 (1.5%)
had scores between 4 and 7 (p < 0.001 vs. CP-group).
When we re-analyzed our data including cesarean section
as mode of induction, the results were essentially unchanged
or even higher (data not shown).
Discussion
In thisNorwegianbirth cohort,we found that labor induction
at term was associated with an excess risk of bilateral spastic
CP, in particular with the quadriplegic subtype.
The exposure data were recorded prospectively in the
MBRNand theCPdatawere collectedwhen the childrenwere
at least 4 years of age and without knowledge of the expo-
sure data. Thus, the risk of information bias is low. However,
detailed data on 80 children (21%) with CP were missing in
CPRN. The reason for missing cases was mainly work over-
load of the neuropediatricians in some centers, while only
eight families (2%) refused to have their children registered.
Most likely these dropouts were therefore at random, and we
ﬁnd it most unlikely that missing children with CP differed
systematically in mode of delivery from the cases included.
Finally, themisclassiﬁcationof these children as non-CP cases
is negligible compared with the 176,591 other control chil-
dren included. Another potential bias in our study could be
that we excluded cases where cesarean section was listed as
the method of induction in the birth register. However, when
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Table 4. Crude and adjusted odds ratios (OR) with 95% conﬁdence intervals (CI) as estimates of the relative risk that children with bilateral spastic
cerebral palsy were born after labor induction compared with children born without labor induction analyzed separately for children born preterm
and at term, Norway 1996–1998.
Preterm Term
CP Non-CP CP Non-CP
n n OR (CI) p-value n n OR (CI) p-value
Induction of labor 23 3,039 1.31 (0.80–2.16) 0.29 14 17,939 4.42 (2.27–8.59) <0.001
Labor not induced 48 8,310 1.00 23 130,303 1.00
OR for CP after labor induction adjusted separately for:
Maternal disease 1.12 (0.68–1.86) 0.65 4.32 (2.19–8.53) <0.001
Birth weight z-score 1.44 (0.89–2.44) 0.14 3.96 (2.00–7.85) <0.001
SGA∗ 1.33 (0.81–2.20) 0.26 3.91 (2.00–7.64) <0.001
PROM/ PPROM 1.28 (0.77–2.10) 0.34 4.14 (2.10–8.16) <0.001
Gestational age 0.86 (0.56–1.62) 0.86 4.50 (2.31–8.75) <0.001
Multivariable adjustment∗∗: 1.02 (0.61–1.71) 0.94 3.65 (1.78–7.49) <0.001
Note; ∗SGA: Small for gestational age, recorded only for pregnancies >28 weeks.
∗∗Odds ratio for CP after labor induction adjusted for: maternal disease, gestational age, z-score for birth weight and PROM/ PPROM.
PROM, Prelabor rupture of membranes, ≥24 hours before delivery.
PPROM, Preterm prelabor rupture of membranes, ≥24 hours before delivery.
Table 5. Classiﬁcation of CP in children born after induced compared with non-induced labor by gestational age, presented for children born preterm
and at term separately, Norway 1997–1998.
Preterm Term
Induced labor Non-induced labor Induced labor Non-induced labor
n = 34(%) n = 71(%) p-value n = 22(%) n = 88(%) p-value
CP subtype:
Unilateral 5 (14.7) 15 (21.1) 0.60 8 (36.4) 34 (38.6) 1.00
Bilateral
Diplegic 21 (61.8) 35 (49.3) 0.30 4 (18.2) 16 (18.2) 1.00
Quadriplegic 2 (5.9) 13 (18.3) 0.14 10 (45.5) 7 (8.0) <0.001
Dyskinetic 0 3 (4.2) 0.55 0 (0) 12 (13.6) 0.12
Ataxic 1 (2.9) 2 (2.8) 1.00 0 (0) 9 (10.2) 0.20
Not classiﬁed 5 (14.7) 3 (4.2) 0.11 0 (0) 10 (11.4) 0.21
we re-analyzed our data including cesarean section the OR
for CP in the induction group was even higher.
Multivariable analysis showed that the excess risk of CP
persisted after adjustment for a number of potential con-
founders available in the medical birth registry. Moreover,
we controlled for preterm birth by applying stratiﬁed anal-
yses. Nonetheless, confounding by variables not available to
us cannot be excluded.
Results from the few studies addressing the link between
CPand inductionof laborhavebeen conﬂicting (21,22).Con-
sistent with our results, a registry-based study in Denmark
by Nielsen et al. (21) showed that labor induction carried an
excess risk of CP (OR: 2.5). In contrast, Gaffney et al. (22)
in UK found no association (OR: 1.2). The latter study used
data abstracted from hospital records, and was restricted to
children born at term. Both studieswere case–control studies;
however, they did not assess the association between induc-
tion and speciﬁc CP subtypes separately. Thus, differences in
study design and population may partly explain the different
results.
Another signiﬁcant difference between our study and the
previous studies was the considerable difference in the pro-
portion of labor induction in the control groups varying
from 3.2% in the Danish to 25.7% in the British study. In our
registry-based cohort study induction of labor was recorded
in 13.4% of all children and in 17.6% if cesarean section was
included. These differences are most likely explained by vari-
ations in clinical practice.Usually induction of labor follows a
stepwise procedure. The ﬁrst step often involves administra-
tion of cervical ripening agents such as local prostaglandin
88
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E analogues. When the cervix is ripe, the common proce-
dure would be amniotomy followed by oxytocin infusion
(10,37,38).
Labor induction is mainly performed to rescue themother
and the offspring from harmful effects of continuation of
pregnancy such as in maternal disease, restricted or exces-
sive intrauterine growth, prolonged rupture of membranes
and prolonged pregnancy. Since such complications are risk
factors for death in utero, it should be emphasized that in-
duction of labor may have saved lives in some of the cases
with CP, and also that it may have saved other children from
developing CP.
Post-termpregnancies account for a signiﬁcant proportion
of induced deliveries. The deﬁnitions of post-termpregnancy
(41 or 42 completed pregnancy weeks) and the policies of in-
duction (induction at 41 weeks or expectant management)
may vary. Thus, differences in clinical practice may also ex-
plain the different results in different studies (21,22). How-
ever, we found that even children born between gestational
weeks 37 and 40 had higher odds forCP after labor induction,
making this explanation seems less likely.
Even if one should be cautious in a causal inference from
epidemiological studies, some ﬁndings of the present study
may be in favor of such a relation. This applies for the mag-
nitude of the association, indicated by a four-fold increased
risk of CP among children born after labor induction, as well
as the predominance of the quadriplegic spastic CP subtype.
We are only able to speculate on possible mechanisms
leading to CP after labor induction due to lack of detailed
data. One possible mechanism could be that induction of
labor is more often required in children with an antenatal
brain insult. This assumption could be supported by animal
studies showing that labor starts late in pregnancies where
the offspring had an antenatal brain insult (39,40).
Alternatively, induction of labor may directly or indirectly
compromise the child during birth and may lead to, or exag-
gerate, a global brain insult.All drugsused for labor induction
may lead to deceleration of the fetal heart rate, tachycardia
or decreased short-term variability; most likely through hy-
perstimulation of the uterus (10,41,42). Hyperstimulation of
the uterus, or excessive uterine activity, leads to less oxygen
supply to the fetal brain (43) and development of metabolic
acidosis (44). This could be consistent with the lower Apgar
score at 5 minutes observed in the CP group, and is fur-
ther supported by the predominance of the bilateral spastic
subtype with four-limb affection (quadriplegia).
Also in favor of this explanation, studies addressing the
short-term outcome of labor induction have described as-
sociations with neonatal seizures (45) and encephalopathy
(46,47) after labor induction. Encephalopathy and seizures
may be early signs of brain injury and an Australian study
have suggested that newborn encephalopathy is the single
most common precursor of CP at term (48) (49). In a study
by Heimstad et al., induction of labor was associated with
poor outcome measured in terms of low Apgar score, low
pH and hypoglycaemia in the newborn (50). However, in
other studies the association between labor induction and
encephalopathy was not statistically signiﬁcant (22,51).
In conclusion, in this study population labor induction at
term was associated with excess risk of bilateral spastic CP
and in particular CP with four-limb involvement. However,
studies including more detailed clinical data are needed to
explore if induction of labor per se may lead or contribute to
a cerebral insult.
Funding
The study was funded by the Liaison Committee between the
Central Norway Regional Health Authority (RHA) and the
Norwegian University of Science and Technology (NTNU).
Acknowledgements
The authors would like to thank the child rehabilitation cen-
ters in Norway for provision of neurodevelopmental data.
References
1. Aicardi J. Diseases of the nervous system in childhood.
London: Mac Keith Press, 2009.
2. Blair E, Stanley F. Aetiological pathways to spastic cerebral
palsy. Paediatr Perinat Epidemiol. 1993;7:302–17.
3. Nelson KB. Causative factors in cerebral palsy. Clin Obstet
Gynecol. 2008;51:749–62.
4. Rennie JM, Hagmann CF, Robertson NJ. Outcome after
intrapartum hypoxic ischaemia at term. Seminars in fetal and
neonatal medicine. [doi: 10.1016/j.siny.2007.07.006].
2007;12:398–407.
5. Andersen GL, Irgens LM, Skranes J, Salvesen KA, Meberg A,
Vik T. Is breech presentation a risk factor for cerebral palsy?
A Norwegian birth cohort study. Dev Med Child Neurol.
2009;51:860–5.
6. Simard-Tremblay E, Shevell M, Dagenais L. Determinants of
ambulation in children with spastic quadriplegic cerebral
palsy: a population-based study. J Child Neurol.
2010;25:669–73.
7. Reddihough DS, Collins KJ. The epidemiology and causes of
cerebral palsy. Aust J Physiother. 2003;49:7–12.
8. The medical birth registry in Norway. Annual report. Oslo:
Norwegian Institute of Public Health, 2010.
9. Information Services NHS Scotland. NHS board variations
in maternity care and outcomes. Edinburgh: NHS National
Services Scotland, 2005.
10. RCOG Royal College of Obstetricians and Gynaecologists.
Labour Induction, clinical guidlines. 2 edn. London: RCOG
Press, 2008.
11. Robson S, Pridmore B, Dodd J. Outcomes of induced labour.
Aust N Z J Obstet Gynaecol. 1997;37:16–19.
c© 2010 The Authors
Acta Obstetricia et Gynecologica Scandinavica c© 2010 Nordic Federation of Societies of Obstetrics and Gynecology 90 (2011) 83–91 89
Induction of labor and cerebral palsy A. I. Elkamil et al.
12. Le Ray C, Carayol M, Breart G, Gofﬁnet F. Elective induction
of labor: failure to follow guidelines and risk of cesarean
delivery. Acta Obstet Gynecol Scand. 2007;86:657–65.
13. Martin JA, Kirmeyer S, Osterman M, Shepherd RA. Born a
bit too early: recent trends in late preterm births. NCHS Data
Brief. 2009:1–8.
14. Mealing NM, Roberts CL, Ford JB, Simpson JM, Morris JM.
Trends in induction of labour, 1998–2007: a
population-based study. Aust N Z J Obstet Gynaecol.
2009;49:599–605.
15. Simpson KR, Thorman KE. Obstetric “Conveniences”:
elective induction of labor, cesarean birth on demand, and
other potentially unnecessary interventions. J Perinat
Neonatal Nurs. 2005;19:134–44.
16. Lerchl A, Reinhard S. Where are the Sunday babies? II.
Declining weekend birth rates in Switzerland.
Naturwissenschaften. [10.1007/s00114-007-0305-4].
2008;95:161–4.
17. Kramer MS. Late preterm birth: appreciable risks, rising
incidence. J Pediatr. 2009;154:159–60.
18. Petrini JR, Dias T, McCormick MC, Massolo ML, Green NS,
Escobar GJ. Increased risk of adverse neurological
development for late preterm infants. J Pediatr.
2009;154:169–76.e3.
19. Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston
R, et al. The contribution of mild and moderate preterm
birth to infant mortality. JAMA. 2000;284:843–9.
20. Goldenberg RL, Culhane JF, Iams JD, Romero R.
Epidemiology and causes of preterm birth. The Lancet.
2008;371:75–84.
21. Nielsen LF, Schendel D, Grove J, Hvidtjorn D, Jacobsson B,
Josiassen T, et al. Asphyxia-related risk factors and their
timing in spastic cerebral palsy. Br J Obstet Gynaecol.
2008;115:1518–28.
22. Gaffney G, Sellers S, Flavell V, Squier M, Johnson A.
Case-control study of intrapartum care, cerebral palsy, and
perinatal death. BMJ. 1994;308:743–50.
23. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. I.
Univariate analysis of risks. Am J Dis Child. 1985
Oct;139:1031–8.
24. Lee J, Croen LA, Lindan C, Nash KB, Yoshida CK, Ferriero
DM, et al. Predictors of outcome in perinatal arterial stroke:
a population-based study. Ann Neurol. 2005;58:303–8.
25. Nelson KB. Perinatal ischemic stroke. Stroke. 2007;38:742–5.
26. Alberman E. Birth weight and length of gestation in cerebral
palsy. Dev Med Child Neurol. 1963;5:388–94.
27. Polani PE. Prematurity and cerebral palsy. Br Med J.
1958;2:1497–9.
28. Miller G. Ataxic cerebral palsy and genetic predisposition.
Arch Dis Child. 1988;63:1260–1.
29. Himmelmann K, Hagberg G, Wiklund LM, Eek MN,
Uvebrant P. Dyskinetic cerebral palsy: a population-based
study of children born between 1991 and 1998. Dev Med
Child Neurol. 2007;49:246–51.
30. Himmelmann K, McManus V, Hagberg G, Uvebrant P,
Krageloh-Mann I, Cans C, et al. Dyskinetic cerebral palsy in
Europe: trends in prevalence and severity. Arch Dis Child.
2009;94:921–6.
31. Andersen GL, Irgens LM, Haagaas I, Skranes JS, Meberg AE,
Vik T. Cerebral palsy in Norway: prevalence, subtypes and
severity. Eur J Paediatr Neurol. 2008;12:4–13.
32. Cans C. Surveillance of cerebral palsy in Europe: a
collaboration of cerebral palsy surveys and registers. Dev
Med Child Neurol. 2000;42:816–24.
33. Hagberg B, Hagberg G, Olow I. The changing panorama of
cerebral palsy in Sweden 1954–1970. I. Analysis of the general
changes. Acta Paediatr Scand. 1975;64:187–92.
34. Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV.
Cerebral palsy epidemiology: where are we now and where
are we going? Dev Med Child Neurol. 1992;34:547–51.
35. Skjaerven R, Gjessing HK, Bakketeig LS. New standards for
birth weight by gestational age using family data. Am J
Obstet Gynecol. 2000;183:689–96.
36. Victora C, Huttly S, Fuchs S, Olinto M. The role of
conceptual frameworks in epidemiological analysis: a
hierarchical approach. Int J Epidemiol. 1997;26:224–7.
37. ACOG American College of Obstetricians and Gynecologists.
Induction of labor. Obstetrics Gynecol Practice Bull.
2009;107.
38. Care in normal birth: a practical guide. Birth. 1997;24:121–3.
39. Gersting J, Schaub CE, Keller-Wood M, Wood CE. Inhibition
of brain prostaglandin endoperoxide synthase-2 prevents the
preparturient increase in fetal adrenocorticotropin secretion
in the sheep fetus. Endocrinology. 2008;149:4128–36.
40. Liggins GC, Kennedy PC, Holm LW. Failure of initiation of
parturition after electrocoagulation of the pituitary of the
fetal lamb. Am J Obstet Gynecol. 1967;98:1080–6.
41. Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal
misoprostol for cervical ripening and induction of labour.
Cochrane Database Syst Rev. 2010;10:CD000941.
42. Crane JM, Young DC, Butt KD, Bennett KA, Hutchens D.
Excessive uterine activity accompanying induced labor.
Obstet Gynecol. 2001;97:926–31.
43. Peebles DM, Spencer JA, Edwards AD, Wyatt JS, Reynolds
EO, Cope M, et al. Relation between frequency of uterine
contractions and human fetal cerebral oxygen saturation
studied during labour by near infrared spectroscopy. Br J
Obstet Gynaecol. 1994;101:44–8.
44. Bakker PCAM, Kurver PHJ, Kuik DJ, Van Geijn HP. Elevated
uterine activity increases the risk of fetal acidosis at birth. Am
J Obstet Gynecol. [doi: 10.1016/j.ajog.2006.11.035].
2007;196:313e1–e6.
45. Minchom P, Niswander K, Chalmers I, Dauncey M,
Newcombe R, Elbourne D, et al. Antecedents and outcome of
very early neonatal seizures in infants born at or after term.
Br J Obstet Gynaecol. 1987;94:431–9.
46. Adamson SJ, Alessandri LM, Badawi N, Burton PR,
Pemberton PJ, Stanley F. Predictors of neonatal
90
c© 2010 The Authors
Acta Obstetricia et Gynecologica Scandinavica c© 2010 Nordic Federation of Societies of Obstetrics and Gynecology 90 (2011) 83–91
A. I. Elkamil et al. Induction of labor and cerebral palsy
encephalopathy in full-term infants. BMJ. 1995;311:
598–602.
47. Gaffney G, Flavell V, Johnson A, Squier M, Sellers S. Cerebral
palsy and neonatal encephalopathy. Arch Dis Child Fetal
Neonatal Ed. 1994;70:F195–200.
48. Badawi N, Felix JF, Kurinczuk JJ, Dixon G, Watson L, Keogh
JM, et al. Cerebral palsy following term newborn
encephalopathy: a population-based study. Dev Med Child
Neurol. 2005;47:293–8.
49. Dixon G, Badawi N, Kurinczuk JJ, Keogh JM, Silburn SR,
Zubrick SR, et al. Early developmental outcomes after
newborn encephalopathy. Pediatrics. 2002;109:
26–33.
50. Heimstad R, Romundstad PR, Eik-Nes SH, Salvesen KA.
Outcomes of pregnancy beyond 37 weeks of gestation. Obstet
Gynecol. 2006;108(3, Part 1):500–8.
51. Dale A, Stanley FJ. An epidemiological study of cerebral palsy
in western Australia, 1956–1975. ii: spastic cerebral palsy and
perinatal factors. Dev Med Child Neurol.
1980;22:13–25.
c© 2010 The Authors
Acta Obstetricia et Gynecologica Scandinavica c© 2010 Nordic Federation of Societies of Obstetrics and Gynecology 90 (2011) 83–91 91
Paper IV

  
The effects of multiple risk factors on cerebral palsy. A register based study.  
Magne Stoknes MSc, Medical- and PhD-student1,2* , Guro L Andersen MD1, 2,3*, 
Areej I Elkamil MD1,2, Lorentz M Irgens MD PhD4, Jon Skranes MD PhD1,2, 
Kjell Å Salvesen MD PhD1,5, Torstein Vik MD PhD1, 2 
1) Department of Laboratory Medicine, Children's and Women's Health, Faculty of 
Medicine, Norwegian University of Science and Technology, Trondheim, Norway 
2) Department of Paediatrics, St. Olavs Hospital/Trondheim University Hospital. 
3) The Norwegian Cerebral Palsy Registry, Habilitation Center, Vestfold Hospital, 
Tønsberg, Norway 
4) Medical Birth Registry of Norway, Locus of Registry-based Epidemiological 
Research, Department of Public Health and Primary Health Care, University of 
Bergen 
5) National Center for Fetal Medicine, Department of Obstetrics and Gynecology, St. 
Olavs Hospital/Trondheim University Hospital. 
* Shared first authorship 
 
The authors have no financial relationships relevant to this article to disclose. 
 
Keywords: Cerebral palsy, risk factors, interaction, epidemiology, risk. 
Abbreviations: AP-attributable proportion, CI-confidence interval, CP-Cerebral 
palsy, CPRN-Norwegian Cerebral Palsy Registry, ICR-interaction contrast ratio, 
MBRN-Medical Birth Registry of Norway, OR-odds ratio, RF-Risk factor, SGA-
small for gestational age. 
 
Correspondence to Magne Stoknes, e-mail: magne.stoknes@gmail.com or Guro L 
Andersen, e-mail: guro.andersen@siv.no. 
  
Contributor’s Statement Page  
Guro L Andersen and Areej I Elkamil initially explored and analyzed the data, while 
Magne Stoknes performed the final as well as the advanced statistical analyses. 
Guro L Andersen and Magne Stoknes together wrote the first version of the 
paper, and completed the final version. They have contributed equally to the 
completion of the manuscript. 
Lorentz M Irgens was principal responsible for the data from the medical 
birth registry, and contributed significantly to the design of the study as well as 
interpretation of the data. 
Jon Skranes and Kjell Å Salvesen contributed significanly to the 
interpretation of the data, Jon Skranes as neuropaediatrician and Kjell Å Salvesen as 
obstetrician. 
Torstein Vik initiated the project, supervised the analyses, was main 
responsible for the interpretation of the data and drafting the manuscript. 
All authors have contributed significantly to the drafting and critically 
reviewed the final version of the article.
  
ABSTRACT 
 
Objective: To examine the effects of multiple risk factors on cerebral palsy (CP). 
Materials/methods: For 176 591 Norwegian infants born 1996-98 and surviving the 
early neonatal period, data on a number of pre- and perinatal risk factors (RFs) for 
CP were available in the Medical Birth Registry of Norway. For 241 children with 
CP detailed clinical data were available in the Norwegian CP registry.  
Results: 43 (18 %) children with CP had none of the available RFs, 22 % had one, 
51 % had two to four, and 10 % had five or more RFs. The odds ratio for CP 
increased exponentially from 2.4 (CI: 1.6; 3.6) for one to 124 (CI: 59; 258) if six or 
more RFs were registered. For children born at term, 30 % had no RF, and none had 
five or more, while in children born preterm, 9 % had no additional RF and another 9 
% had five or more (p<0.001 vs. term). In both groups, few children shared the same 
combination of RFs. The most detrimental effect was observed for the combination 
of maternal disease and low 5-minute Apgar score, registered in 11.2 % of children 
with CP. The combination of maternal disease and premature birth had an interaction 
contrast ratio of 9.25 (CI: 3.56; 14.94), suggesting biological interaction. 
Conclusions: We found an exponentially increased risk for CP with increasing 
number of RFs. Combinations of RFs were more common in children born preterm 
than at term. However, few children shared the same combination.  
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INTRODUCTION 
Cerebral palsy (CP) comprises a group of disorders of movement, posture and 
motor functions due to non-progressive lesions or abnormalities in the immature 
brain1.  Several authors have proposed that CP probably is the result of a cascade 
of events2-7. These events may be associated with a number of risk factors 
occurring before (i.e. pre-pregnancy risk factors) or during pregnancy, or at birth 
and in the first days of life. A number of pre-pregnancy risk factors has been 
described including maternal age7, parity7,8 and maternal diseases including 
epilepsy9, diabetes7 and thyroid disease9-12. In addition a recent study has 
proposed a genetic background by identifying certain single polymorphisms 
associated with cerebral palsy13. Risk factors occurring early or late in pregnancy 
are assisted fertilization14, male gender7, congenital malformation9-11,15,16, multiple 
pregnancy17,18 and intrauterine growth restriction19 Finally, potential risk factors at 
birth include preterm delivery20,21, breech presentation7,22,23, induction of labour24, 
placental abruption25 and low Apgar score26,27. 
Theoretically each of the above mentioned risk factors may reflect events that 
could either trigger, or be part of a cascade leading to an early brain insult. Blair 
and Stanley, in 1993 concluded that many possible routes may lead to CP, 
however each route contributed only to a small proportion of cases10,11. More 
recently, Keogh and Badawi concluded that the future of CP research lies in 
understanding the complex interactions of multiple risk factors3. In this study, we 
aimed to examine the combined effects of multiple risk factors for CP using data 
from the Norwegian Cerebral Palsy Registry and the Medical Birth Registry of 
Norway. 
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Materials and methods 
Study design 
This register study included all live born children in Norway between 1st of 
January 1996 and 31st of December 1998 surviving the neonatal period. Data on 
risk factors were recorded in the Medical Birth Registry of Norway (MBRN)28, 
and the Norwegian Cerebral Palsy Registry (CPRN) provided clinical data on 
children diagnosed with CP. The MBRN linked their data with the data from 
CPRN using each child`s unique 11-digit personal identification code. The CP 
registry is an informed consent based registry collecting data from the 20 pediatric 
habilitation centers in Norway. Details on the registry have been published 
earlier22. The data used in this study were collected between January the 1st of 
2003 and 31st of March 2006, when the children were at least four years old. 
Study population 
During the study period, 176 591 children survived the early neonatal period, and 
373 of them were diagnosed with CP. Parents of six (2 %) children with CP 
refused to participate, while some participating centers could not provide detailed 
data on 72 cases mainly due to work overload.  Fifteen children with CP were 
born abroad and were not registered by the MBRN. Another 15 children had a 
post-neonatal cause of their CP, and for 22 children the MBRN was not able to 
link the data, probably due to an an error in the 11-digit personal identification 
code. Thus, the final study population comprises 241 children with CP and 
176 350 control children. 
 
6 
 
Study variables 
CP was diagnosed and classified according to the recommendations by the 
Surveillance of Cerebral Palsy in Europe1. 
Among the items of data available in the MBRN, twelve risk factors for CP were 
chosen based on the literature (table 1).  
 Maternal disease  (diabetes, anemia, hypertension, preeclampsia, 
eclampsia, epilepsy, thyroid dysfunction, chronic renal disease, urinary tract 
infection, venereal diseases or rubella),  assisted fertilization (in vitro fertilisation 
and/or intra cytoplasmic sperm injection), plurality (number of children born ≥ 2), 
abnormal placental structure (defined as presence of fibrin or calcium depositions, 
placental oedema, bleeding in placenta, infarction in placenta, necrotic placenta or 
other pathological conditions in placenta), bleeding in pregnancy, small for 
gestational age (SGA, birth weight below the 10th percentile for gestational age), 
abnormal presentation (occipital, abnormal cephalic, breech or transverse 
presentation), rupture of membranes 24 hours or more prelabour, placental 
abruption, induction of labour (use of prostaglandin, oxytocin, amniotomy, sectio, 
methylergonovine/Pathergin or other provocation), Apgar score < 7 at five 
minutes and preterm birth (length of gestation < 37 weeks based on last menstrual 
period). The associations between these risk factors and CP are shown in table 1. 
 
Ethics 
Written informed consent to record detailed data in the register and to link data 
from the MBRN with data from the CPRN was obtained from the parents. The 
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study was approved by the Norwegian Data Inspectorate and the Regional Ethical 
Committee (REC) for medical research in Mid-Norway. 
 
Statistical methods 
Statistical analyses were carried out using SPSS (The Statistical Package for 
Social Sciences) for Windows, version 17.0 (SPSS Inc, Chicago, IL, USA). Sun 
Java was applied to generate the syntax used in SPSS, and Eclipse 3.4.0 for 
Windows was used as compiler.  
Odds ratios (OR) with 95 % confidence intervals (CI) were calculated as estimates 
of the relative risk for CP if a specific risk factor was present, using children 
without this risk factor as reference. Odds ratios were also calculated for the 
combinations of two up to seven risk factors, using children without any of the 
recorded risk factors as reference. We also counted the number of cases with each 
specific combination of risk factors in order to identify if some combinations were 
more common than others. For the most common combinations we estimated their 
combined OR and their interaction using the interaction contrast ratio ICR = OR(
AB ) – OR( BA ) – OR( BA )  + 1 where OR( A B ) denotes the OR for the 
combination of risk factor A and B,  OR( BA ) denotes the OR for the presence of 
A, but not B, and OR( BA )  denotes the OR for the presence of B, but not A. An 
ICR-value above 0 indicates that the odds for CP for a given combination of risk 
factors is higher than the additive effect of each of the factors, and may suggest 
biological interaction. For combinations with a positive ICR we calculated the 
proportion attributable (AP) to interaction as AP = ICR/ OR( AB )29,30. For both 
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ICR and AP the confidence intervals were calculated according to the 
methodology described by Hosmer and Lemeshow (1992)31. 
All analyses were done for the total study population as well as for children born 
at term (≥ 37 weeks) and preterm (< 37 weeks) separately. 
 
RESULTS 
Among all children, 43 (18 %) had no risk factors, 22 % had one, 51 % had two to 
four, and 10 % had five or more risk factors (table 2) . The odds ratio for CP 
increased exponentially (p < 0.001) from 2.4 (CI: 1.6; 3.6) if one risk factor was 
present to 2240 (CI: 138; 36395) if eight of the selected risk factors were present 
(table 2). 
Among children born at term 33 (30 %) had no risk factors, 37 % had one, 33 % 
had two or more, and none had five or more risk factors (table 2). The odds ratio 
for CP increased exponentially (p < 0.001) from 2.6 (CI: 1.6; 4.0) if one risk 
factor was observed to 15.9 (CI: 6.2; 40.7) if four risk factors were observed (table 
2). 
Among children born preterm, 9 % had no additional risk factor (p < 0.001 vs. 
term), 21 % had one, and 70 % had two or more (p <0.001 vs. term) risk factors. 
Overall 9 % had five or more additional risk factors (p = 0.001 vs. term). The 
odds ratio for CP in this group increased exponentially (p < 0.001) from 2.5 (CI: 
1.2; 5.5) if one additional risk factor was present to 340 (CI: 177; 654) if seven 
risk factors were present (table 2). However, only one child with CP had seven 
risk factors in the preterm group, and only two children had six risk factors. 
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Among all children the four most common combinations of risk factors were 
maternal disease and preterm delivery, preterm delivery and induction, maternal 
disease and induction, and maternal disease and 5-minute Apgar score < 7 (table 
3). Maternal disease and 5-minute Apgar score < 7 was the combination with the 
highest OR among both term and preterm born children. The only combination 
with an ICR significantly different from zero was the combination of maternal 
disease and preterm birth (table 3). However, the proportion attributable to 
interaction when these two risk factors were present was not statistically 
significantly different from zero (AP = 0.51, CI: -0.34; 1.35). Among children 
born at term (figure 1) as well as for children born preterm (figure 2) very few 
shared the same combinations of risk factors.
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DISCUSSION 
We found an exponentially increasing risk for CP with increasing number of risk 
factors. The combination of several risk factors was more common among 
children born preterm than among those born at term. However, overall very few 
children shared the same combination of risk factors. The most detrimental effects 
of combined risk factors were observed for the combinations of maternal disease 
and low Apgar score at five minutes, maternal disease and preterm delivery and 
preterm delivery and induction of labour. For the combination of maternal disease 
and preterm delivery we found evidence for biological interaction between the 
two risk factors. 
The increasing risk for CP with increasing number of risk factors as well as for 
specific combinations is unlikely to be due to chance, as indicated by the very low 
p-values. The prospective recording of risk factors is a strength of the study. The 
diagnosis of CP was in accordance with European guidelines1, and all children 
were at least four years old when the diagnosis was confirmed. A potential 
limitation may be that clinical data were missing for 80 children in the CPRN. 
However, the reason for missing cases was mainly work overload on the 
neuropediatricians in some centers, while only six families (2 %) refused to have 
their children registered. We find it most unlikely that perinatal data on children 
with CP differed systematically between neuropediatric centres able and unable to 
provide detailed clinical data. These drop outs were therefore most likely at at 
random. Finally the misclassification of these children as non-CP cases is 
negligible compared with the 176 350 other control children included. The wide 
confidence intervals for ICR and AP, probably due to the fact that very few 
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children shared the same combination of risk factors, suggest that the interaction 
observed should be interpreted with caution. The excess risks for CP associated 
with each risk factor separately (table 1) is consistent with a number of previous 
studies suggesting that our CP population is representative4, 13, 14. 
A number of previous studies have explored risk factors for CP7-9,12-27, however 
we have found only one study addressing the risk associated with combinations of 
risk factors10,11. Consistent with our study, Blair and Stanley found that the risk 
for spastic CP increased exponentially with increasing number of risk factors, that 
risk factors were more common in preterm than in term born children, that some 
combinations increased the risk for spastic CP when occurring together, and that 
each route leading to CP contributed only a small proportion of all cases10,11. 
However, even if they included a number of peri- and neonatal clinical risk factors 
not available to us, the proportion without identified risk factors in their study was 
higher (35 %) than in our study (18 %). This difference may partly be explained 
by differences in design, since their study was a nested case- control study of 
children with spastic CP, but also to differences in the quality and availability of 
the recorded risk factors. 
The high and exponentially increasing ORs associated  with increasing number of 
risk factors may be consistent with the concept of a “causal pathway”, meaning 
that the brain injury leading to CP probably is a consequence of several 
consecutive interdependent events; a cascade of events6. This interpretation may 
also be consistent with our finding of  detrimental effects of the consecutive 
combinations of maternal disease and low Apgar score at five minutes, and of 
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maternal disease and preterm delivery, and in particular with the evidence for 
biological interaction between the latter combination.  
On the other hand, Nelson (2008) has proposed that the multiplicity of risk factors 
in the etiology of CP means that a causal web is a more realistic model4, meaning 
that multiple risk factors converge concurrently without an evident linear causal 
chain32,33. Our finding of a large number of different combinations of risk factors, 
but with increasing risk with increasing number may also be consistent with this 
interpretation. 
Overall, the finding that very few children shared the same combinations of risk 
factors suggests that children may have different vulnerability to different risk 
factors4, and that some children in general are more vulnerable to insults than 
others. Consistent with this, recent studies have reported on associations between 
cerebral palsy and a number of candidate genes4,11,32. Further, familial aggregation 
of CP has been reported in populations with high rates of consanguinity4. Thus, 
we speculate that a child’s immanent vulnerability to one or more adverse events 
in utero or at birth represent be the etiological background of CP. 
Multiple risk factors were present in 70 % of children born preterm and in 90 % if 
prematurity is included.as one of the risk factors. Thus, in preterm children the 
theory of a “causal pathway” may be more probable, since it is reasonable to 
assume that the immature brain (in general) is more susceptible to damage34. In 
contrast, among children born at term only 1/3 of the children had more than one 
risk factor, and in this group individual susceptibility, perhaps explained by gene 
polymorphisms, may play a larger role. Thus, in children born at term the causal 
web- theory may be the best model. 
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In conclusion, we found that the risk for CP increased exponentially with 
increasing number of risk factors. However, few children shared the same 
combination of risk factors. Our results may be consistent with the notion that CP 
in preterm children is the result of a cascade of events while in children born at 
term, the child’s individual vulnerability to an adverse event, may play a larger 
role.   
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Figure 1: The distribution of combinations of risk factors for children with CP 
born at term (1: Maternal disease, 2: Assisted fertilization, 3: Plurality, 4: 
Placental structure, 5: Bleeding in pregnancy, 6: Birth weight below the 10th 
percentile for gestational age (SGA), 7: Abnormal presentation, 8: Rupture of 
membranes 24 hours prelabour, 9: Placental abruption, 10: Induction, 11: 5-
minute Apgar score < 7). 
 
           
  
20 
 
Figure 2: The distribution of combinations of risk factors for children with CP 
born preterm (1: Maternal disease, 2: Assisted fertilization, 3: Plurality, 4: 
Placental structure, 5: Bleeding in pregnancy, 6: SGA (birth weight below the 
10th percentile for gestational age), 7: Abnormal presentation, 8: Rupture of 
membranes 24 hours prelabour, 9: Placental abruption, 10: Induction, 11: 5-
minute Apgar score < 7). 
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